title,cluster
Optimisation of electroporation for biochemical experiments in live cells.,3
Kinetics of sealing for transient electropores in isolated mammalian skeletal muscle cells.,3
Antitumor drug delivery by tissue electroporation.,3
Long duration electroporation for achieving high level expression of glucocorticoid receptors in mammalian cell lines.,3
Electric pulse-induced precipitation of biological macromolecules in electroporation.,3
Electroporation therapy: a new approach for the treatment of head and neck cancer.,3
Localized electroporation: a method for targeting expression of genes in avian embryos.,3
Electroporation therapy of solid tumors.,1
Toxicity of anticancer agents mediated by electroporation in vitro.,3
Assessment of electroporation by flow cytometry.,3
Characterization of single-cell electroporation by using patch-clamp and fluorescence microscopy.,3
Electroporation dynamics in biological cells subjected to ultrafast electrical pulses: a numerical simulation study.,3
Quantitative study of electroporation-mediated molecular uptake and cell viability.,3
Advances in plasmid gene delivery and expression in skeletal muscle.,3
DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening.,3
Single-cell electroporation for gene transfer in vivo.,3
Strategy for increased efficiency of transfection in human cell lines using radio frequency electroporation.,3
Gene transfer into cultured mammalian embryos by electroporation.,3
Introduction of DNA into chick embryos by in ovo electroporation.,3
Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach.,3
Intracellular effect of ultrashort electrical pulses.,3
Electroporation of single cells and tissues with an electrolyte-filled capillary.,3
Prediction and optimization of gene transfection and drug delivery by electroporation.,3
Elevated gastrin secretion by in vivo gene electroporation in skeletal muscle.,3
Electroporation for direct spinal gene transfer in rats.,3
Electrotransformation of Lactobacillus delbrueckii subsp. bulgaricus and L. delbrueckii subsp. lactis with various plasmids.,3
Electroporated intact BY-2 tobacco culture cells as a model of transient expression study.,3
High-efficiency gene transfer into adult fish: a new tool to study fin regeneration.,3
Single-cell electroporation.,3
Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy.,7
Combination of electroporation and DNA/dendrimer complexes enhances gene transfer into murine cardiac transplants.,3
Transdermal insulin delivery using lipid enhanced electroporation.,3
Somatic gene transfer into the lactating ovine mammary gland.,3
Electric gene transfer to the liver following systemic administration of plasmid DNA.,3
In vivo electroporation for genetic manipulations of whole Hydra polyps.,3
Targeted electroporation in Xenopus tadpoles in vivo--from single cells to the entire brain.,3
Using electroporation and lipid-mediated transfection of GFP-expressing plasmids to label embryonic avian cells for vital confocal and two-photon microscopy.,3
A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer.,3
Recovery of adherent cells after in situ electroporation monitored electrically.,3
Efficient genetic modification of murine dendritic cells by electroporation with mRNA.,3
Conditions for gene transfection into the HL-60 human leukaemia cell line by electroporation.,3
Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.,3
Effects of electroporation on primary rat hepatocytes in vitro.,3
Electroporation of primary neural cultures: a simple method for directed gene transfer in vitro.,3
Single-cell electroporation.,3
Overview of electroporation.,3
Digression on membrane electroporation for drug and gene delivery.,3
"Highly efficient, large volume flow electroporation.",3
"Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research.",3
Electroporation as a method for high-level nonviral gene transfer to the lung.,3
Electrotransfection of anchorage-dependent mammalian cells.,3
In situ electroporation of radioactive compounds into adherent cells.,3
Rapid and efficient electroporation-based gene transfer into primary dissociated neurons.,3
Efficient in situ electroporation of mammalian cells grown on microporous membranes.,3
Mechanism of electroinduced ionic species transport through a multilamellar lipid system.,3
A practical method for fission yeast transformation by electroporation.,3
Genetic transformation of plants by protoplast electroporation.,3
An optimized electroporation protocol applicable to a wide range of cell lines.,3
[The introduction of the marker gene Neor into hematopoietic stem cells by electroporation].,3
Transformation of Escherichia coli with foreign DNA by electroporation.,3
Studies on the effects of applied voltage and duration on human epidermal membrane alteration/recovery and the resultant effects upon iontophoresis.,1
A comparative evaluation of three transfection procedures as assessed by resistance to G418 conferred to HEPG2 cells.,3
Efficient transfer of antibodies into mammalian cells by electroporation.,1
Application of an optimized electroporation procedure for replacement of the polyhydroxyalkanoate synthase I gene in Nocardia corallina.,3
Gene transfer by electroporation.,3
Electroporation-induced formation of individual calcium entry sites in the cell body and processes of adherent cells.,3
Transient transfection of oligodendrocyte progenitors by electroporation.,3
High-efficiency transformation of Chlamydomonas reinhardtii by electroporation.,3
Direct gene transfer into rat liver cells by in vivo electroporation.,3
Preparation of red blood cells containing exogenous hemoglobin.,1
Highly efficient oligonucleotide transfer into intact yeast cells using square-wave pulse electroporation.,3
Altering the biochemical state of individual cultured cells and organelles with ultramicroelectrodes.,3
The use of recombinant fusion proteases in the affinity purification of recombinant proteins.,3
Cloning and expression of rat glucocorticoid-receptor DNA-binding domain.,3
"Effect of lead concentration on the level of glutathione, glutathione S-transferase, reductase and peroxidase in human blood.",1
Era GTPase of Escherichia coli: binding to 16S rRNA and modulation of GTPase activity by RNA and carbohydrates.,3
One-step purification of the recombinant catalytic subunit of pyruvate dehydrogenase phosphatase.,1
"Glutathione S-transferase, similar to sigma class, from skin secretions of Xenopus laevis.",1
"Glutathione S-transferase isoenzymes in the two-spot ladybird, Adalia bipunctata (Coleoptera: Coccinellidae).",1
Comparative study of the purification and characterization of the cytosolic glutathione S-transferases from two salmonid species: Atlantic salmon (Salmo salar) and brown trout (Salmo trutta).,1
Anti-SLA seropositive autoimmune hepatitis sera recognize distinct subunits of glutathione S-transferase: high prevalence of the Ya autoantigen.,1
Purification and partial characterization of seven glutathione S-transferase isoforms from the clam Ruditapes decussatus.,1
A new method for the preparation of human parathyroid hormone 1-34 peptides.,3
Processing of Norwalk virus nonstructural proteins by a 3C-like cysteine proteinase.,3
The precursor of pea ferredoxin-NADP+ reductase synthesized in Escherichia coli contains bound FAD and is transported into chloroplasts.,3
A testicular protein important for fertility has glutathione S-transferase activity and is localized extracellularly in the seminiferous tubules.,1
A fast method for obtaining highly pure recombinant herpes simplex virus type 1 thymidine kinase.,3
"Overproduction, purification and structural characterization of the functional N-terminal DNA-binding domain of the fru repressor from Escherichia coli K-12.",3
"pLEF, a novel vector for expression of glutathione S-transferase fusion proteins in mammalian cells.",3
Drosophila ribosomal protein PO contains apurinic/apyrimidinic endonuclease activity.,3
Expression of a synthetic gene for initiation factor 4E-binding protein 1 in Escherichia coli and its interaction with eIF-4E and eIF-4E x m7GTP complex.,3
Continuous superporous agarose beds for chromatography and electrophoresis.,1
External versus internal source of calcium during the gelation of alginate beads for DNA encapsulation.,1
Synthetic nano-scale fibrous extracellular matrix.,1
Porous chitosan scaffolds for tissue engineering.,1
Fabrication of porous gelatin scaffolds for tissue engineering.,1
[Preliminay studies on polyvinyl alcohol gel and its transderman therapeutic system].,1
Preparative electrochromatography of proteins in various types of porous media.,1
Preparation and compressive strength of alpha-tricalcium phosphate/gelatin gel composite cement.,1
Novel fabrication of open-pore chitin matrixes.,1
Synthesis of in situ cross-linkable macroporous biodegradable poly(propylene fumarate-co-ethylene glycol) hydrogels.,1
Simultaneous detection of multiple green fluorescent proteins in live cells by fluorescence lifetime imaging microscopy.,3
Simultaneous detection of multiple green fluorescent proteins in live cells by fluorescence lifetime imaging microscopy.,3
Photobleaching GFP reveals protein dynamics inside live cells.,3
Ca2+ activation of hSlo K+ channel is suppressed by N-terminal GFP tag.,1
Rapid selection of tetracycline-controlled inducible cell lines using a green fluorescent-transactivator fusion protein.,3
Imaging cells in the developing nervous system with retrovirus expressing modified green fluorescent protein.,3
Generation of a new protein purification matrix by loading ceramic hydroxyapatite with metal ions--demonstration with poly-histidine tagged green fluorescent protein.,3
Receptor-mediated Moloney murine leukemia virus entry can occur independently of the clathrin-coated-pit-mediated endocytic pathway.,3
Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation.,1
Green fluorescent protein-based direct viable count to verify a viable but non-culturable state of Salmonella typhi in environmental samples.,3
"Rapid internalization and surface expression of a functional, fluorescently tagged G-protein-coupled glutamate receptor.",1
Analysis with flow cytometry of green fluorescent protein expression in leukemic cells.,3
Colonization pattern of the biocontrol strain Pseudomonas chlororaphis MA 342 on barley seeds visualized by using green fluorescent protein.,3
"Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic.",3
Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors.,3
GFP-aided confocal laser scanning microscopy can monitor Agrobacterium tumefaciens cell morphology and gene expression associated with infection.,3
Use of the green fluorescent protein for investigations of Paecilomyces fumosoroseus in insect hosts.,3
Visualising the actin cytoskeleton.,3
Fluorescence lifetime imaging of receptor tyrosine kinase activity in cells.,3
Fluorescence lifetime imaging of receptor tyrosine kinase activity in cells.,3
Comparative analysis and application of fluorescent protein-tagged connexins.,3
Internalization of mammalian fluorescent cellular prion protein and N-terminal deletion mutants in living cells.,3
Detection of chromosomes tagged with green fluorescent protein in live Arabidopsis thaliana plants.,3
Roles of PI3Ks in leukocyte chemotaxis and phagocytosis.,3
Simultaneous detection of EGFP and cell surface markers by fluorescence microscopy in lymphoid tissues.,3
"TGN38-green fluorescent protein hybrid proteins expressed in stably transfected eukaryotic cells provide a tool for the real-time, in vivo study of membrane traffic pathways and suggest a possible role for ratTGN38.",3
Studying neuronal peptide release and secretory granule dynamics with green fluorescent protein.,3
Stage-specific assays to study biosynthetic cargo selection and role of SNAREs in export from the endoplasmic reticulum and delivery to the Golgi.,3
Secretory bulk flow of soluble proteins is efficient and COPII dependent.,3
COPII vesicles derived from mammalian endoplasmic reticulum microsomes recruit COPI.,3
Antibody purification methods.,1
Detection of IgM antibodies against Babesia bovis in cattle.,1
Method for the preparation of bispecific F(ab')2mu fragments from mouse monoclonal antibodies of the immunoglobulin M class and characterization of the fragments.,1
"Evaluation of an Epstein-Barr virus (EBV) immunoglobulin M enzyme-linked immunosorbent assay using a synthetic convergent peptide library, or mixotope, for diagnosis of primary EBV infection.",1
Evaluation of four methods for detection of immunoglobulin M antibodies to dengue virus.,1
Affinity-purification of a TMV-specific recombinant full-size antibody from a transgenic tobacco suspension culture.,1
Performance of thiophilic adsorption chromatography in the purification of rat IgG2b monoclonal antibodies from serum- and protein-free culture supernatants.,1
"Development of a rapid, single-step procedure using protein G affinity chromatography to deplete fetal calf serum of its IgG and to isolate murine IgG1 monoclonal antibodies from supernatants of hybridoma cells.",1
Chromatographic purification of the C(H)2 domain of the monoclonal antibody MAK33.,1
Three-step purification of bacterially expressed human single-chain Fv antibodies for clinical applications.,1
Study of the protective effects of hyperimmune immunoglobulins G and M against endotoxin in mice and rats.,1
Immune complexes from serum of patients with lyme disease contain Borrelia burgdorferi antigen and antigen-specific antibodies: potential use for improved testing.,1
"Polyreactivity as an acquired artefact, rather than a physiologic property, of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH.",1
Production and functional characterization of two mouse/human chimeric antibodies with specificity for the tumor-associated Tn-antigen.,1
Partial characterization of serum immunoglobulins of Oreochromis mossambicus.,1
"[Production, characterization and purification of monoclonal antibodies against antigens of Mycobacterium tuberculosis H37Rv strain].",1
Characterization of Japanese eel immunoglobulin M and its level in serum.,1
"Monoclonal and polyclonal antibodies against human ferritin, a nonspecific tumor marker.",1
Preparation of monoclonal antibody against human m3 receptor.,1
"Monoclonal antibodies against the major allergen of Plantago lanceolata pollen, Pla l 1: affinity chromatography purification of the allergen and development of an ELISA method for Pla l 1 measurement.",1
An alternative form of IL-18 in human blood plasma: complex formation with IgM defined by monoclonal antibodies.,1
"Presence of IgM in cutaneous mucus, but not in gut mucus of Atlantic salmon, Salmo salar. Serum IgM is rapidly degraded when added to gut mucus.",1
Novel ligands for the affinity-chromatographic purification of antibodies.,1
IgM detection via selective recognition by mannose-binding protein.,1
Coxsackievirus and adenovirus receptor (CAR) binds immunoglobulins.,1
In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone.,1
Use of a modified zirconia support in the separation of immunoproteins.,1
Purification of antibodies by affinity chromatography.,1
Manufacture and quality control of CAMPATH-1 antibodies for clinical trials.,1
Separation of IgG and IgM from albumin in citrated human plasma using electrodialysis and metal ion affinity precipitation.,1
Production and characterization of an anti-idiotypic single chain Fv that recognizes an anti-DNA antibody.,1
Immunoglobulin purification by affinity chromatography using protein A mimetic ligands prepared by combinatorial chemical synthesis.,1
Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12.,1
"Monoclonal antibodies for the measurement of class-specific antibody responses in the green turtle, Chelonia mydas.",1
Binding of the O-antigen of Shigella dysenteriae type 1 and 26 related synthetic fragments to a monoclonal IgM antibody.,1
Purification of monoclonal antibodies with light-chain heterogeneity produced by mouse hybridomas raised with NS-1 myelomas: application of hydrophobic interaction high-performance liquid chromatography.,1
Production and characterization of monoclonal antibodies differentiating subpopulations of porcine B lymphocytes in blood and lymphoid tissues.,1
Glycolipids noncovalently bound to DEAE-Sephadex. Use of the complexes for purification of IgM and IgG anti-(Gal beta 1-->3 GalNAc-) antibodies.,1
Relationship between anti-phospholipid and anti-endothelial cell antibodies III: beta 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules.,1
Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses.,1
Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. Implications for a single-step purification of bispecific antibodies.,1
Anti-lipid A monoclonal antibodies alter human endothelial cell ICAM-1 expression in vitro.,1
Purification of monoclonal antibodies to Le(y) and Le(d) carbohydrate antigens by ion-exchange and thiophilic-adsorption chromatography.,1
Identification and purification of armadillo (Dasypus novemcinctus) immunoglobulins: preparation of specific antisera to evaluate the immune response in these animals.,1
Purification of murine immunoglobulin M from spent tissue culture supernatant by one-step gel filtration chromatography procedure.,1
Identification of liver endothelial cells as the primary site of IgM catabolism in the rat.,1
Isolation and characterization of serum immunoglobulin classes of the ostrich (Struthio camelus).,1
Polyreactive IgM antibodies in the circulation are masked by antigen binding.,1
Peroxidase labeling of IgMs fragment of ABO blood group specific mouse monoclonal IgM.,1
Rat interleukin-2 immunoglobulin M fusion proteins are cytotoxic in vitro for cells expressing the IL-2 receptor and can abolish cell-mediated immunity in vivo.,1
Monoclonal IgM from patients with peripheral demyelinating neuropathies cross-react with bacterial polypeptides.,1
Monoclonal antibodies against urease from Canavalia ensiformis.,1
Cloning of human anti-GM1 antibodies from motor neuropathy patients.,1
Preparation of F(ab')2 mu fragments from rat IgM monoclonal antibodies and their application to the enzyme immunoassay of mouse interleukin-6.,1
Semi-preparative purification and validation of monoclonal antibodies for immunotherapy in mice.,1
Purification of mouse antibodies and Fab fragments.,1
Purification and immunochemical characterization of a natural human polyreactive monoclonal IgM antibody.,1
Expression of monovalent fragments derived from a human IgM autoantibody in E. coli. The input of the somatically mutated CDR1/CDR2 and of the CDR3 into antigen binding specificity.,1
Quantification of natural antibody producing B cells in rats by an improved ELISPOT technique using the polyvinylidene difluoride membrane as the solid support.,1
Humoral immune response in a marsupial Monodelphis domestica: anti-isotypic and anti-idiotypic responses detected by species-specific monoclonal anti-immunoglobulin reagents.,1
Autoantibodies inhibit interleukin-7-mediated proliferation and are associated with the age-dependent loss of pre-B cells in autoimmune New Zealand Black Mice.,1
"Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome.",1
Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans.,1
High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis?,1
IgM rheumatoid factor estimation by ELISA in seronegative rheumatoid arthritis before and after IgM fractionation: does seronegative RA exist?,1
Effect of valency on binding properties of the antihuman IgM monoclonal antibody 202.,1
Rapid purification and monitoring of immunoglobulin M from ascites by perfusion ion-exchange chromatography.,1
A rapid method for purification of monoclonal human IgM from mass culture.,1
Pilot scale purification of human monoclonal IgM (COU-1) for clinical trials.,1
Human monoclonal antibodies to human blood group antigens Kidd Jka and Jkb.,1
Monoclonal and polyclonal antibodies to chicken immunoglobulin isotypes specifically detect turkey immunoglobulin isotypes.,1
Effect of salt concentration gradient on separation of different types of specific immunoglobulins by ion-exchange chromatography on DEAE cellulose.,1
Characteristics of the adsorption of immunoglobulin M onto Q Sepharose Fast Flow ion-exchangers.,1
Efficient purification of mouse anti-FGF receptor IgM monoclonal antibody by magnetic beads.,1
A kinetics approach to the characterization of an IgM specific for the glycolipid asialo-GM1.,1
Cross-species reactivity of a monoclonal antibody against glutathione S-transferase fusion protein of human beta 2-adrenergic receptor.,1
New approach to steroid separation based on a low affinity IgM antibody.,1
Affinity purification of immunoglobulin M using a novel synthetic ligand.,1
Long-term production of human monoclonal antibodies by five human-mouse heterohybridomas in a serum-free medium.,1
"Protein LA, a novel hybrid protein with unique single-chain Fv antibody- and Fab-binding properties.",3
"The essential role of Saccharomyces cerevisiae CDC6 nucleotide-binding site in cell growth, DNA synthesis, and Orc1 association.",3
Formaldehyde cross-linking for studying nucleosomal dynamics.,3
"Spermine-induced aggregation of DNA, nucleosome, and chromatin.",3
Crosslinking of proteins to DNA in human nuclei using a 60 femtosecond 266 nm laser.,3
Distinction between AP1 and NF-E2 factor-binding at specific chromatin regions in mammalian cells.,3
Identification of cohesin association sites at centromeres and along chromosome arms.,3
Purification and initial characterization of primate satellite chromatin.,3
"Drosophila ORC specifically binds to ACE3, an origin of DNA replication control element.",3
Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects.,3
In vivo cross-linking and immunoprecipitation for studying dynamic Protein:DNA associations in a chromatin environment.,3
Subnuclear distribution of the entire complement of linker histone variants in Arabidopsis thaliana.,3
An efficient method for simultaneous isolation of biologically active transcription factors and DNA.,3
A method for efficient extraction of bovine papilloma virus-based minichromosomes that preserves native chromatin structure.,3
The organized chromatin domain of the repressed yeast a cell-specific gene STE6 contains two molecules of the corepressor Tup1p per nucleosome.,3
TATA-binding protein mutants that increase transcription from enhancerless and repressed promoters in vivo.,3
Lif1p targets the DNA ligase Lig4p to sites of DNA double-strand breaks.,3
Histone H2A.Z is widely but nonrandomly distributed in chromosomes of Drosophila melanogaster.,3
Nutrient regulation of gene expression by the sterol regulatory element binding proteins: increased recruitment of gene-specific coregulatory factors and selective hyperacetylation of histone H3 in vivo.,3
Evidence for nucleic acid binding ability and nucleosome association of Bombyx mori nucleopolyhedrovirus BRO proteins.,3
Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation.,3
"Rad22 protein, a rad52 homologue in Schizosaccharomyces pombe, binds to DNA double-strand breaks.",3
Identification of genomic DNA sequences bound by mutant p53 protein (Gly245-->Ser) in vivo.,3
Targeting of high mobility group-14/-17 proteins in chromatin is independent of DNA sequence.,3
Promoter-specific targeting of human SWI-SNF complex by Epstein-Barr virus nuclear protein 2.,3
The distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin: distribution in human fetal fibroblasts.,3
XIST RNA associates with specific regions of the inactive X chromatin.,3
FR900482 class of anti-tumor drugs cross-links oncoprotein HMG I/Y to DNA in vivo.,3
c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells.,3
ATP-driven chromatin remodeling activity and histone acetyltransferases act sequentially during transactivation by RAR/RXR In vitro.,3
Matrix attachment region-dependent function of the immunoglobulin mu enhancer involves histone acetylation at a distance without changes in enhancer occupancy.,3
Acetylation of a specific promoter nucleosome accompanies activation of the epsilon-globin gene by beta-globin locus control region HS2.,3
The budding yeast proteins Spc24p and Spc25p interact with Ndc80p and Nuf2p at the kinetochore and are important for kinetochore clustering and checkpoint control.,3
A novel chromatin immunoprecipitation and array (CIA) analysis identifies a 460-kb CENP-A-binding neocentromere DNA.,3
In vivo chromatin remodeling by yeast ISWI homologs Isw1p and Isw2p.,3
Identification of a nuclear protein ArpN as a component of human SWI/SNF complex and its selective association with a subset of active genes.,3
Diversity of the damage recognition step in the global genomic nucleotide excision repair in vitro.,3
The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements.,3
Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.,3
Kinetics of p53 binding to promoter sites in vivo.,3
Isolation of extrachromosomal elements by histone immunoprecipitation.,3
Location analysis of DNA-bound proteins at the whole-genome level: untangling transcriptional regulatory networks.,3
Sfl1 functions via the co-repressor Ssn6-Tup1 and the cAMP-dependent protein kinase Tpk2.,3
In vivo analysis of the model tyrosine aminotransferase gene reveals multiple sequential steps in glucocorticoid receptor action.,3
Recruitment of multiple interferon regulatory factors and histone acetyltransferase to the transcriptionally active interferon a promoters.,3
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.,3
"Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus.",3
In vivo interactions of archaeal Cdc6/Orc1 and minichromosome maintenance proteins with the replication origin.,3
Use of chromatin immunoprecipitation to clone novel E2F target promoters.,3
Transcription factor FoxA (HNF3) on a nucleosome at an enhancer complex in liver chromatin.,3
Specific distribution of the Saccharomyces cerevisiae linker histone homolog HHO1p in the chromatin.,3
Molecular mechanisms mediating methylation-dependent silencing of ribosomal gene transcription.,3
Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation.,3
c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism.,3
"A unique downstream estrogen responsive unit mediates estrogen induction of proteinase inhibitor-9, a cellular inhibitor of IL-1beta- converting enzyme (caspase 1).",3
Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.,3
"Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.",3
Analysis of chromatin-immunopurified MeCP2-associated fragments.,3
Distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin II: distribution in human adult fibroblasts.,3
Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae.,3
Application of the chromatin immunoprecipitation method to identify in vivo protein-DNA associations in fission yeast.,3
Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo.,4
Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis.,3
Identification of a binding region for human origin recognition complex proteins 1 and 2 that coincides with an origin of DNA replication.,3
Isolation of transcriptionally active chromatin from human breast cancer cells using Sulfolink coupling gel chromatography.,3
Histone deacetylation inhibits IL4 gene expression in T cells.,3
Role of de novo DNA methyltransferases and methyl CpG-binding proteins in gene silencing in a rat hepatoma.,3
Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.,3
GATA-1 binding sites mapped in the beta-globin locus by using mammalian chIp-chip analysis.,3
"CENP-A, -B, and -C chromatin complex that contains the I-type alpha-satellite array constitutes the prekinetochore in HeLa cells.",3
Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter.,3
DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha.,3
Combining chromatin immunoprecipitation and DNA footprinting: a novel method to analyze protein-DNA interactions in vivo.,3
"POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1.",3
The origin recognition complex marks a replication origin in the human TOP1 gene promoter.,3
CENP-C binds the alpha-satellite DNA in vivo at specific centromere domains.,3
A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes.,3
Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.,3
Dissecting long-range transcriptional mechanisms by chromatin immunoprecipitation.,3
Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation.,3
Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation.,3
Silencing of the mouse H-rev107 gene encoding a class II tumor suppressor by CpG methylation.,3
"Hrp3, a chromodomain helicase/ATPase DNA binding protein, is required for heterochromatin silencing in fission yeast.",3
Apaf-1 is a mediator of E2F-1-induced apoptosis.,4
Profiling methyl-CpG specific determinants on transcriptionally silent chromatin.,3
Regulation of alpha-fetoprotein expression by Nkx2.8.,3
GAGA factor and the TFIID complex collaborate in generating an open chromatin structure at the Drosophila melanogaster hsp26 promoter.,3
The chromatin remodeling complex NoRC targets HDAC1 to the ribosomal gene promoter and represses RNA polymerase I transcription.,3
A chromatin remodelling complex that loads cohesin onto human chromosomes.,3
Identification of direct p73 target genes combining DNA microarray and chromatin immunoprecipitation analyses.,4
14-3-3sigma is a cruciform DNA binding protein and associates in vivo with origins of DNA replication.,3
Role of histone H3 lysine 27 methylation in Polycomb-group silencing.,3
Human Mcm proteins at a replication origin during the G1 to S phase transition.,3
Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.,3
Identification of E2A target genes in B lymphocyte development by using a gene tagging-based chromatin immunoprecipitation system.,3
Centromeric retroelements and satellites interact with maize kinetochore protein CENH3.,3
Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.,3
Telomeric DNA ends are essential for the localization of Ku at telomeres in fission yeast.,3
Transcription factor occupancy of the insulin gene in vivo. Evidence for direct regulation by Nkx2.2.,3
Developmental changes in the Sciara II/9A initiation zone for DNA replication.,3
In vivo functional dissection of human inner kinetochore protein CENP-C.,3
Role for a Drosophila Myb-containing protein complex in site-specific DNA replication.,3
[Identification of two new p53 target genes through implementation of the modified chromatin immunoprecipitation method and inverse PCR].,3
Interaction of NF-E2 in the human beta-globin locus control region before chromatin remodeling.,3
Chromatin immunoprecipitation (ChIP) studies indicate a role for CCAAT enhancer binding proteins alpha and epsilon (C/EBP alpha and C/EBP epsilon ) and CDP/cut in myeloid maturation-induced lactoferrin gene expression.,3
Identification of target genes for EWS/ATF-1 chimeric transcription factor.,3
Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy.,3
In vivo cloning and characterization of a new growth suppressor protein TOE1 as a direct target gene of Egr1.,3
CDK- and Cdc45-dependent priming of the MCM complex on chromatin during S-phase in Xenopus egg extracts: possible activation of MCM helicase by association with Cdc45.,3
Transcriptional activation of the enterocyte differentiation marker intestinal alkaline phosphatase is associated with changes in the acetylation state of histone H3 at a specific site within its promoter region in vitro.,3
"Transcription, nucleosome positioning and protein binding modulate nucleotide excision repair of the Saccharomyces cerevisiae MET17 promoter.",3
Additional targets of the Bacillus subtilis global regulator CodY identified by chromatin immunoprecipitation and genome-wide transcript analysis.,3
Chromatin repression by COUP-TFII and HDAC dominates activation by NF-kappaB in regulating major histocompatibility complex class I transcription in adenovirus tumorigenic cells.,3
[Use of the modified method of chromatin immunoprecipitation for the isolation of actively transcribed loci].,3
The cyclic adenosine 5'-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism.,3
In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading.,3
Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.,3
Genomic targets of the human c-Myc protein.,3
Vitamin D-dependent recruitment of DNA-PK to the chromatinized negative vitamin D response element in the PTHrP gene is required for gene repression by vitamin D.,3
"Protein kinase A-anchoring protein AKAP95 interacts with MCM2, a regulator of DNA replication.",3
The role of DNA methylation in setting up chromatin structure during development.,3
Differential regulation of E2F1 apoptotic target genes in response to DNA damage.,4
Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.,4
Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene.,3
The transcription factor CCAAT-binding factor CBF/NF-Y regulates the proximal promoter activity in the human alpha 1(XI) collagen gene (COL11A1).,3
"Organization and function of APT, a subcomplex of the yeast cleavage and polyadenylation factor involved in the formation of mRNA and small nucleolar RNA 3'-ends.",3
v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.,3
GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling.,3
"In vivo roles of Rad52, Rad54, and Rad55 proteins in Rad51-mediated recombination.",3
Recruitment of the recombinational repair machinery to a DNA double-strand break in yeast.,3
An Sp1-NF-Y/progesterone receptor DNA binding-dependent mechanism regulates progesterone-induced transcriptional activation of the rabbit RUSH/SMARCA3 gene.,3
Occupancy and function of the -150 sterol regulatory element and -65 E-box in nutritional regulation of the fatty acid synthase gene in living animals.,3
"Cha, a basic helix-loop-helix transcription factor involved in the regulation of upstream stimulatory factor activity.",3
A comprehensive search for HNF-3alpha-regulated genes in mouse hepatoma cells by 60K cDNA microarray and chromatin immunoprecipitation/PCR analysis.,5
Architecture of the budding yeast kinetochore reveals a conserved molecular core.,3
Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression.,3
Analysis of nucleosome assembly and histone exchange using antibodies specific for acetylated H4.,3
The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.,3
Mapping Polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin.,3
Isolation of a thyroid hormone-responsive gene by immunoprecipitation of thyroid hormone receptor-DNA complexes.,3
Cloning of an antibody binding DNA sequence: pitfalls of DNA/protein immunoprecipitation reactions.,3
Parental nucleosomes segregated to newly replicated chromatin are underacetylated relative to those assembled de novo.,3
Identification of novel Pax-2 binding sites by chromatin precipitation.,3
Rapid identification of homeodomain binding sites in the Wnt-5a gene using an immunoprecipitation strategy.,3
Chromatin organization in the homogeneously staining regions of a methotrexate-resistant mouse cell line: interspersion of inactive and active chromatin domains distinguished by acetylation of histone H4.,3
Endo-exonuclease of human leukaemic cells: evidence for a role in apoptosis.,3
Analysis of chromatin structure by in vivo formaldehyde cross-linking.,3
UV-laser crosslinking of proteins to DNA.,3
In vivo interaction of human MCM heterohexameric complexes with chromatin. Possible involvement of ATP.,3
Chromosomal mapping of core histone acetylation by immunoselection.,3
A preparative method for crosslinking proteins to DNA in nuclei by single-pulse UV laser irradiation.,3
p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes.,3
Isolation of nuclei for chromatin analysis in fission yeast.,3
Clusters of nucleosomes containing chromosomal protein HMG-17 in chromatin.,3
Distinctive patterns of histone H4 acetylation are associated with defined sequence elements within both heterochromatic and euchromatic regions of the human genome.,3
Heritable chromatin states induced by the Polycomb and trithorax group genes.,3
Cell cycle- and chromatin binding state-dependent phosphorylation of human MCM heterohexameric complexes. A role for cdc2 kinase.,3
Human minichromosome maintenance proteins and human origin recognition complex 2 protein on chromatin.,3
Chromatin structure and analysis of mechanisms of activators and repressors.,3
Quantitation of multiple gene expression by in situ hybridization autoradiography: accurate normalization using Bayes classifier.,5
Chasing the dream: plant EST microarrays.,5
High-fidelity mRNA amplification for gene profiling.,5
Normalization strategies for cDNA microarrays.,5
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.,5
Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations.,5
Discovery of new inducible genes in in vitro decidualized human endometrial stromal cells using microarray technology.,3
Gene expression data analysis.,5
A concise guide to cDNA microarray analysis.,5
Coupled two-way clustering analysis of gene microarray data.,5
Analyzing high-density oligonucleotide gene expression array data.,5
General nonlinear framework for the analysis of gene interaction via multivariate expression arrays.,5
Generation of patterns from gene expression data by assigning confidence to differentially expressed genes.,5
MAD: a suite of tools for microarray data management and processing.,5
The Stanford Microarray Database.,5
High throughput screening of gene expression signatures.,5
Preprocessing implementation for microarray (PRIM): an efficient method for processing cDNA microarray data.,5
Quantitative assessment of DNA microarrays--comparison with Northern blot analyses.,5
Analysis of hypertrophic and normal scar gene expression with cDNA microarrays.,5
Maximization of signal derived from cDNA microarrays.,5
Applications of biochip and microarray systems in pharmacogenomics.,5
"Cambridge Healthtech Institute's Third Annual Conference on Lab-on-a-Chip and Microarrays. 22-24 January 2001, Zurich, Switzerland.",5
A nonparametric scoring algorithm for identifying informative genes from microarray data.,5
Basic microarray analysis: grouping and feature reduction.,5
Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis.,5
On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data.,5
Comparison of normal human skin gene expression using cDNA microarrays.,5
Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization.,5
Testing for differentially-expressed genes by maximum-likelihood analysis of microarray data.,5
Analysis of variance for gene expression microarray data.,5
Computational analysis of microarray data.,5
"Microarrays in brain research: the good, the bad and the ugly.",5
A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes.,5
Missing value estimation methods for DNA microarrays.,5
SVDMAN--singular value decomposition analysis of microarray data.,5
AMADA: analysis of microarray data.,5
Transcript analysis of 1003 novel yeast genes using high-throughput northern hybridizations.,5
"Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects.",5
A comparison of microarray databases.,5
Quantitative quality control in microarray image processing and data acquisition.,5
Bootstrapping cluster analysis: assessing the reliability of conclusions from microarray experiments.,5
CLIFF: clustering of high-dimensional microarray data via iterative feature filtering using normalized cuts.,5
Centralization: a new method for the normalization of gene expression data.,5
Image metrics in the statistical analysis of DNA microarray data.,5
Cluster-Rasch models for microarray gene expression data.,5
Correspondence analysis applied to microarray data.,5
Argus--a new database system for Web-based analysis of multiple microarray data sets.,5
Unfolding of microarray data.,5
Critical assessment of microarray data analysis: the 2001 challenge.,5
A statistical method for flagging weak spots improves normalization and ratio estimates in microarrays.,5
A simple method for statistical analysis of intensity differences in microarray-derived gene expression data.,5
Cluster inference methods and graphical models evaluated on NCI60 microarray gene expression data.,5
Gene expression profile analysis by DNA microarrays: promise and pitfalls.,5
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data.,5
Assessing gene significance from cDNA microarray expression data via mixed models.,5
Identifying differentially expressed genes in cDNA microarray experiments.,5
Exploring relationships in gene expressions: a partial least squares approach.,5
Aligning experimental design with bioinformatics analysis to meet discovery research objectives.,5
Microarray data analysis: a practical approach for selecting differentially expressed genes.,5
Evaluation of normalization procedures for oligonucleotide array data based on spiked cRNA controls.,5
Automated screening for genomic imbalances using matrix-based comparative genomic hybridization.,5
Characterization of the expression ratio noise structure in high-density oligonucleotide arrays.,5
DNA array analysis in a Microsoft Windows environment.,5
Analysis of cDNA microarray images.,5
Tumor classification by partial least squares using microarray gene expression data.,5
Genesis: cluster analysis of microarray data.,5
Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.,5
Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data.,5
Adjustments and measures of differential expression for microarray data.,5
Correcting for signal saturation errors in the analysis of microarray data.,5
"MarC-V: a spreadsheet-based tool for analysis, normalization, and visualization of single cDNA microarray experiments.",5
Microarray data quality analysis: lessons from the AFGC project. Arabidopsis Functional Genomics Consortium.,5
Thresholding rules for recovering a sparse signal from microarray experiments.,5
Generation of EST and cDNA microarray resources for the study of bovine immunobiology.,5
Monitoring of cDNA microarray with common primer target and hybridization specificity with selected targets.,5
Improved background correction for spotted DNA microarrays.,5
Singular value decomposition regression models for classification of tumors from microarray experiments.,5
Normalizing DNA microarray data.,5
A mixture model-based approach to the clustering of microarray expression data.,5
Iterative normalization of cDNA microarray data.,5
Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis.,5
Permutation-validated principal components analysis of microarray data.,5
Tree-based analysis of microarray data for classifying breast cancer.,5
Making sense of microarray data distributions.,5
Microarray analysis of gene expression patterns during healing of rat corneas after excimer laser photorefractive keratectomy.,5
Time-dependent changes in ARE-driven gene expression by use of a noise-filtering process for microarray data.,5
Statistical issues with microarrays: processing and analysis.,5
How many replicates of arrays are required to detect gene expression changes in microarray experiments? A mixture model approach.,5
Unsupervised technique for robust target separation and analysis of DNA microarray spots through adaptive pixel clustering.,5
GP3: GenePix post-processing program for automated analysis of raw microarray data.,5
Microarray optimizations: increasing spot accuracy and automated identification of true microarray signals.,5
Toward a universal standard: comparing two methods for standardizing spotted microarray data.,5
Local mean normalization of microarray element signal intensities across an array surface: quality control and correction of spatially systematic artifacts.,5
Monitoring of representational difference analysis subtraction procedures by global microarrays.,5
Arrayplot for visualization and normalization of cDNA microarray data.,5
The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data.,5
Deriving quantitative conclusions from microarray expression data.,5
Global analysis of mRNA decay and abundance in Escherichia coli at single-gene resolution using two-color fluorescent DNA microarrays.,5
Models for microarray gene expression data.,5
Practical approaches to analyzing results of microarray experiments.,5
Simulation of cDNA microarrays via a parameterized random signal model.,5
A conditional density error model for the statistical analysis of microarray data.,5
"MArray: analysing single, replicated or reversed microarray experiments.",5
Statistical methods for microarray assays.,5
Profound effect of normalization on detection of differentially expressed genes in oligonucleotide microarray data analysis.,5
Normalization and analysis of DNA microarray data by self-consistency and local regression.,5
Factor analysis of cluster-specific gene expression levels from cDNA microarrays.,5
Effect of local background intensities in the normalization of cDNA microarray data with a skewed expression profiles.,5
Ratio statistics of gene expression levels and applications to microarray data analysis.,5
Ranking genes with respect to differential expression.,5
A new non-linear normalization method for reducing variability in DNA microarray experiments.,5
Control analysis of DNA microarray expression data.,5
Bayesian hierarchical model for identifying changes in gene expression from microarray experiments.,5
Cross-species hybridisation of pig RNA to human nylon microarrays.,5
Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study.,5
Genomic DNA standards for gene expression profiling in Mycobacterium tuberculosis.,5
Assessing sources of variability in microarray gene expression data.,5
Block principal component analysis with application to gene microarray data classification.,5
New protocol in spotting microarray technique.,5
Comparison of microarray designs for class comparison and class discovery.,5
Nonparametric methods for identifying differentially expressed genes in microarray data.,5
SNOMAD (Standardization and NOrmalization of MicroArray Data): web-accessible gene expression data analysis.,5
Zipf's law in importance of genes for cancer classification using microarray data.,5
Within the fold: assessing differential expression measures and reproducibility in microarray assays.,5
"Gene expression studies using microarrays: principles, problems, and prospects.",5
Fundamentals of experimental design for cDNA microarrays.,5
Microarray data normalization and transformation.,5
Analysis of high density expression microarrays with signed-rank call algorithms.,5
Calculation of the minimum number of replicate spots required for detection of significant gene expression fold change in microarray experiments.,5
Statistical analysis of high-density oligonucleotide arrays: a multiplicative noise model.,5
Analysis of whole-genome microarray replicates using mixed models.,5
Prediction of biologically significant components from microarray data: Independently Consistent Expression Discriminator (ICED).,5
Neurokinin 1 receptors and neprilysin modulation of mouse bladder gene regulation.,5
Generation of expressed sequence tags from a normalized porcine skeletal muscle cDNA library.,5
Bayesian analysis of gene expression levels: statistical quantification of relative mRNA level across multiple strains or treatments.,5
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.,5
Combinatorial image analysis of DNA microarray features.,5
An associative analysis of gene expression array data.,5
AVA: visual analysis of gene expression microarray data.,5
Differential analysis of DNA microarray gene expression data.,5
Identification and removal of contaminating fluorescence from commercial and in-house printed DNA microarrays.,5
A classification-based machine learning approach for the analysis of genome-wide expression data.,5
Receiver operating characteristic analysis: a general tool for DNA array data filtration and performance estimation.,5
Normalization methods for analysis of microarray gene-expression data.,5
Automatic analysis of DNA microarray images using mathematical morphology.,5
Gene expression data preprocessing.,5
MatArray: a Matlab toolbox for microarray data.,5
Data extraction from composite oligonucleotide microarrays.,5
Modeling gene expression measurement error: a quasi-likelihood approach.,5
Computational selection of distinct class- and subclass-specific gene expression signatures.,5
Spectral biclustering of microarray data: coclustering genes and conditions.,5
Monitoring global messenger RNA changes in externally controlled microarray experiments.,5
Contrast normalization of oligonucleotide arrays.,5
To confirm or not to confirm (microarray data)--that is the question.,5
Statistical tests for identifying differentially expressed genes in time-course microarray experiments.,5
Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.,5
Analysis of microarray data using Z score transformation.,5
Testing for differentially expressed genes with microarray data.,5
Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.,5
Treatment of microarray experiments as split-plot designs.,5
Microarray standard data set and figures of merit for comparing data processing methods and experiment designs.,5
Approximate variance-stabilizing transformations for gene-expression microarray data.,5
Use of a three-color cDNA microarray platform to measure and control support-bound probe for improved data quality and reproducibility.,5
Statistical approach to DNA chip analysis.,5
Quantitative assessment of the importance of dye switching and biological replication in cDNA microarray studies.,5
The construction and use of bacterial DNA microarrays based on an optimized two-stage PCR strategy.,5
Estimating dataset size requirements for classifying DNA microarray data.,5
Statistical methods for analyzing microarray feature data with replications.,5
Modeling of DNA microarray data by using physical properties of hybridization.,5
Identification of novel cellular targets in biliary tract cancers using global gene expression technology.,7
Statistical implications of pooling RNA samples for microarray experiments.,5
INCLUSive: A web portal and service registry for microarray and regulatory sequence analysis.,5
GenePublisher: Automated analysis of DNA microarray data.,5
ExpressYourself: A modular platform for processing and visualizing microarray data.,5
The analysis of microarray data.,5
Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study.,1
Technical evaluation of cDNA microarrays.,5
Spurious spatial periodicity of co-expression in microarray data due to printing design.,5
Shrinkage-based similarity metric for cluster analysis of microarray data.,5
Experiments using microarray technology: limitations and standard operating procedures.,5
The design and analysis of microarray experiments: applications in parasitology.,5
The efficiency of pooling mRNA in microarray experiments.,5
"Exploration, normalization, and summaries of high density oligonucleotide array probe level data.",5
"The Longhorn Array Database (LAD): an open-source, MIAME compliant implementation of the Stanford Microarray Database (SMD).",5
Evaluation of normalization methods for microarray data.,5
Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction.,5
Probabilistic estimation of microarray data reliability and underlying gene expression.,5
[Validation of cDNA microarray technology].,5
"Multiplex messenger assay: simultaneous, quantitative measurement of expression of many genes in the context of T cell activation.",5
Progress and variations in two-hybrid and three-hybrid technologies.,3
Dynamics and elasticity of the fibronectin matrix in living cell culture visualized by fibronectin-green fluorescent protein.,3
Dual-colour imaging with GFP variants.,3
Using GFP in FRET-based applications.,3
Visualization of internalization and recycling of the gastrin releasing peptide receptor-green fluorescent protein chimera expressed in epithelial cells.,3
Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays.,3
"Patterns of cellular activities based on protein sorting in cell motility, endocytosis and cytokinesis.",3
Single-cell measurements of ion concentrations within the intracellular parasite.,3
Mercury-induced anti-nucleolar autoantibodies can transgress the membrane of living cells in vivo and in vitro.,3
Yeast Bim1p promotes the G1-specific dynamics of microtubules.,3
Confocal imaging of microglial cell dynamics in hippocampal slice cultures.,3
Application of real-time confocal microscopy for observation of living cells in tissue specimens.,3
Model system for plant cell biology: GFP imaging in living onion epidermal cells.,3
Time-resolved analysis and visualization of dynamic processes in living cells.,3
Membrane protein-ligand interactions in Escherichia coli vesicles and living cells monitored via a biosynthetically incorporated tryptophan analogue.,3
Probing the molecular environment of membrane proteins in vivo.,3
Tracking RPE transplants labeled by retroviral gene transfer with green fluorescent protein.,3
Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein.,3
"Protein-protein interactions between the testis brain RNA-binding protein and the transitional endoplasmic reticulum ATPase, a cytoskeletal gamma actin and Trax in male germ cells and the brain.",3
"Transient, phorbol ester-induced DOC2-Munc13 interactions in vivo.",3
Quantification of protein-protein interactions using fluorescence polarization.,3
Cyclic AMP-dependent protein kinase binding to A-kinase anchoring proteins in living cells by fluorescence resonance energy transfer of green fluorescent protein fusion proteins.,3
"Optical nanosensors for chemical analysis inside single living cells. 1. Fabrication, characterization, and methods for intracellular delivery of PEBBLE sensors.",3
RET: a poly A-trap retrovirus vector for reversible disruption and expression monitoring of genes in living cells.,3
Detection of cytokeratin dynamics by time-lapse fluorescence microscopy in living cells.,3
"Visualization of interstitial cells of Cajal in living, intact tissues.",3
Green fluorescent protein as a reporter for macromolecular localization in bacterial cells.,3
Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein.,3
Protein-disulfide isomerase (PDI) in FRTL5 cells. pH-dependent thyroglobulin/PDI interactions determine a novel PDI function in the post-endoplasmic reticulum of thyrocytes.,3
A fluorescent indicator for visualizing cAMP-induced phosphorylation in vivo.,3
Green fluorescent protein gene insertion of Sendai Virus infection in nude mice: possibility as an infection tracer.,3
Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).,3
Association between elongation factor-1alpha and microtubules in vivo is domain dependent and conditional.,3
High mobility of proteins in the mammalian cell nucleus.,3
Analysis of fast dynamic processes in living cells: high-resolution and high-speed dual-color imaging combined with automated image analysis.,3
Anomalous diffusion of fluorescent probes inside living cell nuclei investigated by spatially-resolved fluorescence correlation spectroscopy.,3
In vivo observation of a nuclear channel-like system: evidence for a distinct interchromosomal domain compartment in interphase cells.,3
Fluorescent probes: looking backward and looking forward.,3
The dynamic behavior of the APC-binding protein EB1 on the distal ends of microtubules.,0
The dynamic behavior of the APC-binding protein EB1 on the distal ends of microtubules.,0
TNF-alpha associated with extracellular matrix fibronectin provides a stop signal for chemotactically migrating T cells.,3
Interactions of the chemotaxis signal protein CheY with bacterial flagellar motors visualized by evanescent wave microscopy.,3
Actin dynamics at the living cell submembrane imaged by total internal reflection fluorescence photobleaching.,3
Development of a destabilized firefly luciferase enzyme for measurement of gene expression.,3
Live dynamics of GFP-calponin: isoform-specific modulation of the actin cytoskeleton and autoregulation by C-terminal sequences.,3
Intact Ca(2+)-binding sites are required for targeting of annexin 1 to endosomal membranes in living HeLa cells.,3
Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells.,3
Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy.,3
Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.,3
Protein-protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two-fusion fluorescence resonance energy transfer (FRET).,3
Investigation of nucleo-cytoplasmic transport using UV-guided microinjection.,3
Visualization of gene activity in living cells.,3
Monitoring agonist-induced phospholipase C activation in live cells by fluorescence resonance energy transfer.,3
The beauty of the yeast: live cell microscopy at the limits of optical resolution.,3
Imaging FRET between spectrally similar GFP molecules in single cells.,3
Watching proteins in the wild: fluorescence methods to study protein dynamics in living cells.,3
A study of protein-protein interactions in living cells using luminescence resonance energy transfer (LRET) from Renilla luciferase to Aequorea GFP.,3
Macromolecular dynamics in living cell nuclei revealed by fluorescence redistribution after photobleaching.,3
Methods for visualizing RNA processing and transport pathways in living cells.,5
In vivo interaction between dynamitin and MacMARCKS detected by the fluorescent resonance energy transfer method.,3
Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*.,1
Cell cycle-dependent changes in microtubule dynamics in living cells expressing green fluorescent protein-alpha tubulin.,3
Monitoring of in vitro and in vivo translation of green fluorescent protein and its fusion proteins by fluorescence correlation spectroscopy.,3
Imaging biochemistry inside cells.,3
"The scaffold protein, Homer1b/c, regulates axon pathfinding in the central nervous system in vivo.",3
Binding of agonist but not antagonist leads to fluorescence resonance energy transfer between intrinsically fluorescent gonadotropin-releasing hormone receptors.,1
Nucleolar assembly of the rRNA processing machinery in living cells.,3
From fixed to FRAP: measuring protein mobility and activity in living cells.,3
Studying protein dynamics in living cells.,3
Subcellular localization and oligomerization of the Arabidopsis thaliana somatic embryogenesis receptor kinase 1 protein.,3
Dimerization of receptor protein-tyrosine phosphatase alpha in living cells.,3
Application of fluorescence resonance energy transfer to the GroEL-GroES chaperonin reaction.,3
Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy.,3
A pair of fluorescent resonance energy transfer-based probes for tyrosine phosphorylation of the CrkII adaptor protein in vivo.,3
Targeted fluorescent probes in peroxisome function.,3
Direct visualization of protein interactions in plant cells.,3
Probing molecular processes in live cells by quantitative multidimensional microscopy.,3
Internalization of the epidermal growth factor receptor: role in signalling.,3
Fluorescence resonance energy transfer analysis of cell surface receptor interactions and signaling using spectral variants of the green fluorescent protein.,3
Fluorescence resonance energy transfer microscopy: a mini review.,3
Four-dimensional imaging and quantitative reconstruction to analyse complex spatiotemporal processes in live cells.,3
A method to measure the interaction of Rac/Cdc42 with their binding partners using fluorescence resonance energy transfer between mutants of green fluorescent protein.,3
Fluorescence resonance energy transfer microscopy of localized protein interactions in the living cell nucleus.,3
Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes.,3
Preassociation of calmodulin with voltage-gated Ca(2+) channels revealed by FRET in single living cells.,3
p32 (gC1qBP) is a general protein kinase C (PKC)-binding protein; interaction and cellular localization of P32-PKC complexes in ray hepatocytes.,3
Impact of oligomerization on the function of the human serotonin transporter.,3
Rapid dynamics of the microtubule binding of ensconsin in vivo.,3
Taking cell-matrix adhesions to the third dimension.,3
N-terminal domains of plant poly(ADP-ribose) polymerases define their association with mitotic chromosomes.,3
Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells.,3
Functional expression and FRET analysis of green fluorescent proteins fused to G-protein subunits in rat sympathetic neurons.,1
Bioluminescence imaging of lymphocyte trafficking in vivo.,3
Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells.,3
Measurement of molecular interactions in living cells by fluorescence resonance energy transfer between variants of the green fluorescent protein.,3
The use of FRET imaging microscopy to detect protein-protein interactions and protein conformational changes in vivo.,3
Uncoating ATPase Hsc70 is recruited by invariant chain and controls the size of endocytic compartments.,3
Noninvasive quantitative imaging of protein-protein interactions in living subjects.,3
Analysis of MADS box protein-protein interactions in living plant cells.,3
Nanosecond fluorescence resonance energy transfer-fluorescence lifetime imaging microscopy to localize the protein interactions in a single living cell.,3
Fluorescent indicators for imaging protein phosphorylation in single living cells.,3
High-order photobleaching of green fluorescent protein inside live cells in two-photon excitation microscopy.,3
Live-cell fluorescent biosensors for activated signaling proteins.,3
Protein dynamics in the nuclear compartment.,3
Protein-protein interactions monitored in mammalian cells via complementation of beta -lactamase enzyme fragments.,3
Desmosomes: interconnected calcium-dependent structures of remarkable stability with significant integral membrane protein turnover.,3
Cytoplasmic dynein intermediate chain and heavy chain are dependent upon each other for microtubule end localization in Aspergillus nidulans.,3
Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation.,3
Principles and biophysical applications of lanthanide-based probes.,3
Noninvasive imaging of protein-protein interactions in living animals.,3
Fluorescence resonance energy transfer analysis of protein-protein interactions in single living cells by multifocal multiphoton microscopy.,3
Coordinated traffic of Grb2 and Ras during epidermal growth factor receptor endocytosis visualized in living cells.,3
Quantification of cytoskeletal deformation in living cells based on hierarchical feature vector matching.,3
Spectral profiling for the simultaneous observation of four distinct fluorescent proteins and detection of protein-protein interaction via fluorescence resonance energy transfer in tobacco leaf nuclei.,3
Advances in in vivo bioluminescence imaging of gene expression.,3
Optical imaging fiber-based single live cell arrays: a high-density cell assay platform.,3
"Genomes, proteomes, and dynamic networks in the cell nucleus.",3
Activation of rac and cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells.,3
The dynamic microbe: green fluorescent protein brings bacteria to light.,3
Use of fluorescence resonance energy transfer to analyze oligomerization of G-protein-coupled receptors expressed in yeast.,3
Measurement of changes in fluorescence resonance energy transfer between gonadotropin-releasing hormone receptors in response to agonists.,3
Monitoring receptor-mediated activation of heterotrimeric G-proteins by fluorescence resonance energy transfer.,3
Methods to map protein interactions in mammalian cells: different tools to address different questions.,3
G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase.,1
It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology.,3
The use of resonance energy transfer in high-throughput screening: BRET versus FRET.,3
Advancing animal models of neoplasia through in vivo bioluminescence imaging.,3
EB1-microtubule interactions in Xenopus egg extracts: role of EB1 in microtubule stabilization and mechanisms of targeting to microtubules.,3
Time-lapse imaging of a dynamic phosphorylation-dependent protein-protein interaction in mammalian cells.,3
Two-photon tissue imaging: seeing the immune system in a fresh light.,3
Trafficking of green fluorescent protein-tagged SNARE proteins in HSY cells.,3
Spectral imaging and linear un-mixing enables improved FRET efficiency with a novel GFP2-YFP FRET pair.,3
"Homogeneous time-resolved fluorescence assay for identifying p53 interactions with its protein partners, directly in a cellular extract.",3
Applications of novel resonance energy transfer techniques to study dynamic hormone receptor interactions in living cells.,3
Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies.,3
Creating new fluorescent probes for cell biology.,3
P-selectin mediates platelet-endothelial cell interactions and reperfusion injury in the mouse liver in vivo.,1
A homogeneous and noncompetitive immunoassay based on the enhanced fluorescence resonance energy transfer by leucine zipper interaction.,3
A general method for the covalent labeling of fusion proteins with small molecules in vivo.,3
Picosecond-hetero-FRET microscopy to probe protein-protein interactions in live cells.,3
Fluorescence resonance energy transfer-based stoichiometry in living cells.,3
Live cell imaging: approaches for studying protein dynamics in living cells.,3
Total internal reflection fluorescence microscopy for single-molecule imaging in living cells.,3
Role of the promyelocytic leukemia body in the dynamic interaction between the androgen receptor and steroid receptor coactivator-1 in living cells.,3
Imaging protein-protein interactions in living cells.,3
"Protein-protein interactions in the secretory pathway, a growing demand for experimental approaches in vivo.",3
Interaction of histone acetylases and deacetylases in vivo.,3
Using FRAP and mathematical modeling to determine the in vivo kinetics of nuclear proteins.,3
Characterization of one- and two-photon excitation fluorescence resonance energy transfer microscopy.,3
Visualizing protein-protein interactions in living animals.,3
Seeing what was unseen: new analytical methods for molecular imaging.,3
Live-cell monitoring of tyrosine phosphorylation in focal adhesions following microtubule disruption.,3
Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations.,3
Solvent-sensitive dyes to report protein conformational changes in living cells.,3
G beta 5.RGS7 inhibits G alpha q-mediated signaling via a direct protein-protein interaction.,3
Development and use of fluorescent protein markers in living cells.,3
Oligomerization of transcriptional intermediary factor 1 regulators and interaction with ZNF74 nuclear matrix protein revealed by bioluminescence resonance energy transfer in living cells.,3
Spectral imaging and its applications in live cell microscopy.,3
Xeroderma pigmentosum group A protein loads as a separate factor onto DNA lesions.,3
The interaction between human PEX3 and PEX19 characterized by fluorescence resonance energy transfer (FRET) analysis.,3
The minus end-directed motor Kar3 is required for coupling dynamic microtubule plus ends to the cortical shmoo tip in budding yeast.,3
Real-time imaging of green fluorescent protein-tagged beta 2-adrenergic receptor distribution in living cells.,3
Yellow fluorescent protein-tagged and cyan fluorescent protein-tagged imaging analysis of glucocorticoid receptor and importins in single living cells.,3
Direct measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopy.,3
Photobleaching and photoactivation: following protein dynamics in living cells.,3
4D imaging to assay complex dynamics in live specimens.,3
"Human regulatory subunit RI beta of cAMP-dependent protein kinases: expression, holoenzyme formation and microinjection into living cells.",3
Analysis of biochemical processes in single living cells by quantitative microscopy.,3
[Expression of myogenic differentiation program in cultured normal postmitotic mononucleated myoblasts and the aberrant differentiation in rhabdomyosarcoma cells].,3
Fluorescent actin analogs with a high affinity for profilin in vitro exhibit an enhanced gradient of assembly in living cells.,3
Biological applications of atomic force microscopy.,3
Vinblastine suppresses dynamics of individual microtubules in living interphase cells.,3
Double labelling of subcellular structures with organelle-targeted GFP mutants in vivo.,3
Fluorescence resonance energy transfer between blue-emitting and red-shifted excitation derivatives of the green fluorescent protein.,3
Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway.,3
Site-directed mutagenesis of the phosphorylation site of cofilin: its role in cofilin-actin interaction and cytoplasmic localization.,3
GFP tagging of budding yeast chromosomes reveals that protein-protein interactions can mediate sister chromatid cohesion.,3
Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor.,3
Microtubules orient the mitotic spindle in yeast through dynein-dependent interactions with the cell cortex.,3
A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation.,3
Interactions between heterologous FtsA and FtsZ proteins at the FtsZ ring.,3
Photoactivation turns green fluorescent protein red.,3
"Soluble, highly fluorescent variants of green fluorescent protein (GFP) for use in higher plants.",3
Simultaneous detection of two GFP spectral mutants during in vivo confocal microscopy of migrating Dictyostelium cells.,3
Quantitative fluorescence resonance energy transfer measurements using fluorescence microscopy.,3
"The emergence of flow cytometry for sensitive, real-time measurements of molecular interactions.",3
Simultaneous visualization of the yellow and green forms of the green fluorescent protein in living cells.,3
Visualization of Pit-1 transcription factor interactions in the living cell nucleus by fluorescence resonance energy transfer microscopy.,3
Trafficking of androgen receptor mutants fused to green fluorescent protein: a new investigation of partial androgen insensitivity syndrome.,3
PRIM: proximity imaging of green fluorescent protein-tagged polypeptides.,3
One-tube fluorogenic reverse transcription-polymerase chain reaction for the quantitation of feline coronaviruses.,5
Allelic discrimination using fluorogenic probes and the 5' nuclease assay.,5
Fluorotyping of HLA-DRB by sequence-specific priming and fluorogenic probing.,5
Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system.,5
Detection of viable Listeria monocytogenes with a 5' nuclease PCR assay.,5
Development of a fluorogenic polymerase chain reaction assay (TaqMan) for the detection and quantitation of varicella zoster virus.,5
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression.,3
Evaluation of TaqMan PCR assay for detecting Salmonella in raw meat and shrimp.,5
High-throughput genotyping method for glutathione S-transferase T1 and M1 gene deletions using TaqMan probes.,5
Semi-automated fluorogenic PCR assays (TaqMan) forrapid detection of Escherichia coli O157:H7 and other shiga toxigenic E. coli.,5
"Seven-color, homogeneous detection of six PCR products.",5
"Automated detection of prevalent mutations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allelic discrimination assay.",5
Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine.,5
Rapid detection of the HIV type 1 reverse transcriptase codon T215Y by reverse transcription-polymerase chain reaction with fluorogenic probes.,5
Real-time 5'-->3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32).,5
Allelic discrimination of factor V Leiden using a 5' nuclease assay.,5
Detection and quantification of Salmonella in pure cultures using 5'-nuclease polymerase chain reaction.,5
A novel assay for allelic discrimination that combines the fluorogenic 5' nuclease polymerase chain reaction (TaqMan) and mismatch amplification mutation assay.,5
High-resolution typing for HLA-DRB1*15 amd -DRB1*16 by fluorescence-marked sequence-specific priming (TaqMan assay).,5
3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures.,5
"5' Nuclease assays for the loci CCR5-+/Delta32, CCR2-V64I, and SDF1-G801A related to pathogenesis of AIDS.",5
Mutation detection by TaqMan-allele specific amplification: application to molecular diagnosis of glycogen storage disease type Ia and medium-chain acyl-CoA dehydrogenase deficiency.,5
A real time quantitative PCR-based method for the detection and quantification of simian virus 40.,5
Real time quantitative PCR as a method to evaluate simian virus 40 removal during pharmaceutical protein purification.,5
Development of conventional and real-time PCR assays for the rapid detection of group B streptococci.,5
Quantitative detection of dengue 2 virus using fluorogenic RT-PCR based on 3'-noncoding sequence.,5
Development of a fluorogenic probe-based PCR assay for detection of Bacillus cereus in nonfat dry milk.,5
Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples.,5
High throughput genotyping for the detection of a single nucleotide polymorphism in NAD(P)H quinone oxidoreductase (DT diaphorase) using TaqMan probes.,5
Homogeneous scoring of single-nucleotide polymorphisms: comparison of the 5'-nuclease TaqMan assay and Molecular Beacon probes.,5
Using the fluorogenic 5' nuclease assay for high-throughput detection of (CA)n repeats in radiation hybrid mapping.,5
Application of real-time polymerase chain reaction for the quantitation of interleukin-1beta mRNA upregulation in brain ischemic tolerance.,5
Rapid identification of Yersinia enterocolitica in blood by the 5' nuclease PCR assay.,5
Detection of Yersinia pestis by pesticin fluorogenic probe-coupled PCR.,5
Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA.,5
"Detection of Ralstonia solanacearum strains with a quantitative, multiplex, real-time, fluorogenic PCR (TaqMan) assay.",5
A 5' nuclease PCR (TaqMan) high-throughput assay for detection of the mecA gene in staphylococci.,5
High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies.,5
High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system.,5
Development of a fluorogenic 5' nuclease PCR assay for detection of the ail gene of pathogenic Yersinia enterocolitica.,5
Application of the 5'-nuclease PCR assay in evaluation and development of methods for quantitative detection of Campylobacter jejuni.,5
Rapid 5' nuclease (TaqMan) assay for detection of virulent strains of Yersinia enterocolitica.,5
Automated 5' nuclease PCR assay for identification of Salmonella enterica.,5
Factor V Leiden genotyping using real-time fluorescent polymerase chain reaction.,5
A real-time one-step reverse transcriptase-polymerase chain reaction method to quantify c-erbB-2 expression in human breast cancer.,5
Quantitation of minimal residual disease in multiple myeloma using an allele-specific real-time PCR assay.,5
"Application of 5'-nuclease PCR for quantitative detection of Listeria monocytogenes in pure cultures, water, skim milk, and unpasteurized whole milk.",5
High throughput detection of drug-metabolizing enzyme polymorphisms by allele-specific fluorogenic 5' nuclease chain reaction assay.,5
Quantitative analysis of small-subunit rRNA genes in mixed microbial populations via 5'-nuclease assays.,5
Rapid detection and quantification of members of the archaeal community by quantitative PCR using fluorogenic probes.,5
Identification of ciprofloxacin-resistant Campylobacter jejuni by use of a fluorogenic PCR assay.,5
Real-time quantitative PCR for human herpesvirus 6 DNA.,5
Simultaneous detection of Salmonella strains and Escherichia coli O157:H7 with fluorogenic PCR and single-enrichment-broth culture.,5
Evaluation of 5' nuclease assay for detection of Actinobacillus pleuropneumoniae.,5
Use of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus levels in mAb cell-culture and downstream processing.,5
Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA.,5
Fluorescence polarization in homogeneous nucleic acid analysis II: 5'-nuclease assay.,5
Quantitative plasmid mixture analysis using the fluorogenic 5'-nuclease polymerase chain reaction assay.,5
Evaluation of a 5'-nuclease (TaqMan) assay for the detection of virulent strains of Yersinia enterocolitica in raw meat and tofu samples.,5
Detection and quantitation of Aspergillus fumigatus in pure culture using polymerase chain reaction.,5
Quantitation of HIV-1 by real-time PCR with a unique fluorogenic probe.,5
Detection and quantification of infectious hypodermal and hematopoietic necrosis virus in penaeid shrimp by real-time PCR.,5
Specific detection of Stachybotrys chartarum in pure culture using quantitative polymerase chain reaction.,5
Automated 5' nuclease assay for detection of virulence factors in porcine Escherichia coli.,5
Development of a real-time PCR assay for detection of Toxoplasma gondii in pig and mouse tissues.,5
Development of a fluorogenic RT-PCR system for quantitative identification of dengue virus serotypes 1-4 using conserved and serotype-specific 3' noncoding sequences.,5
Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for measurement of cytokine and growth factor mRNA expression with fluorogenic probes or SYBR Green I.,5
Comparison of TaqMan Salmonella amplification/detection kit with standard culture procedure for detection of Salmonella in meat samples.,5
"Fluorogenic PCR-based quantitative detection of a murine pathogen, Helicobacter hepaticus.",5
Quantitative real-time PCR assay for determining transgene copy number in transformed plants.,5
An improved real time PCR method for simultaneous detection of C282Y and H63D mutations in the HFE gene associated with hereditary hemochromatosis.,5
"Quantification of the carbazole 1,9a-dioxygenase gene by real-time competitive PCR combined with co-extraction of internal standards.",5
Fluorogenic RT-PCR assay (TaqMan) for detection and classification of bovine viral diarrhea virus.,5
Development of a fluorogenic RT-PCR assay (TaqMan) for the detection of Hendra virus.,5
"Comparison of culture, multiplex, and 5' nuclease polymerase chain reaction assays for the rapid detection of Yersinia enterocolitica in swine and pork products.",5
"TaqMan PCR for detection of Vibrio cholerae O1, O139, non-O1, and non-O139 in pure cultures, raw oysters, and synthetic seawater.",5
"Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens.",5
Efficient and cost-effective single nucleotide polymorphism detection with different fluorescent applications.,5
Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus.,5
Development and evaluation of a fluorogenic 5' nuclease assay to detect and differentiate between Ebola virus subtypes Zaire and Sudan.,5
[Real time quantitative PCR].,5
Rapid diagnosis of leishmaniasis by fluorogenic polymerase chain reaction.,5
TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening.,5
Multiplex PCR for detection of Enterobacteriaceae in blood.,5
Detection of DNA adducts using a quantitative long PCR technique and the fluorogenic 5' nuclease assay (TaqMan).,5
Development and evaluation of a fluorogenic 5'-nuclease assay to identify Marburg virus.,5
Self-quenched covalent fluorescent dye-nucleic acid conjugates as polymeric substrates for enzymatic nuclease assays.,5
Radiation exposure assessment using cytological and molecular biomarkers.,5
Modeling of 5' nuclease real-time responses for optimization of a high-throughput enrichment PCR procedure for Salmonella enterica.,5
Viral replication and host gene expression in alveolar macrophages infected with Ebola virus (Zaire strain).,5
Factor V Leiden and factor V R2 allele: high-throughput analysis and association with venous thromboembolism.,5
Evaluation of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus in mAb cell-culture.,5
Detection of root mat associated Agrobacterium strains from plant material and other sample types by post-enrichment TaqMan PCR.,5
Rapid and specific detection of the Mycobacterium tuberculosis complex using fluorogenic probes andreal-time PCR.,5
Single rapid TaqMan fluorogenic probe based PCR assay that detects all four dengue serotypes.,5
Nucleic acid molecular biomarkers for diagnostic biodosimetry applications: use of the fluorogenic 5'-nuclease polymerase chain reaction assay.,5
Application of a 5' nuclease assay for detection of Lawsonia intracellularis in fecal samples from pigs.,5
Minor groove binder-conjugated DNA probes for quantitative DNA detection by hybridization-triggered fluorescence.,5
Human platelet antigen 1 (HPA 1) genotyping with 5' nuclease assay and sequence-specific primers reveals a single nucleotide deletion in intron 2 of the HPA 1a allele of platelet glycoprotein IIIa.,5
Transcripts of developmentally regulated Plasmodium falciparum genes quantified by real-time RT-PCR.,3
Rapid type-specific diagnosis of adenovirus type 4 infection using a hexon-based quantitative fluorogenic PCR.,5
Detection of apple chlorotic leaf spot virus using a 5' nuclease assay with a fluorescent 3' minor groove binder-DNA probe.,5
Detection of rodent coronaviruses by use of fluorogenic reverse transcriptase-polymerase chain reaction analysis.,5
Usefulness of a TaqMan-based polymerase chain reaction assay for the detection of the fish pathogen Flavobacterium psychrophilum.,5
"New generation pharmacogenomic tools: a SNP linkage disequilibrium Map, validated SNP assay resource, and high-throughput instrumentation system for large-scale genetic studies.",5
"Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.",5
Nuclease fluorescence assay for the detection of verotoxin genes in raw milk.,5
Real-time polymerase chain reaction detection of bovine DNA in meat and bone meal samples.,5
Fluorescent multicolor multiplex homogeneous assay for the simultaneous analysis of the two most common hemochromatosis mutations.,5
SNP genotyping using single-tube fluorescent bidirectional PCR.,5
Sex determination of bovine embryo blastomeres by fluorogenic probes.,5
"Comparison of multiplex PCR, PCR-ELISA and fluorogenic 5' nuclease PCR assays for detection of plasmid-bearing virulent Yersinia enterocolitica in swine feces.",5
"Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay.",5
Detection of rodent Helicobacter spp. by use of fluorogenic nuclease polymerase chain reaction assays.,5
Single nucleotide polymorphism detection: allelic discrimination using TaqMan.,5
Factors affecting the performance of 5' nuclease PCR assays for Listeria monocytogenes detection.,5
Detection of enteroviruses in shellfish by fluorogenic polymerase chain reaction integrated with 96-well microplate scanning.,5
Identification of Agrobacterium spp. present within Brassica napus seed by TaqMan PCR--implications for GM screening procedures.,5
Tracking T cell clonotypes in complex T lymphocyte populations by real-time quantitative PCR using fluorogenic complementarity-determining region-3-specific probes.,5
Quantification of microcystin-producing cyanobacteria and E. coli in water by 5'-nuclease PCR.,5
Application of the fluorogenic probe technique (TaqMan PCR) to the detection of Enterococcus spp. and Escherichia coli in water samples.,5
Development of a TaqMan PCR assay with internal amplification control for the detection of African swine fever virus.,5
Simultaneous identification of Mycobacterium genus and Mycobacterium tuberculosis complex in clinical samples by 5'-exonuclease fluorogenic PCR.,5
Real-time quantitative RT-PCR assay of GADD45 gene expression changes as a biomarker for radiation biodosimetry.,5
Species-specific detection of three human-pathogenic microsporidial species from the genus Encephalitozoon via fluorogenic 5' nuclease PCR assays.,5
Utilization of fluorogenic assay for rapid detection of Escherichia coli in acidic fruit juice.,5
Evaluation of automated RT-PCR to accelerate the laboratory diagnosis of foot-and-mouth disease virus.,5
Cytokine expression in respiratory syncytial virus-infected mice as measured by quantitative reverse-transcriptase PCR.,5
Molecular identification of Paracoccidioides brasiliensis by 5' nuclease assay.,5
Detection of Listeria monocytogenes from a model food by fluorescence resonance energy transfer-based PCR with an asymmetric fluorogenic probe set.,5
Development of a 5' fluorogenic nuclease-based real-time PCR assay for quantitative detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis.,5
Detection of lymphocytic choriomeningitis virus by use of fluorogenic nuclease reverse transcriptase-polymerase chain reaction analysis.,5
Development of a 5' nuclease assay to detect ciprofloxacin resistant isolates of the biowarfare agent Yersinia pestis.,5
Development of a 5'-nuclease PCR assay for detecting Shiga toxin-producing Escherichia coli O145 based on the identification of an 'O-island 29' homologue.,5
Detection of pathogenic Vibrio parahaemolyticus in oyster enrichments by real time PCR.,5
Use of an internal standard in a closed one-tube RT-PCR for the detection of equine arteritis virus RNA with fluorescent probes.,5
Ethidium monoazide for DNA-based differentiation of viable and dead bacteria by 5'-nuclease PCR.,5
Detection of sendai virus and pneumonia virus of mice by use of fluorogenic nuclease reverse transcriptase polymerase chain reaction analysis.,5
Specific quantification of human genomes from low copy number DNA samples in forensic and ancient DNA studies.,5
A fluorescent based PCR assay for the detection and quantitation of Giardia duodenalis genotypes in mixed populations.,5
Detection and characterization of verocytotoxin-producing Escherichia coli by automated 5' nuclease PCR assay.,5
Rapid detection of Candida albicans in clinical blood samples by using a TaqMan-based PCR assay.,5
Development of a 5' nuclease-based real-time PCR assay for quantitative detection of cariogenic dental pathogens Streptococcus mutans and Streptococcus sobrinus.,5
Pathogen genotyping in polyclonal infections: application of a fluorogenic polymerase-chain-reaction assay in malaria.,5
Detection of Reovirus type 3 by use of fluorogenic nuclease reverse transcriptase polymerase chain reaction.,5
Use of a fluorogenic probe in a PCR-based assay for the detection of Listeria monocytogenes.,5
Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.,5
Topographical characterization of the DNA polymerase from Thermus aquaticus. Defining groups of inhibitor mAbs by epitope mapping and functional analysis using surface plasmon resonance.,1
Spectrofluorometric assay for rapid detection of total and fecal coliforms from surface water.,5
Detection of HIV-1 DNA in cells and tissue by fluorescent in situ 5'-nuclease assay (FISNA).,5
A novel method for real time quantitative RT-PCR.,5
Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system.,5
Fluorometric polymerase chain reaction (PCR) enzyme-linked immunosorbent assay for quantification of immuno-PCR products in microplates.,5
[A novel quantitative PCR with fluorogenic probe].,5
The evaluation of a fluorogenic polymerase chain reaction assay for the detection of Salmonella species in food commodities.,5
A rapid method for semiquantitative analysis of the human V beta-repertoire using TaqManR PCR.,5
"A sensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA.",5
The potential of 5' nuclease PCR for detecting a single-base polymorphism in Orthopoxvirus.,5
Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification.,5
Double-labeled fluorescent probes for 5' nuclease assays: purification and performance evaluation.,5
"A rapid, sensitive and automated method for detection of Salmonella species in foods using AG-9600 AmpliSensor Analyzer.",5
Identification of pathogenic Leptospira genospecies by continuous monitoring of fluorogenic hybridization probes during rapid-cycle PCR.,5
Fluorotyping of HLA-C: differential detection of amplicons by sequence-specific priming and fluorogenic probing.,5
Advances in quantitative PCR technology: 5' nuclease assays.,5
Real-time microchip PCR for detecting single-base differences in viral and human DNA.,5
[Quantitative PCR system].,5
Utility of random amplified polymorphic DNA PCR and TaqMan automated detection in molecular identification of Aspergillus fumigatus.,5
Novel 5' exonuclease-based real-time PCR assay for the detection of t(14;18)(q32;q21) in patients with follicular lymphoma.,5
5' nuclease PCR assay to detect Yersinia pestis.,5
Developments in quantitative PCR.,5
A novel approach to the detection of classical swine fever virus by RT-PCR with a fluorogenic probe (TaqMan).,5
PCR-based DNA amplification and presumptive detection of Escherichia coli O157:H7 with an internal fluorogenic probe and the 5' nuclease (TaqMan) assay.,5
Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system.,5
Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes.,5
Fluorotyping of HLA-A by sequence-specific priming and fluorogenic probing.,5
High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA.,5
Differential induction of chemokines in human microglia by type I and II interferons.,1
Modulation of fas-ligand (Fas-L) on human microglial cells: an in vitro study.,4
The current state of multiple sclerosis genetic research.,1
Genetic control of pathogenic mechanisms in autoimmune demyelinating disease.,1
Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation.,3
Genetic models for CNS inflammation.,1
"Lack of association between the interferon regulatory factor-1 (IRF1) locus at 5q31.1 and multiple sclerosis in Germany, northern Italy, Sardinia and Sweden.",1
The interferon gene cluster: a candidate region for MS predisposition? Multiple Sclerosis Study Group.,6
[Multiple sclerosis: the recent progress of research and treatment].,1
Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.,1
IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system.,3
IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.,1
Cloning and expression of murine IFN beta and a TNF antagonist for gene therapy of experimental allergic encephalomyelitis.,1
Fatal familial insomnia: a new Austrian family.,8
Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.,8
Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease.,8
[Prion diseases in pediatrics].,8
Neuropathology of prion diseases.,8
A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein.,8
A subtype of sporadic prion disease mimicking fatal familial insomnia.,8
[Prion disease and brain amyloidosis].,8
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.,8
The human prion diseases. A review with special emphasis on new variant CJD and comments on surveillance.,8
Prion protein glycotype analysis in familial and sporadic Creutzfeldt-Jakob disease patients.,8
Generation of monoclonal antibodies against prion proteins with an unconventional nucleic acid-based immunization strategy.,8
Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene.,8
Type 1 protease resistant prion protein and valine homozygosity at codon 129 of PRNP identify a subtype of sporadic Creutzfeldt-Jakob disease.,8
Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2.,8
"Normal inhibitory avoidance learning and anxiety, but increased locomotor activity in mice devoid of PrP(C).",8
Mutation at codon 210 (V210I) of the prion protein gene in a North African patient with Creutzfeldt-Jakob disease.,8
Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene.,8
Novel PRNP sequence variant associated with familial encephalopathy.,8
Novel twelve-generation kindred of fatal familial insomnia from germany representing the entire spectrum of disease expression.,8
Creutzfeldt-Jakob disease profile in patients homozygous for the PRNP E200K mutation.,8
How is Creutzfeldt-Jakob disease acquired?,8
Functional and structural differences between the prion protein from two alleles prnp(a) and prnp(b) of mouse.,8
[Mechanisms of neuroinvasion by prions: molecular principles and present state of research].,8
"Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype.",8
Epithelial and endothelial expression of the green fluorescent protein reporter gene under the control of bovine prion protein (PrP) gene regulatory sequences in transgenic mice.,8
[Bovine spongiform encephalopathy and food safety].,1
A three-sister sibship of Gerstmann-Sträussler-Scheinker disease with a CJD phenotype.,8
Intracerebral distribution of the abnormal isoform of the prion protein in sporadic Creutzfeldt-Jakob disease and fatal insomnia.,8
Japanese scrapie cases.,8
Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease.,8
Familial Creutzfeldt-Jakob disease in a patient carrying both a presenilin 1 missense substitution and a prion protein gene insertion.,8
Familial Creutzfeldt-Jakob disease in a patient carrying both a presenilin 1 missense substitution and a prion protein gene insertion.,8
Identification of a novel gene encoding a PrP-like protein expressed as chimeric transcripts fused to PrP exon 1/2 in ataxic mouse line with a disrupted PrP gene.,8
Laboratory diagnosis of variant Creutzfeldt-Jakob disease.,8
Creutzfeldt-Jakob disease with a novel four extra-repeat insertional mutation in the PrP gene.,8
A rapid and efficient method for the detection of point mutations of the human prion protein gene (PRNP) by direct sequencing.,8
Examination of the human prion protein-like gene doppel for genetic susceptibility to sporadic and variant Creutzfeldt-Jakob disease.,8
Inherited prion encephalopathy associated with the novel PRNP H187R mutation: a clinical study.,8
Molecular genetics of human prion diseases in Germany.,8
[Recent data on prion diseases].,8
"A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V.",8
Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype.,8
Prions: pathogenesis and reverse genetics.,8
A single amino acid alteration in murine PrP dramatically alters TSE incubation time.,8
Does PRNP gene control the clinical and pathological phenotype of human spongiform transmissible encephalopathies?,8
Creutzfeldt-Jakob disease segregating in a three generation Danish family.,8
"Clinical signs, histopathology and genetics of experimental transmission of BSE and natural scrapie to sheep and goats.",8
Prion protein with an E200K mutation displays properties similar to those of the cellular isoform PrP(C).,8
Isolation and functional characterisation of the promoter region of the human prion protein gene.,8
Genetic and environmental factors modify bovine spongiform encephalopathy incubation period in mice.,8
Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells.,8
Genetic epidemiology of Creutzfeldt-Jakob disease in Europe.,8
Increased incidence of sporadic Creutzfeldt-Jakob disease on the island of Crete associated with a high rate of PRNP 129-methionine homozygosity in the local population.,8
Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies.,8
[Creutzfeldt-Jakob disease: the most frequent spongiform encephalopathy in humans].,8
Mutation of the PRNP gene at codon 211 in familial Creutzfeldt-Jakob disease.,8
Florid plaques in ovine PrP transgenic mice infected with an experimental ovine BSE.,8
The prion gene complex encoding PrP(C) and Doppel: insights from mutational analysis.,8
"Codon 129 polymorphism of the PRNP gene in normal Polish population and in Creutzfeldt-Jakob disease, and the search for new mutations in PRNP gene.",8
"Genomic organization, comparative analysis, and genetic polymorphisms of the bovine and ovine prion Doppel genes (PRND).",8
Creutzfeldt-Jakob disease: a protein disease.,8
Report on the first polish case of the Gerstmann-Sträussler-Scheinker syndrome.,8
In situ hybridization analysis of PrP mRNA in human CNS tissues.,8
Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt-Jakob Disease phenotype.,8
Sporadic--but not variant--Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1.,8
A new PRNP mutation (G131V) associated with Gerstmann-Sträussler-Scheinker disease.,8
"Similar target, different effects: late-onset ataxia and spatial learning in prion protein-deficient mouse lines.",8
Biology of the prion gene complex.,8
Inherited prion disease caused by the V210I mutation: transmission to transgenic mice.,8
[Diagnosis of bovine spongiform encephalopathy and scrapie by western blot].,8
Insomnia associated with thalamic involvement in E200K Creutzfeldt-Jakob disease.,8
Distribution of the M129V polymorphism of the prion protein gene in a Turkish population suggests a high risk for Creutzfeldt-Jakob disease.,8
Expression of doppel in the CNS of mice does not modulate transmissible spongiform encephalopathy disease.,8
[Genetics of human subacute spongiform encephalopathies].,8
PRNP contains both intronic and upstream regulatory regions that may influence susceptibility to Creutzfeldt-Jakob Disease.,8
Molecular genetics of transmissible spongiform encephalopathies: an introduction.,8
"Influence of the prion protein gene, Prnp, on scrapie susceptibility in sheep.",8
Molecular advances in understanding inherited prion diseases.,8
Spontaneous mutations in the prion protein gene causing transmissible spongiform encephalopathy.,8
Analysis of the prion protein in primates reveals a new polymorphism in codon 226 (Y226F).,8
[Sporadic Creutzfeldt-Jakob disease: phenotypic variability].,8
Dominant-negative inhibition of prion replication in transgenic mice.,8
Codon 219 in Creutzfeldt-Jakob disease in Poland.,8
Mutations of the prion protein gene phenotypic spectrum.,8
Does the prion protein gene 129 codon polymorphism influence sleep? Evidence from a fatal familial insomnia kindred.,8
Thermostability of mouse-passaged BSE and scrapie is independent of host PrP genotype: implications for the nature of the causal agents.,8
Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice.,8
Genomic characterization of the human prion protein (PrP) gene locus.,8
[Biology and pathology of prion diseases].,8
Sporadic Creutzfeldt-Jakob disease with MM1-type prion protein and plaques.,8
Upstream AUGs modulate prion protein translation in vitro.,8
Stability of the prion protein-encoding (PRNP) gene in HeLa cells.,8
Accumulation of pathogenic prion protein (PrPSc) in nervous and lymphoid tissues of sheep with subclinical scrapie.,8
Cell-associated variants of disease-specific prion protein immunolabelling are found in different sources of sheep transmissible spongiform encephalopathy.,8
[Usefulness of molecular genetic analysis of the PRNP gene in patients with cerebellar ataxia: a new case of fatal familial insomnia].,8
Phenotypic variability in the brains of a family with a prion disease characterized by a 144-base pair insertion in the prion protein gene.,8
Early detection of PrPres in BSE-infected bovine PrP transgenic mice.,8
Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease.,8
"Susceptibility of transgenic mice expressing chimeric sheep, bovine and human PrP genes to sheep scrapie.",8
Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics.,8
Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia.,8
Efficient and specific down-regulation of prion protein expression by RNAi.,8
Prion octapeptide-repeat polymorphism in Polish Black-and-White cattle.,8
Prion susceptibility and protective alleles exhibit marked geographic differences.,8
Familial and sporadic fatal insomnia.,8
Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line.,8
Abnormal segregation of prion protein octapeptide-repeat alleles in cattle.,8
Neuronal and astrocytic responses involving the serotonergic system in human spongiform encephalopathies.,8
Sporadic and familial CJD: classification and characterisation.,8
"Acquired prion disease: iatrogenic CJD, variant CJD, kuru.",8
Transmission of murine scrapie to P101L transgenic mice.,8
Molecular biology and pathology of scrapie and the prion diseases of humans.,8
Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165.,8
The transmissible spongiform encephalopathies.,8
"Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features.",8
[Molecular genetics in Creutzfeldt-Jakob disease].,8
"[Prion protein: structure, functions and polymorphisms associated with human spongiform encephalopathies].",8
Gerstmann-Sträussler-Scheinker disease with mutation at codon 102 and methionine at codon 129 of PRNP in previously unreported patients.,8
[Natural history of human transmissible subacute spongiform encephalopathies].,8
[Molecular basis of familial and sporadic forms of human prion diseases].,8
A simple and rapid method for sequencing the entire coding region of the human prion protein (PrP) gene.,8
Frequencies of PrP gene variants in healthy cattle and cattle with BSE in Scotland.,8
Genetics of human prion disease.,8
"PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie.",8
Genetics of prion diseases and prion diversity in mice.,8
Molecular genetics of human prion diseases.,8
Human prion diseases with variant prion protein.,8
Molecular biology and genetics of prion diseases.,8
Transmissible spongiform encephalopathies or prion disorders--current views.,8
Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease.,8
The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation.,8
[Human transmissible subacute spongiform encephalopathy].,8
Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele.,8
[Genome diagnosis in domestic animals].,8
Molecular genetics of prion diseases in France. French Research Group on Epidemiology of Human Spongiform Encephalopathies.,8
Molecular genetic studies of Creutzfeldt-Jakob disease.,8
A novel mechanism of phenotypic heterogeneity demonstrated by the effect of a polymorphism on a pathogenic mutation in the PRNP (prion protein gene).,8
Genetic analysis of Creutzfeldt-Jakob disease and related disorders.,8
Overview of the transmissible spongiform encephalopathies: prion protein disorders.,8
PrP gene and its association with spongiform encephalopathies.,8
Human prion diseases.,8
Prion encephalopathies of animals and humans.,8
In situ hybridization and immunohistochemistry for prion protein (PrP) in bovine spongiform encephalopathy (BSE).,8
Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200(Lys) mutation.,8
[Importance of genetic factors in pathogenesis of subacute spongiform viral encephalitis].,8
The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.,8
Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice.,8
Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene.,8
Prion disease associated with a novel nine octapeptide repeat insertion in the PRNP gene.,8
Familial Creutzfeldt-Jakob disease with a five-repeat octapeptide insert mutation.,9
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Sträussler-Scheinker disease (PrP-P102L mutation).,8
Human prion diseases.,8
Mad cow disease and Creutzfeldt-Jakob disease--is there a link?,8
Mutation of the prion protein gene at codon 208 in familial Creutzfeldt-Jakob disease.,8
Novel polymorphisms in the caprine PrP gene: a codon 142 mutation associated with scrapie incubation period.,8
Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease.,8
Characterisation of two promoters for prion protein (PrP) gene expression in neuronal cells.,8
A novel hamster prion protein mRNA contains an extra exon: increased expression in scrapie.,8
Characterization of the bovine prion protein gene: the expression requires interaction between the promoter and intron.,8
[Prion diseases--general aspect].,8
[Prion diseases and a new variant of Creutzfeldt-Jakob disease].,8
Familial prion disease with a novel 144-bp insertion in the prion protein gene in a Basque family.,8
Transgenic analysis of prion diseases.,8
PrP genetics in sheep and the applications for scrapie and BSE.,8
Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews.,8
The nature of transmission in prion diseases.,8
"Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent.",8
Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease.,8
The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.,8
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease.,8
A comparative study of abnormal prion protein isoforms between Gerstmann-Sträussler-Scheinker syndrome and Creutzfeldt-Jakob disease.,8
The prion diseases.,8
Molecular analysis of prion protein gene (PRNP) in Korean patients with Creutzfeldt-Jakob disease.,8
Genomic structure of the bovine PrP gene and complete nucleotide sequence of bovine PrP cDNA.,8
"Creutzfeldt-Jakob disease: clinical features, epidemiology and tests.",8
Prion's progress: patterns and rates of molecular evolution in relation to spongiform disease.,8
APOE in non-Alzheimer amyloidoses: transmissible spongiform encephalopathies.,6
[Spongiform encephalopathies in animals and humans].,8
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity.,8
Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease.,8
A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler-Scheinker phenotype but no alterations in the PRNP gene.,8
Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues.,8
Familial mutations and the thermodynamic stability of the recombinant human prion protein.,8
Phenotypic variability in fatal familial insomnia (D178N-129M) genotype.,8
Japanese Creutzfeldt-Jakob disease patients exhibiting high incidence of the E200K PRNP mutation and located in the basin of a river.,8
Genetic risk factors in Alzheimer's disease.,9
Genetic risk factors in Alzheimer's disease.,9
Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques.,1
[Molecular genetic analysis of Alzheimer's dementia in the Czech population. The APP-717 mutation in the gene for amyloid protein precursor].,9
Genetic epidemiology of Alzheimer's disease.,9
Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.,9
Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease.,6
"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.",1
Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE).,6
Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE).,6
Genetic interactions between error-prone and error-free postreplication repair pathways in Saccharomyces cerevisiae.,3
"UBC13, a DNA-damage-inducible gene, is a member of the error-free postreplication repair pathway in Saccharomyces cerevisiae.",3
Two RING finger proteins mediate cooperation between ubiquitin-conjugating enzymes in DNA repair.,3
"MPH1, a yeast gene encoding a DEAH protein, plays a role in protection of the genome from spontaneous and chemically induced damage.",3
The Saccharomyces cerevisiae RAD6 group is composed of an error-prone and two error-free postreplication repair pathways.,3
Molecular cloning and functional characterization of two murine cDNAs which encode Ubc variants involved in DNA repair and mutagenesis.,3
TAK1 is a ubiquitin-dependent kinase of MKK and IKK.,7
Noncovalent interaction between ubiquitin and the human DNA repair protein Mms2 is required for Ubc13-mediated polyubiquitination.,3
The srs2 suppressor of UV sensitivity acts specifically on the RAD5- and MMS2-dependent branch of the RAD6 pathway.,4
Identification of a protein essential for a major pathway used by human cells to avoid UV- induced DNA damage.,3
The Chfr mitotic checkpoint protein functions with Ubc13-Mms2 to form Lys63-linked polyubiquitin chains.,3
Genetic analysis of mitomycin C-hypersensitive Chinese hamster cell mutants.,3
Mechanisms determining sensitivity to cisplatin in three mutant Chinese hamster ovary cell lines.,3
The products of the yeast MMS2 and two human homologs (hMMS2 and CROC-1) define a structurally and functionally conserved Ubc-like protein family.,3
"Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor.",0
"Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor.",0
Analysis of masked mutations in familial adenomatous polyposis.,0
5'-Cytosine DNA-methyltransferase mRNA levels in hereditary colon carcinoma.,7
Detection of mutations in the DNA polymerase delta gene of human sporadic colorectal cancers and colon cancer cell lines.,0
Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer.,0
Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice.,0
A common human skin tumour is caused by activating mutations in beta-catenin.,3
"Effects of paclitaxel on the growth of normal, polyposis, and cancerous human colonic epithelial cells.",3
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.,3
Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis.,0
Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis.,0
Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated beta-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc.,0
Exon 14-skipping of the adenomatous polyposis coli gene in purified epithelial cells of colonic mucosa and tumors.,0
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.,3
Dysregulation of beta-catenin is common in canine sporadic colorectal tumors.,0
Protein synthesis inhibitor-mediated stability of adenomatous polyposis coli mRNA levels in HCT-116 colon cancer cells.,0
Public health perspectives on testing for colorectal cancer susceptibility genes.,0
The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.,0
"Intracellular distribution of beta-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps.",0
Colorectal cancer: molecules and populations.,0
Colossal crypts bordering colon adenomas in Apc(Min) mice express full-length Apc.,0
Upper gastrointestinal polyps in familial adenomatous polyposis.,0
"Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.",0
Germline mutations are frequent in the APC gene but absent in the beta-catenin gene in familial adenomatous polyposis patients.,0
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.,0
"Four new colon cancer susceptibility loci, Scc6 to Scc9 in the mouse.",0
CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling.,0
Attenuated familial adenomatous polyposis in a man with an interstitial deletion of chromosome arm 5q.,0
Mouse models for colorectal cancer.,0
Colorectal cancer with and without microsatellite instability involves different genes.,0
Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer.,7
APC: the plot thickens.,0
A correlation of APC and c-myc mRNA levels in lung cancer cell lines.,0
The APC protein binds to A/T rich DNA sequences.,0
"Identification and characterization of E-APC, a novel Drosophila homologue of the tumour suppressor APC.",0
Genetic susceptibility to non-polyposis colorectal cancer.,0
Colon polyps: a damaged developmental system and a precursor to cancer.,0
Mechanisms of APC-driven tumorigenesis: lessons from mouse models.,0
Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin.,4
The identical 5' splice-site acceptor mutation in five attenuated APC families from Newfoundland demonstrates a founder effect.,0
Genetic testing and counseling for hereditary forms of colorectal cancer.,0
Catenins and their associated proteins in colorectal cancer.,0
The adenomatous polyposis coli protein.,0
The adenomatous polyposis coli protein.,0
The adenomatous polyposis coli protein.,0
"AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.",0
Defects in the regulation of beta-catenin in colorectal cancer.,0
APC mutation and phenotypic spectrum of Singapore familial adenomatous polyposis patients.,0
Truncated adenomatous polyposis coli (APC) tumour suppressor protein can undergo tyrosine phosphorylation.,0
Modulation by dietary factors in murine FAP models.,0
Down-regulation of beta-catenin by the colorectal tumor suppressor APC requires association with Axin and beta-catenin.,0
Prevalence of the APC E1317Q variant in colorectal cancer patients.,0
"APC mutations in sporadic colorectal tumors: A mutational ""hotspot"" and interdependence of the ""two hits"".",0
The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.,0
Genetic analysis of multiple synchronous lesions of the colon adenoma-carcinoma sequence.,0
Response to genetic counseling and testing for the APC I1307K mutation.,0
"Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos.",1
Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis.,1
"Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522.",0
Biology of the adenomatous polyposis coli tumor suppressor.,0
Familial adenomatous polyposis.,0
gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.,0
Mlh1 deficiency enhances several phenotypes of Apc(Min)/+ mice.,0
Somatic mutations of the APC gene in primary breast cancers.,0
Proteomic analysis of the small intestine and colon epithelia of adenomatous polyposis coli gene-mutant mice by two-dimensional gel electrophoresis.,0
"Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.",3
Genetics of hereditary colon cancer - a basis for prevention?,0
Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.,3
[Mutations of APC gene MCR region in sporadic colorectal adenomas and carcinomas].,0
[Mutation of APC gene in sporadic colorectal tumors].,0
Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis.,0
Beta-catenin and adenomatous polyposis coli (APC) mutations in adenomas from hereditary non-polyposis colorectal cancer patients.,0
Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia.,0
The Adenomatous Polyposis Coli-protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain.,0
Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis.,0
Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.,0
Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover.,0
"Familial adenomatous polyposis, hereditary nonpolyposis colon cancer, and familial risk: what are the implications for the surgeon?",0
The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.,1
Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.,3
E-cadherin and adenomatous polyposis coli mutations are synergistic in intestinal tumor initiation in mice.,0
Expression of beta-catenin and full-length APC protein in normal and neoplastic colonic tissues.,0
[From gene to disease; the APC gene and familial adenomatous polyposis coli].,0
"Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane.",0
"The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.",0
"The adenomatous polyposis coli (APC) tumour suppressor--genetics, function and disease.",0
Methylation of CpG loci in 5'-flanking region alters steady-state expression of adenomatous polyposis coli gene in colon cancer cell lines.,0
Apical membrane localization of the adenomatous polyposis coli tumor suppressor protein and subcellular distribution of the beta-catenin destruction complex in polarized epithelial cells.,0
Apical membrane localization of the adenomatous polyposis coli tumor suppressor protein and subcellular distribution of the beta-catenin destruction complex in polarized epithelial cells.,0
Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3 beta phosphorylation.,0
Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3 beta phosphorylation.,0
"Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.",0
Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal.,4
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].,7
"A molecular variant of the APC gene at codon 1822: its association with diet, lifestyle, and risk of colon cancer.",0
A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.,0
Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells.,3
The many faces of the tumor suppressor gene APC.,0
The many faces of the tumor suppressor gene APC.,0
The many faces of the tumor suppressor gene APC.,0
"Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.",3
"Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.",0
Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity.,0
The ABC of APC.,0
The ABC of APC.,0
A double germline mutations in the APC and p53 genes.,0
p53-dependent transcriptional regulation of the APC promoter in colon cancer cells treated with DNA alkylating agents.,0
A role for the Adenomatous Polyposis Coli protein in chromosome segregation.,0
A role for the Adenomatous Polyposis Coli protein in chromosome segregation.,0
Nine novel APC mutations in Italian FAP patients.,0
Biomarkers for early detection of colon cancer.,2
Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.,3
Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.,1
Aneuploid colon cancer cells have a robust spindle checkpoint.,3
Cyclooxygenase-2: a novel target for cancer chemotherapy?,4
Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer.,0
Expression of the gut-enriched Krüppel-like factor (Krüppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2.,0
Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.,0
"Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis.",0
The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effect.,0
[Familial colonic polyposis: effect of molecular analysis on the diagnostic-therapeutic approach].,0
Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.,0
Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and beta(2)-microglobulin-deficient mouse.,0
ARM domain-dependent nuclear import of adenomatous polyposis coli protein is stimulated by the B56 alpha subunit of protein phosphatase 2A.,0
Mechanisms of oncogenesis in colon versus rectal cancer.,0
Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis.,0
Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer.,0
Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.,7
Studies on human colon cancer gene APC by targeted expression in Drosophila.,0
Studies on human colon cancer gene APC by targeted expression in Drosophila.,0
COL11A1 in FAP polyps and in sporadic colorectal tumors.,0
Computer modeling implicates stem cell overproduction in colon cancer initiation.,0
Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.,0
Attenuated familial adenomatous polyposis: an evolving and poorly understood entity.,0
Detection of APC mutations in fecal DNA from patients with colorectal tumors.,0
Serrated adenoma in familial adenomatous polyposis: relation to germline APC gene mutation.,0
"Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or ""multiple"" colorectal adenomas.",0
"Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability.",0
Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane.,0
APC germline mutations identified in Czech patients with familial adenomatous polyposis.,0
Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein.,0
The APC gene in colorectal cancer.,0
Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.,0
The subcellular destinations of APC proteins.,0
Familial adenomatous polyposis in two Black South African families.,0
Molecular analysis of the APC gene in 71 Israeli families: 17 novel mutations.,0
Genetic and clinical characterisation of familial adenomatous polyposis: a population based study.,0
The DNA polymerase beta replication error spectrum in the adenomatous polyposis coli gene contains human colon tumor mutational hotspots.,0
Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation.,0
"Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis.",0
Molecular causes of colon cancer.,3
Intestinal adenomas can develop with a stable karyotype and stable microsatellites.,0
"Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.",0
Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.,7
Adenomatous polyposis coli gene as a gatekeeper.,0
"[Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].",0
Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.,0
Preliminary results of the molecular diagnosis of familial adenomatous polyposis in Cuban families.,0
Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma.,7
What can humans learn from flies about adenomatous polyposis coli?,0
What can humans learn from flies about adenomatous polyposis coli?,0
The genetics of colorectal cancer.,0
APC-dependent suppression of colon carcinogenesis by PPARgamma.,1
Suppression of kinesin expression disrupts adenomatous polyposis coli (APC) localization and affects beta-catenin turnover in young adult mouse colon (YAMC) epithelial cells.,0
Suppression of kinesin expression disrupts adenomatous polyposis coli (APC) localization and affects beta-catenin turnover in young adult mouse colon (YAMC) epithelial cells.,0
Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway.,0
Effect of sulindac treatment for attenuated familial adenomatous polyposis with a new germline APC mutation at codon 161: report of a case.,0
Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.,3
Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis.,0
Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.,0
Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.,0
The molecular and genetic basis of colon cancer.,0
Germline APC mutation on the beta-catenin binding site is associated with a decreased apoptotic level in colorectal adenomas.,0
Novel mutations of the APC gene in familial adenomatous polyposis in Greek patients.,0
Dietary factors and the occurrence of truncating APC mutations in sporadic colon carcinomas: a Dutch population-based study.,0
Familial adenomatous polyposis as a precancerosis of colon cancer.,0
Mutated APC and Asef are involved in the migration of colorectal tumour cells.,0
Mutated APC and Asef are involved in the migration of colorectal tumour cells.,0
Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription.,0
Alterations of anaphase-promoting complex genes in human colon cancer cells.,0
Expressions of two adenomatous polyposis coli and E-cadherin proteins on human colorectal cancers.,0
Genetic analysis of familial colorectal cancer in Israeli Arabs.,0
Cigarette smoking and genetic alterations in sporadic colon carcinomas.,3
[Familial adenomatous polyposis: review of the literature and report of 3 cases].,0
Rapidly progressive adenomatous polyposis in a patient with germline mutations in both the APC and MLH1 genes: the worst of two worlds.,0
Genetic testing for high-risk colon cancer patients.,0
Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation.,0
Molecular changes in the Ki-ras and APC genes in primary colorectal carcinoma and synchronous metastases compared with the findings in accompanying adenomas.,0
beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.,0
Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene.,3
Immunohistochemical analyses of colon cancer in I1307K APC mutation carriers compared with noncarriers.,0
Genetic alterations of the APC gene in familial adenomatous polyposis patients of the hellenic group for the study of colorectal cancer.,0
Regulation of caspase expression and apoptosis by adenomatous polyposis coli.,0
"Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer.",0
Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines.,4
Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse.,0
Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.,4
Profuse familial adenomatous polyposis with an adenomatous polyposis coli exon 3 mutation.,0
Spontaneous aberrant crypt foci in Apc1638N mice with a mutant Apc allele.,0
Purification of the adenomatous polyposis coli (APC) gene product.,0
APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis.,0
The adenomatous polyposis coli gene and human cancers.,0
"The clinical [corrected] background of familial adenomatous polyposis. History, epidemiology, diagnosis and treatment.",0
Microsatellite instability in colorectal adenocarcinoma cell lines that have full-length adenomatous polyposis coli protein.,0
Effects of docosahexaenoic acid (DHA) on intestinal polyp development in Apc delta 716 knockout mice.,0
Genetics of colon cancer: impact of inheritance on colon cancer risk.,0
APC binds to the novel protein EB1.,0
"Molecular, cytogenetic, and phenotypic studies of a constitutional reciprocal translocation t(5;10)(q22;q25) responsible for familial adenomatous polyposis in a Dutch pedigree.",0
Genetic predispositions to colorectal cancer.,0
Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.,0
Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms.,0
[New strategies in the clinical evaluation of patients with colon cancer based on molecular studies].,0
Somatic APC and K-ras codon 12 mutations in periampullary adenomas and carcinomas from familial adenomatous polyposis patients.,0
Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.,0
Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations.,0
E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.,0
E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.,0
Mutational analysis of the first 14 exons of the adenomatous polyposis coli (APC) gene.,0
Identification of germ line mutation of APC gene in possible carriers of familial adenomatous polyposis (FAP).,0
Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP).,0
"Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene.",0
Phosphorylation of the adenomatous polyposis coli protein and its possible regulatory effects in cells.,0
Phosphorylation of the adenomatous polyposis coli protein and its possible regulatory effects in cells.,0
Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer.,0
Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer.,0
Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons.,0
Mutations of the adenomatous polyposis coli gene in the mutation cluster region: comparison of human pancreatic and colorectal cancers.,0
Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro.,0
[Familial adenomatous polyposis].,0
Inactivation of both APC alleles in human and mouse tumors.,0
"The capacity for growth stimulation by TGF beta 1 seen only in advanced colon cancers cannot be ascribed to mutations in APC, DCC, p53 or ras.",0
Southwestern internal medicine conference: hereditary predisposition to colorectal cancer: new insights.,0
[Contribution of genetic typing for the diagnosis of familial adenomatous polyposis in pediatrics].,0
[Detection of a gene mutation in familial adenomatous polyposis families by PCR-RFLP method].,0
Association of APC gene mutations and histological characteristics of colorectal adenomas.,0
Wild-type but not mutant APC associates with the microtubule cytoskeleton.,0
Wild-type but not mutant APC associates with the microtubule cytoskeleton.,0
The APC gene product associates with microtubules in vivo and promotes their assembly in vitro.,0
The APC gene product associates with microtubules in vivo and promotes their assembly in vitro.,0
Adenomatous polyposis coli and a cytogenetic deletion of chromosome 5 resulting from a maternal intrachromosomal insertion.,0
Knowledge of the adenomatous polyposis coli gene and its clinical application.,0
A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.,0
[Genetic alterations of human colorectal cancer].,0
Mutations of the APC (adenomatous polyposis coli) gene.,0
Exon eight APC mutations account for a disproportionate number of familial adenomatous polyposis families.,0
Mutation in a splice-donor site of the APC gene in a family with polyposis and late age of colonic cancer death.,0
"A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene.",7
[Molecular genetics of colorectal cancer and carcinogenesis].,0
Frequency of common and novel inactivating APC mutations in 202 families with familial adenomatous polyposis.,0
Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli.,0
Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.,0
Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation.,0
APC gene messenger RNA: novel isoforms that lack exon 7.,0
Molecular diagnosis of familial adenomatous polyposis.,0
Dimer formation by an N-terminal coiled coil in the APC protein.,0
Alleles of the APC gene: an attenuated form of familial polyposis.,0
Association of the APC gene product with beta-catenin.,0
Association of the APC tumor suppressor protein with catenins.,0
Improved predictive carrier testing for familial adenomatous polyposis using DNA from a single archival specimen and polymorphic markers with multiple alleles.,0
The effect of sulindac on colon polyps: circumvention of a transformed phenotype--a hypothesis.,0
APC mutation in the alternatively spliced region of exon 9 associated with late onset familial adenomatous polyposis.,0
Expression of the APC gene after transfection into a colonic cancer cell line.,0
[Hereditary solitary adenoma].,0
Familial adenomatous polyposis: a submicroscopic deletion at the APC locus in a family with mentally normal patients.,0
"Establishment and characterization of a human colon cancer cell line, OUMS-23, from a patient with familial adenomatous polyposis.",0
"A tale of four syndromes: familial adenomatous polyposis, Gardner syndrome, attenuated APC and Turcot syndrome.",0
APC gene: database of germline and somatic mutations in human tumors and cell lines.,0
Molecular biology of colon polyps and colon cancer.,0
Cranial desmoid tumor associated with homozygous inactivation of the adenomatous polyposis coli gene in a 2-year-old girl with familial adenomatous polyposis.,0
Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients.,0
Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP.,0
Multistep carcinogenesis in colorectal cancers.,0
Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.,0
Attenuated familial adenomatous polyposis due to a mutation in the 3' part of the APC gene. A clue for understanding the function of the APC protein.,0
MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.,0
[Use of molecular genetics in the early diagnosis of familial adenomatous polyposis].,0
"Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer.",0
The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration.,0
Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.,3
Emergent issues in the genetics of intestinal neoplasia.,0
[Genetic diagnosis of colorectal cancer].,7
Apoptosis and APC in colorectal tumorigenesis.,0
"The genetic background of familial adenomatous polyposis. Linkage analysis, the APC gene identification and mutation screening.",0
APC mutations in colorectal tumors with mismatch repair deficiency.,0
Germline APC mutation (Gln1317) in a cancer-prone family that does not result in familial adenomatous polyposis.,0
Molecular genetic analysis of exons 1 to 6 of the APC gene in non-polyposis familial colorectal cancer.,0
An EcoRI RFLP in human APC gene.,0
The genetic basis of colorectal cancer risk.,0
Mutation detection in exons 1-14 of the adenomatous polyposis coli gene: identification of an alternatively spliced transcript.,0
[The APC gene].,0
[The APC gene].,0
Germline mutations in the 3' part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli.,0
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).,0
Extracolonic features of familial adenomatous polyposis in patients with sporadic colorectal cancer.,0
The APC gene product and colorectal carcinogenesis.,0
A Drosophila homolog of the tumor suppressor gene adenomatous polyposis coli down-regulates beta-catenin but its zygotic expression is not essential for the regulation of Armadillo.,0
Genotype-phenotype correlations at the adenomatous polyposis coli (APC) gene.,0
Adenomatous polyposis coli tumor suppressor protein has signaling activity in Xenopus laevis embryos resulting in the induction of an ectopic dorsoanterior axis.,0
APC mutation and the crypt cycle in murine and human intestine.,0
Genetic alterations and epithelial dysplasia in juvenile polyposis syndrome and sporadic juvenile polyps.,3
A mouse model of human familial adenomatous polyposis.,0
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.,0
Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.,0
"Molecular analysis of the adenomatous polyposis coli gene in sarcomas, hematological malignancies and noncolonic, neoplastic tissues.",0
Phenotypic expression of disease in families that have mutations in the 5' region of the adenomatous polyposis coli gene.,0
Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein.,0
[Familial adenomatous polyposis: establishing a registry and genetic and molecular analysis].,0
Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice.,0
"Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.",0
Molecular genetics of colon cancer.,0
The adenomatous polyposis coli (APC) tumor suppressor.,0
The use of DNA markers in the pre-clinical diagnosis of familial adenomatous polyposis.,0
The clinical correlates of a 3' truncating mutation (codons 1982-1983) in the adenomatous polyposis coli gene.,0
Variations in the expression of the adenomatous polyposis coli (APC) tumor suppressor gene in human cancer cell lines of different tissue origin.,0
[Genetic and environmental factors in colorectal cancer. Mutations in the familial adenomatous polyposis gene].,0
Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q.,0
Recent advances in molecular genetics of colorectal cancer.,0
Hereditary colon cancer.,0
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.,0
Colon cancer. Molecular biology of the APC protein.,0
Colon cancer. Molecular biology of the APC protein.,0
Constitutive APC exon 14 skipping in early-onset familial adenomatous polyposis reveals a dramatic quantitative distortion of APC gene-specific isoforms.,0
Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene.,0
Familial juvenile polyposis coli with APC gene mutation.,0
[APC mutation analysis in sporadic colorectal cancer].,0
Activation of adenomatous polyposis coli (APC) gene expression by the DNA-alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine requires p53.,0
APC gene: database of germline and somatic mutations in human tumors and cell lines.,0
The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.,2
[Colon carcinoma: molecular diagnosis and therapy].,0
No involvement of APC gene mutations in ulcerative colitis-associated rat colon carcinogenesis induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate.,0
Molecular biology of colorectal cancer.,0
"APC genotype, polyp number, and surgical options in familial adenomatous polyposis.",0
AOM-induced mouse colon tumors do not express full-length APC protein.,0
[Familial adenomatous polyposis coli in the Czech population. I. Detection of an additional 3 mutations out of a total of 7 in exon 15 of the APC gene].,0
Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours.,0
Enhanced intestinal adenomatous polyp formation in Pms2-/-;Min mice.,0
High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat.,0
[Current data on the role of APC protein in the origin of colorectal cancer].,0
Genetic alterations are frequent in APC but rare in the TGF-beta type II receptor gene in cancer in adenomas of the colon.,0
Familial adenomatous polyposis: from bedside to benchside.,0
[Genetic diagnosis of familial adenomatous polyposis: detection of APC gene mutations based on an in vitro synthetized protein].,0
Genotype-phenotype correlations in attenuated adenomatous polyposis coli.,0
Identification of APC exon 15 mutations in families suspected of familial adenomatous polyposis (FAP).,0
A family with attenuated familial adenomatous polyposis due to a mutation in the alternatively spliced region of APC exon 9.,0
Mutations of the Apc gene in experimental colorectal carcinogenesis induced by azoxymethane in F344 rats.,0
A domain within the tumor suppressor protein APC shows very similar biochemical properties as the microtubule-associated protein tau.,0
A domain within the tumor suppressor protein APC shows very similar biochemical properties as the microtubule-associated protein tau.,0
"The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.",0
Genetics of colonic cancer.,0
Aspirin prevents tumors in a murine model of familial adenomatous polyposis.,1
The adenomatous polyposis coli-binding protein EB1 is associated with cytoplasmic and spindle microtubules.,0
The adenomatous polyposis coli-binding protein EB1 is associated with cytoplasmic and spindle microtubules.,0
"The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history.",0
A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice.,0
Infrequent somatic mutation of the adenomatous polyposis coli gene in aberrant crypt foci of human colon tissue.,0
APC in the regulation of intestinal crypt fission.,0
Genetics of hereditary colon cancer: a model for prevention.,0
Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status.,0
Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps.,0
Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis.,0
Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer.,0
The I1307K polymorphism of the APC gene in colorectal cancer.,0
[Tumor suppressor genes with special emphasis on the APC tumor suppressor gene].,0
Genotype-phenotype correlation in murine Apc mutation: differences in enterocyte migration and response to sulindac.,0
Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition.,0
[The role of APC in colonic cancerogenesis: zeroing in on Myc].,0
[The role of APC in colonic cancerogenesis: zeroing in on Myc].,0
Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.,0
Organization of the human orphan nuclear receptor Nurr1 gene.,3
The genetics of Parkinson's disease.,9
Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells.,3
"The constitutive and inducible expression of Nurr1, a key regulator of dopaminergic neuronal differentiation, in human neural and non-neural cell lines.",1
Molecular mechanisms of selective dopaminergic neuronal death in Parkinson's disease.,1
Denervation and repeated L-DOPA induce a coordinate expression of the transcription factor NGFI-B in striatal projection pathways in hemi-parkinsonian rats.,1
Expression of NOR-1 and its closely related members of the steroid/thyroid hormone receptor superfamily in human neuroblastoma cell lines.,7
Comparative distribution of NURR1 and NUR77 nuclear receptors in the mouse central nervous system.,3
Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system.,1
Distribution of messenger RNAs for the orphan nuclear receptors Nurr1 and Nur77 (NGFI-B) in adult rat brain using in situ hybridization.,1
Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors.,3
Dopamine neuron agenesis in Nurr1-deficient mice.,1
Genetics of Parkinson's disease.,9
Differential regulation of the transcriptional activity of the orphan nuclear receptor NGFI-B by membrane depolarization and nerve growth factor.,3
The NGFI-B subfamily of the nuclear receptor superfamily (review).,1
C-terminal Src kinase associates with ligand-stimulated insulin-like growth factor-I receptor.,7
"Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.",7
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.,2
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.,2
Insulin/IGF-I hybrid receptors play a major role in IGF-I signaling in thyroid cancer.,1
Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.,2
Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.,2
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.,2
Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.,2
Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells.,4
Characterization of an antibody that can detect an activated IGF-I receptor in human cancers.,1
Discordant expression of insulin-like growth factors and their receptor messenger ribonucleic acids in endometrial carcinomas relative to normal endometrium.,7
Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition.,7
Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition.,7
Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells.,7
Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.,3
The intracellular mechanism of insulin resistance in pancreatic cancer patients.,7
"Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.",2
Function of the IGF-I receptor in breast cancer.,2
Function of the IGF-I receptor in breast cancer.,2
IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation.,7
Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.,7
New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia.,7
"Role of insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding protein-2 in human colorectal cancers.",7
[Detection of overexpression of insulin receptor gene in laryngeal carcinoma cells by using differential display method].,7
Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.,2
Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer.,2
Inhibition of mitogen-activated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulin-like growth factor I-mediated mitogen-activated protein kinase activation.,7
AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells.,7
Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.,7
Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects.,7
Multiple signal transduction pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase/Delta5-Delta4 isomerase in normal and tumoral target tissues.,7
Blockage of IGF-1R signaling sensitizes urinary bladder cancer cells to mitomycin-mediated cytotoxicity.,4
Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A.,7
In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR).,7
Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.,7
Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.,7
IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?,7
Structure and autoregulation of the insulin-like growth factor 1 receptor kinase.,7
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer.,7
[Expression and prognostic significance in epithelial ovarian cancer].,2
Oestrogen/insulin-like growth factor-I receptor interaction in early breast cancer: clinical implications.,2
Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells.,7
Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.,7
Amino acid transport in a human neuroblastoma cell line is regulated by the type I insulin-like growth factor receptor.,1
IGF1 receptor expression protects against microenvironmental stress found in the solid tumor.,4
Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis.,4
Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling.,7
Effects of genetic blockade of the insulin-like growth factor receptor in human colon cancer cell lines.,4
Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer.,7
"Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer.",7
Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications.,7
Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype.,2
In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.,7
Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate antitumor effects on lung cancer.,7
Insulin-like growth factor II receptor gene-167 genotype increases the risk of oral squamous cell carcinoma in humans.,2
A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.,7
Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer.,1
Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1.,7
The insulin-like growth factor system and cancer.,7
Conjugated linoleic acid downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.,7
Insulin-like growth factor system gene expression in women with type 2 diabetes and breast cancer.,2
"Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.",7
An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.,7
Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.,2
Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.,2
Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.,2
The insulin-like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer.,2
Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.,2
Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid.,2
Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles.,7
Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity.,7
Analysis of the IGF-II receptor gene copy number in breast carcinoma.,2
Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression.,7
Increased expression of insulin receptor substrate-1 in human pancreatic cancer.,7
Insulin-like growth factor expression in human cancer cell lines.,2
Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.,2
Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.,2
Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.,7
Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.,4
Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.,2
"Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.",7
Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.,7
Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells.,7
The insulin receptor content is increased in breast cancers initiated by three different oncogenes in transgenic mice.,2
Insulin receptor expression and clinical outcome in node-negative breast cancer.,2
Sporadic amplification of the insulin receptor gene in human breast cancer.,2
Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer.,2
Type I insulin-like growth factor receptor function in breast cancer.,2
"Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.",7
"Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells.",7
"A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.",7
Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer.,7
Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.,2
Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.,7
Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation.,7
Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice.,4
Basic and clinical studies on ApoE gene typing by line probe assay (LiPA) as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan.,6
White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype.,6
Specific regional transcription of apolipoprotein E in human brain neurons.,6
Plasma levels of apolipoprotein E and genetic markers in elderly patients with Alzheimer's disease.,6
Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population.,6
beta-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients.,6
Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease.,6
"CYP2D6 polymorphisms in Alzheimer's disease, with and without extrapyramidal signs, showing no apolipoprotein E epsilon 4 effect modification.",6
Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations.,6
Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.,6
Is there a genetic basis for the deposition of beta-amyloid after fatal head injury?,6
"Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease.",6
Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.,6
Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4.,6
[The relation between alpha1-antichymotrypsin gene polymorphism and epsilon4 allele of apolipoprotein E gene in Alzheimer disease in Chinese].,6
A genealogical study of Alzheimer disease in the Saguenay region of Quebec.,6
The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease.,6
"Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease.",6
A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease.,6
[Inheritable causes and risk factors of Alzheimer's disease].,9
[Inheritable causes and risk factors of Alzheimer's disease].,9
Apolipoprotein E isoform-specific reduction of extracellular amyloid in neuronal cultures.,6
Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease.,6
Apolipoprotein E genetic variation and Alzheimer's disease. a meta-analysis.,6
Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease.,6
Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease.,6
Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner.,6
[Recent advances in the studies on Alzheimer's diseases].,9
[Recent advances in the studies on Alzheimer's diseases].,9
"Apolipoprotein E and Alzheimer's disease: a genetic, molecular and neuroimaging review.",6
Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease.,6
The role of the polymorphic genes apolipoprotein E and methylene- tetrahydrofolate reductase in the development of dementia of the Alzheimer type.,6
Astrogliosis and the ApoE genotype. an immunohistochemical study of postmortem human brain tissue.,6
Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.,6
Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam Study.,6
Failure to confirm a synergistic effect between the K-variant of the butyrylcholinesterase gene and the epsilon4 allele of the apolipoprotein gene in Japanese patients with Alzheimer's disease.,6
Hippocampal alterations of apolipoprotein E and D mRNA levels in vivo and in vitro following kainate excitotoxicity.,1
Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion.,1
Butyrycholinesterase K variant and Alzheimer's disease.,6
Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease.,6
Memory self-appraisal in middle-aged and older adults with the apolipoprotein E-4 allele.,6
Apo E genotypes and risk of dementia in Down syndrome.,6
Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.,6
Role of APOE in dementia: A critical reappraisal.,6
Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.,6
Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity.,6
"Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.",6
Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions.,6
A role for apoE in regulating the levels of alpha-1-antichymotrypsin in the aging mouse brain and in Alzheimer's disease.,6
Genetics of Alzheimer's disease.,9
Genetics of Alzheimer's disease.,9
Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid.,6
Lack of allelic imbalance in APOE epsilon3/4 brain mRNA expression in Alzheimer's disease.,6
Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.,6
Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.,6
Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset.,6
Apolipoprotein E epsilon4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease.,6
A quantitative and immunohistochemical study on apolipoprotein E in brain tissue in Alzheimer's disease.,6
[Frequency of the APOE-4 allele in Alzheimer's disease and its variation with age in Asturias (Spain)].,6
Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture.,1
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study.,6
Herpes simplex virus type 1 and Alzheimer's disease.,6
"Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease.",6
Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.,6
[Genetic factors and a polygenic model of Alzheimer's disease].,9
[Genetic factors and a polygenic model of Alzheimer's disease].,9
Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans.,6
[Alzheimer's disease: lesions and their progression].,9
[The role of apolipoprotein E in the pathogenesis of Alzheimer disease].,6
Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease.,6
Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids.,6
E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease.,6
Cholinergic dysfunction in diseases with Lewy bodies.,1
Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain.,6
Apolipoprotein E and apolipoprotein D expression in a murine model of singlet oxygen-induced cerebral stroke.,6
Molecular genetics of Alzheimer's disease.,9
Molecular genetics of Alzheimer's disease.,9
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.,6
Apolipoprotein E genotype and lipid and lipoprotein levels in dementia.,6
Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women.,6
Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele?,6
Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease.,6
Analyses of serum concentrations of apolipoproteins in the demented elderly.,6
Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: A clinicopathological study.,6
Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: A clinicopathological study.,6
Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer's disease in a Southern Brazilian population.,6
Genetics and brain injury: apolipoprotein E.,6
ApoE polymorphism accounts for only part of the genetic variation in quantitative ApoE levels.,6
Apolipoprotein E polymorphism and serum concentrations in patients with glycogen storage disease type Ia.,6
Effect of apolipoprotein E on cell viability in a human neuroblastoma cell line: influence of oxidation and lipid-association.,6
Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease.,6
Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides.,6
"Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer's disease.",6
Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.,6
Amyloid-beta-induced degeneration of human brain pericytes is dependent on the apolipoprotein E genotype.,6
"Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype.",6
"Severity of cardiovascular disease, apolipoprotein E genotype, and brain pathology in aging and dementia.",6
"beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury.",6
Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.,6
Presence of apolipoprotein E immunoreactivity in degenerating neurones of mice is dependent on the severity of kainic acid-induced lesion.,1
Comparison of astrocytic and myocytic metabolic dysregulation in apolipoprotein E deficient and human apolipoprotein E transgenic mice.,6
"Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia--an epidemiological study using the polymerase chain reaction (PCR) method.",6
"The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models.",6
How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies.,6
Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study.,6
Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.,6
Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population.,6
Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.,9
The cholinergic neuronal phenotype in Alzheimer's disease.,1
The cholinergic neuronal phenotype in Alzheimer's disease.,1
The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection.,6
A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults.,6
Apolipoprotein-E epsilon 4 allele frequency and conferred risk for Cuban Americans with Alzheimer's disease.,6
APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome.,6
Molecular genetics of Alzheimer's disease: what have we learned?,9
Molecular genetics of Alzheimer's disease: what have we learned?,9
Neuropathological heterogeneity in Alzheimer's disease: a study of 80 cases using principal components analysis.,6
Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease.,6
Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.,6
Cerebrospinal fluid lipoproteins in Alzheimer's disease.,6
"Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.",6
Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.,6
Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.,6
Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia.,6
Patterns of brain activation in people at risk for Alzheimer's disease.,6
No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo.,6
Elevated A beta and apolipoprotein E in A betaPP transgenic mice and its relationship to amyloid accumulation in Alzheimer's disease.,6
Genetics of Alzheimer's disease--routes to the pathophysiology.,9
APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.,6
Apolipoprotein E in Southern Italy: protective effect of epsilon 2 allele in early- and late-onset sporadic Alzheimer's disease.,6
Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses.,6
Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.,6
Genotypes and phenotypes for apolipoprotein E and Alzheimer disease in the Honolulu-Asia aging study.,6
Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?,6
Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells.,6
Apolipoprotein E polymorphism and serum concentration in Alzheimer's disease in nine European centres: the ApoEurope study. ApoEurope group.,6
Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer's disease in a Japanese population.,6
Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease.,6
Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan.,6
Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.,6
The genetics of Alzheimer's disease.,9
The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.,6
Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication?,6
Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides.,1
Genetic susceptibility factors for Alzheimer's disease.,6
Is ApoE gene a risk factor for vascular dementia in Han Chinese?,6
High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease.,6
Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern.,6
Genetic association between Alzheimer disease and the alpha-synuclein gene.,6
Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms.,6
Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism.,6
Apolipoprotein E and Alzheimer's disease.,6
Molecular pathogenesis of apolipoprotein E-mediated amyloidosis in late-onset Alzheimer's disease.,6
Causes of Alzheimer's disease.,9
Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response.,6
Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.,6
Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.,6
Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow.,6
Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.,6
APOE epsilon4 and Alzheimer's disease: positive association in a Colombian clinical series and review of the Latin-American studies.,6
Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease.,6
[Causative genes in Alzheimer's disease].,6
Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.,6
Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice.,1
Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients.,6
Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease.,6
Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): implications for Alzheimer's disease.,6
Experience of ApoE study in Thai elderly.,6
Conversion of brain apolipoprotein E to an insoluble form in a mouse model of Alzheimer disease.,6
The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease.,6
Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease.,6
Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls.,6
Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation to the development of Alzheimer's disease.,6
[Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].,6
Variation in the LRP-associated protein gene (LRPAP1) is associated with late-onset Alzheimer disease.,6
Gender and age modify the association between APOE and AD-related neuropathology.,6
Alzheimer beta amyloid deposition enhanced by apoE epsilon4 gene precedes neurofibrillary pathology in the frontal association cortex of nondemented senior subjects.,6
Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.,6
Apolipoprotein E and Alzheimer's disease: signal transduction mechanisms.,6
Apolipoprotein E gene and Alzheimer's disease: is tau the link?,6
Apolipoprotein E and beta A4-amyloid: signals and effects.,6
The genetics of late-onset Alzheimer's disease.,9
Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology.,1
Oxidative damage is the earliest event in Alzheimer disease.,6
Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion.,6
Interaction between apolipoprotein-E and angiotensin-converting enzyme genotype in Alzheimer's disease.,6
Clinical features and alterations in the inferior horn sizes in lateral ventricle in Alzheimer's patients with different ApoE genotype in Japanese population.,6
Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study.,6
A study of apolipoproteins E and A-I in cutaneous amyloids.,6
Gene identification in Alzheimer's disease.,9
Astrocytes down-regulate neuronal beta-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner.,6
Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease.,6
Genetic risk factors in familial Alzheimer's disease.,9
Genetic risk factors in familial Alzheimer's disease.,9
"Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue.",9
Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.,6
Head circumference and incident Alzheimer's disease: modification by apolipoprotein E.,6
Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.,6
APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.,6
New frontiers in Alzheimer's disease genetics.,9
New frontiers in Alzheimer's disease genetics.,9
Association of the apolipoprotein E epsilon4 allele with late-onset depression.,6
Apolipoprotein E: far more than a lipid transport protein.,6
Potential genetic markers of sporadic Alzheimer's dementia.,6
Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics.,1
[The association between microsatellite polymorphism of alpha 1-antichymotrypsin gene and Alzheimer's disease].,6
Apolipoprotein E and age at onset of Alzheimer's disease in African American patients.,6
Significance of the variant and full-length forms of the very low density lipoprotein receptor in brain.,1
The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation.,9
Gene dose effect of the APOE-epsilon4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease.,1
[Apolipoprotein E 4 gene is a risk factor for Alzheimer's disease].,6
Recent developments in Alzheimer's disease.,9
Recent developments in Alzheimer's disease.,9
[Analysis of causative genes and genetic risk factor in Alzheimer's disease].,9
[Analysis of causative genes and genetic risk factor in Alzheimer's disease].,9
Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.,6
Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.,6
Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE.,6
"Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease.",6
Dancing in the dark? The status of late-onset Alzheimer's disease genetics.,9
Dancing in the dark? The status of late-onset Alzheimer's disease genetics.,9
Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy.,6
Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele.,6
"Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein.",1
"[Association between apolipoprotein E polymorphism and Alzheimer's disease: A population-based study in Guangzhou, China].",6
The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.,6
"The domain-specific, stage-limited impact of the apolipoprotein E epsilon-4 allele on cognitive functions in Alzheimer's disease.",6
Of replications and refutations: the status of Alzheimer's disease genetic research.,6
ApoE epsilon3-haplotype modulates Alzheimer beta-amyloid deposition in the brain.,6
Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice.,1
Lack of association between the apolipoprotein E genotype and depression in Alzheimer's disease.,6
Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease.,6
Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.,6
Genetics of Alzheimer's disease.,6
Genetics of Alzheimer's disease.,6
ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model.,6
Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.,3
Candidate gene association studies in sporadic Alzheimer's disease.,6
Apolipoprotein E: a major piece in the Alzheimer's disease puzzle.,6
Apolipoproteins and aging: emerging mechanisms.,6
The Th1/E47cs-G apolipoprotein E (APOE) promoter allele is a risk factor for Alzheimer disease of very later onset.,6
Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.,6
Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function.,1
Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.,6
No synergistic effect between -850 tumor necrosis factor-alpha promoter polymorphism and apolipoprotein E epsilon 4 allele in Alzheimer's disease.,6
Generation and characterization of two transgenic mouse lines expressing human ApoE2 in neurons and glial cells.,6
Depression in Alzheimer's disease might be associated with apolipoprotein E epsilon 4 allele frequency in women but not in men.,6
"Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease.",6
Identification of a protective allele against Alzheimer disease in the APOE gene promoter.,6
"APOE polymorphism and clinical duration determine regional neuropathology in Swedish APP(670, 671) mutation carriers: implications for late-onset Alzheimer's disease.",6
APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.,6
Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.,6
Cerebrospinal fluid lipoprotein delivery to human neuronal cells is increased in Alzheimer's disease and is dependent on apoE monomer concentration.,6
Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.,6
[Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].,6
Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.,6
Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12.,6
APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress.,1
Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitro.,6
Low-density lipoprotein receptor-related protein 8 (apolipoprotein E receptor 2) gene polymorphisms in Alzheimer's disease.,6
Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype.,6
"The 4,752 C/T polymorphism in the presenilin 1 gene increases the risk of Alzheimer's disease in apolipoprotein E4 carriers.",6
"The 4,752 C/T polymorphism in the presenilin 1 gene increases the risk of Alzheimer's disease in apolipoprotein E4 carriers.",6
Apolipoprotein E alters the processing of the beta-amyloid precursor protein in APP(V717F) transgenic mice.,9
Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.,1
Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.,6
Apolipoprotein E genotypes in a group of elderly subjects of Spanish descent living in Mexico City.,6
"Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.",1
Apolipoprotein E and Reelin ligands modulate tau phosphorylation through an apolipoprotein E receptor/disabled-1/glycogen synthase kinase-3beta cascade.,1
Apolipoprotein E and presenilin-1 allelic variation and Alzheimer's disease in India.,6
Endocytic pathway alterations in human hippocampus after global ischemia and the influence of APOE genotype.,6
Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.,6
"Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.",6
"[Serum apolipoprotein A I, B100 and E levels and apolipoprotein E polymorphism in patients with Alzheimer's disease and multiple infarction dementia in Chinese population].",6
APOE E4 is a determinant for Alzheimer type pathology in progressive supranuclear palsy.,6
Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.,6
Gene x environment interaction and cognitive performance: animal studies on the role of corticosterone.,1
"Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients.",6
Gene expression in Alzheimer's disease.,9
Gene expression in Alzheimer's disease.,9
Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease.,6
Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice.,6
Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.,6
Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals.,1
5-Hydroxytryptamine 6 receptor (5-HT(6)) receptor and apolipoprotein E (ApoE) polymorphisms in patients with Alzheimer's disease in the Basque Country.,6
[Alzheimer's disease. Present and future role of genetics].,9
[Alzheimer's disease. Present and future role of genetics].,9
Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians.,6
Alzheimer's disease: the cholesterol connection.,1
Apolipoprotein E (apoE) uptake and distribution in mammalian cell lines is dependent upon source of apoE and can be monitored in living cells.,6
Lack of influence of the apolipoprotein E genotype on the outcome of selegiline treatment in Alzheimer's disease.,6
[A Japanese family with familial Alzheimer's disease associated with presenilin 1 mutation: relationship between younger age of onset and ApoE gene polymorphism].,6
[A Japanese family with familial Alzheimer's disease associated with presenilin 1 mutation: relationship between younger age of onset and ApoE gene polymorphism].,6
APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.,6
Causative and susceptibility genes for Alzheimer's disease: a review.,9
Causative and susceptibility genes for Alzheimer's disease: a review.,9
The renin-angiotensin-aldosterone system and Alzheimer s disease?,6
Modulation of disease risk according to a cathepsin D / apolipoprotein E genotype in Parkinson's disease.,6
[Familial forms of Alzheimer's disease].,9
[Familial forms of Alzheimer's disease].,9
Apolipoprotein E3Basel: new insights into a highly conserved protein region.,6
Apolipoprotein D levels are elevated in prefrontal cortex of subjects with Alzheimer's disease: no relation to apolipoprotein E expression or genotype.,6
Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon4 allele.,6
"Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1.",9
Late onset Alzheimer's disease and apolipoprotein association in the Irish population: relative risk and attributable fraction.,6
Apolipoprotein E genotype in patients with Alzheimer's disease.,6
The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease.,1
"Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients.",6
"APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.",6
Apolipoprotein E -491 promoter polymorphism is an independent risk factor for Alzheimer's disease in the Chinese population.,6
Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.,6
Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol.,6
Apolipoprotein E epsilon 4 allele is a risk factor for familial and sporadic presenile Alzheimer's disease in both homozygote and heterozygote carriers.,6
ApoE immunoreactivity and microglial cells in Alzheimer's disease brain.,6
[Isoform 4 of apolipoprotein E and Alzheimer disease. Specificity and clinical study].,6
Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative.,6
Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives.,6
Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.,6
Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.,6
Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease.,6
Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease.,6
"Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.",6
Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease.,6
ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome.,6
Progress in Alzheimer's disease genetics.,9
Progress in Alzheimer's disease genetics.,9
Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury.,6
Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease.,6
Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease.,6
Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease.,6
"Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease.",6
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain.,6
Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis.,6
Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation.,6
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.,6
A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Dutch Study Group on Down's Syndrome and Ageing.,6
Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.,6
[The apolipoprotein E gene and Alzheimer disease phenotype].,6
Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.,6
APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.,6
"Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids.",6
Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy.,6
Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.,6
Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.,6
Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.,6
"Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease.",6
Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.,6
Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases.,6
Is Alzheimer's disease an apolipoprotein E amyloidosis?,6
Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).,6
Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.,6
Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients.,6
ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val-->Ile mutated families.,6
Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease.,6
The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival.,6
Apolipoprotein E and Alzheimer disease.,6
Influence of the susceptibility genes apolipoprotein E-epsilon 4 and apolipoprotein E-epsilon 2 on the rate of disease expressivity of late-onset Alzheimer's disease.,6
APOE is a major susceptibility gene for Alzheimer's disease.,6
"Apolipoprotein E genotype, Alzheimer's pathologies and related gene expression in the aged population.",6
Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease.,6
"Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study.",6
Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease.,6
Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.,6
[The apolipoprotein E-epsilon 4 allele is a risk factor for Alzheimer disease with early and late onset].,6
Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans.,6
Neurite degeneration elicited by apolipoprotein E peptides.,6
ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease.,6
"Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia.",6
Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition.,6
Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks.,6
Apolipoprotein E and Alzheimer's disease.,6
[Apolipoprotein E4 and late-onset Alzheimer's disease].,6
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.,6
Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease.,6
Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease.,6
Apolipoprotein-E epsilon-4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer's disease.,1
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.,6
Alzheimer's disease. The apolipoprotein E connection.,6
The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease.,6
Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease.,6
"Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer's disease.",6
Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia.,6
Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia.,6
The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies.,6
Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.,6
Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease.,6
"Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls.",6
Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.,6
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.,6
Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.,6
Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease.,6
Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium?,6
The apolipoprotein epsilon 4 allele in Parkinson's disease with and without dementia.,6
Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.,6
The role of apolipoprotein E in the nervous system.,6
Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease.,6
APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease.,6
Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals.,6
"Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.",6
Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.,6
Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.,6
[Pathology of the human apolipoprotein E gene].,6
"Apolipoprotein E expression at neuromuscular junctions in mouse, rat and human skeletal muscle.",6
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study.,6
Isoform-specific binding of apolipoprotein E to beta-amyloid.,6
Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E.,6
Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23.,1
The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease.,6
Apolipoprotein E: risk factor for Alzheimer disease.,6
Molecular genetics of Alzheimer's disease.,9
Molecular genetics of Alzheimer's disease.,9
Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.,6
"Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: prevalence, plasma cholesterol levels and cerebrovascular change.",6
Apolipoprotein E and cholesterol affect neuronal calcium signalling: the possible relationship to beta-amyloid neurotoxicity.,1
Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys.,6
ApoE epsilon 4 allelic association with Alzheimer's disease: independent confirmation using denaturing gradient gel electrophoresis.,6
Confirmation of the epsilon 4 allele of the apolipoprotein E gene as a risk factor for late-onset Alzheimer's disease.,6
Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype.,6
Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia.,6
Apolipoprotein E and the apolipoprotein E-deficient mouse.,6
Association of apolipoprotein E but not B with Alzheimer's disease.,6
Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease.,6
Alzheimer pathology of patients carrying apolipoprotein E epsilon 4 allele.,6
Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease.,6
Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample.,6
Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus.,6
Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese.,6
Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.,6
Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group.,6
Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group.,6
Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.,6
Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.,6
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.,6
High apolipoprotein E epsilon 4 allele frequency in age-related memory decline.,6
"Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease.",1
"Morphological, biochemical, and genetic support for an apolipoprotein E effect on microtubular metabolism.",6
Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology.,6
"Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease.",6
Alzheimer's disease and apolipoprotein E in Italy.,6
Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease.,6
"Amyloid beta-protein, APOE genotype and head injury.",6
Apolipoprotein E polymorphism is associated with both senile plaque load and Alzheimer-type neurofibrillary tangle formation.,6
Differential regulation of APP secretion by apolipoprotein E3 and E4.,6
The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation.,6
"Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease.",6
"Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.",6
Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women.,6
SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.,6
Alzheimer's disease and apolipoprotein E-4 allele in an Amish population.,6
"Apolipoprotein E, synaptic plasticity and Alzheimer's disease.",6
[Apolipoprotein E polymorphism and Alzheimer disease].,6
Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.,6
Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide A beta.,6
Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease.,1
[Alzheimer disease: hypotheses implicating apolipoproteins E].,6
The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.,6
Allelic association but only weak evidence for linkage to the apolipoprotein E locus in late-onset Swedish Alzheimer families.,6
Immunohistochemical study on the deposition of apolipoprotein E in cerebral and islet amyloidoses in cynomolgus monkeys (Macaca fascicularis).,6
Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E.,6
Apolipoprotein E genotype and Alzheimer's disease in an elderly Norwegian cohort.,6
Molecular genetics of Alzheimer's disease.,9
Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia.,6
Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.,6
"Apolipoprotein E, memory and Alzheimer's disease.",6
Lack of association of very low density lipoprotein receptor gene polymorphism with Caucasian Alzheimer's disease.,6
Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease.,6
Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides.,6
Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease.,6
"Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease.",1
"Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients.",6
"Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients.",6
Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.,6
Apolipoprotein E genotype and concomitant clinical features in early-onset Alzheimer's disease.,6
The intracellular fate of apolipoprotein E is tau dependent and apoe allele-specific.,6
Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster.,6
Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls.,6
Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease.,6
Apolipoprotein E in the brain and its role in Alzheimer's disease.,6
Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.,6
Evidence for apolipoprotein E epsilon 4 association in early-onset Alzheimer's patients with late-onset relatives.,6
Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease.,6
Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.,6
Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease.,6
Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians.,6
A closely linked gene to apolipoprotein E may serve as an additional risk factor for Alzheimer's disease.,6
Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease.,6
Apolipoprotein E and Alzheimer's disease.,6
Inconstant apolipoprotein E (ApoE)-like immunoreactivity in amyloid beta protein deposits: relationship with APOE genotype in aging brain and Alzheimer's disease.,6
Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias.,6
Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease.,6
"Apolipoprotein E polymorphism and susceptibility to early- and late-onset sporadic Alzheimer's disease in Hokkaido, the northern part of Japan.",6
"Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men.",6
Apo-E genotype and verbal deficits in Alzheimer's disease.,6
Apolipoprotein E in neurology.,6
Genetic factors for the development of Alzheimer disease in the Cherokee Indian.,6
Apolipoprotein E polymorphism in patients with different neurodegenerative disorders.,6
"The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease.",6
Apolipoprotein E and Alzheimer's disease: strength of association is related to age at onset.,6
Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression.,6
Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up.,6
The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.,6
Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.,1
Distinct distribution of apolipoprotein E and beta-amyloid immunoreactivity in the hippocampus of Parkinson dementia complex of Guam.,6
Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis.,6
The biology of Alzheimer's disease.,9
The Alzheimer diseases.,9
No association between apolipoprotein E epsilon4 allele and the age of onset in type I familial amyloid polyneuropathy.,6
"In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.",1
Human apolipoprotein E: the Alzheimer's disease connection.,6
"Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population.",6
"Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population.",6
Genetics of Alzheimer's disease.,9
Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.,6
Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains.,6
Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele.,6
"Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.",6
"Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease.",6
Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.,6
Apolipoprotein E genotype and gender influence response to tacrine therapy.,6
"Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.",6
Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease.,6
ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.,6
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.,6
"Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype.",6
Distribution of apolipoprotein E gene polymorphisms in Japanese patients with Alzheimer's disease and in Japanese centenarians.,6
The effect of apolipoprotein E genotype on expression of an autosomal dominant schizophreniform disorder with progressive dementia and neurofibrillary tangles.,6
Isoform-specific binding of human apolipoprotein E to the non-amyloid beta component of Alzheimer's disease amyloid.,6
Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.,6
Altered amyloid protein processing in platelets of patients with Alzheimer disease.,9
Apolipoprotein E allele frequencies in patients with late-onset sporadic Alzheimer's dementia in Hungary.,6
Exploring the etiology of Alzheimer disease using molecular genetics.,9
Exploring the etiology of Alzheimer disease using molecular genetics.,9
Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease.,6
Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques.,6
Abeta1-40 but not Abeta1-42 levels in cortex correlate with apolipoprotein E epsilon4 allele dosage in sporadic Alzheimer's disease.,6
Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates beta-amyloid protein activation of complement in vitro.,1
Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.,6
"Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects. Relation to dementia, apolipoprotein E polymorphism, cerebral atrophy, and white matter lesions.",6
Immunohistochemical study of constituents other than beta-protein in canine senile plaques and cerebral amyloid angiopathy.,1
Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls.,6
Distribution of apolipoprotein E in senile plaques in brains with Alzheimer's disease: investigation with the confocal laser scan microscope.,6
Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study.,6
[Risk factors of Alzheimer's disease. Epidemiologic approach].,9
No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease.,6
Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease.,6
Apolipoprotein E and Alzheimer's disease: a review of recent studies.,6
No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.,6
The mean A beta load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease.,6
Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease.,6
The apolipoprotein E gene in Binswanger's disease and vascular dementia.,6
The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease.,6
A subset of senile dementia with high incidence of the apolipoprotein E epsilon2 allele.,6
"The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.",6
Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease.,6
No association between the very low density lipoprotein receptor gene and late-onset Alzheimer's disease nor interaction with the apolipoprotein E gene in population-based and clinic samples.,6
Apolipoprotein E suppresses glial cell secretion of TNF alpha.,6
"Association of human, rat, and rabbit apolipoprotein E with beta-amyloid.",6
Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization.,1
Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence.,6
No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.,6
"Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease.",6
Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein.,6
alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.,6
Apolipoprotein E uptake and low-density lipoprotein receptor-related protein expression by the NTera2/D1 cell line: a cell culture model of relevance for late-onset Alzheimer's disease.,6
"Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.",6
"No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease.",6
"Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients.",6
Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.,6
"Nicotinic receptors, muscarinic receptors and choline acetyltransferase activity in the temporal cortex of Alzheimer patients with differing apolipoprotein E genotypes.",6
Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and alpha1-antichymotrypsin type A allele in Alzheimer's disease.,6
E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.,6
E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.,6
Cerebrospinal fluid apo E and apo A-I concentrations in early- and late-onset Alzheimer's disease.,6
Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.,6
The apolipoprotein E epsilon 4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease.,6
Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's Disease.,6
Apolipoprotein E epsilon2 does not increase risk of early-onset sporadic Alzheimer's disease.,6
Molecular genetics of Alzheimer's disease.,9
Molecular genetics of Alzheimer's disease.,9
The genetics of Alzheimer's disease.,9
The genetics of Alzheimer's disease.,9
Apolipoprotein E and apolipoprotein A-1 knock-out mice readily develop amyloid A protein amyloidosis.,6
ApoE genotype and Alzheimer's disease in adults with Down syndrome: meta-analysis.,6
Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.,6
"Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease?",1
"ApoE, Alzheimer's disease, and recovery from brain stress.",6
Behavioral changes associated with different apolipoprotein E genotypes in dementia.,6
[Alzheimer's disease and genes].,9
[Alzheimer's disease and genes].,9
Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease.,6
"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.",6
[Apolipoprotein E genotype as a risk factor in Japanese patients with early-onset and late-onset Alzheimer's disease].,6
Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's disease.,6
Apolipoprotein E accumulates with the progression of A beta deposition in transgenic mice.,6
Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent.,6
Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia.,6
[The apolipoprotein E genotype and Down's syndrome].,6
A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.,6
"A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality.",6
Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning.,1
Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer's disease.,6
A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.,6
The Lewy body variant of Alzheimer disease.,1
"Apolipoprotein E gene in Parkinson's disease, Lewy body dementia and Alzheimer's disease.",6
[Genotype and phenotype of apolipoprotein E in patients with Alzheimer's disease in Castille and Leon].,6
The apolipoprotein CI A allele as a risk factor for Alzheimer's disease.,6
Interaction of apolipoprotein E epsilon 4 with other genetic and non-genetic risk factors in late onset Alzheimer disease: problems facing the investigator.,6
Gender effect on apolipoprotein E epsilon4 allele-associated risk for sporadic Alzheimer's disease.,6
Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases.,6
"Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease.",6
Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.,6
"The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.",6
ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families.,6
ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families.,6
The genetics of Alzheimer disease: current status and future prospects.,9
"Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.",6
"Apolipoprotein E type epsilon4 allele, heritability and age at onset in twins with Alzheimer disease and vascular dementia.",6
Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.,6
Beta-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons.,6
Apolipoprotein E polymorphism in elderly east Africans.,6
Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly.,6
Senile dementia with tangles (tangle predominant form of senile dementia).,6
Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype.,6
Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins.,6
Prevalence of Alzheimer's disease and apolipoprotein E allele frequencies in the Old Order Amish.,6
"Genetic risk factors in Japanese Alzheimer's disease patients: alpha1-ACT, VLDLR, and ApoE.",6
Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene.,6
Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's disease.,6
[Molecular genetics of Alzheimer's disease--presenilin and other genes].,6
[Molecular genetics of Alzheimer's disease--presenilin and other genes].,6
ApoE polymorphism in Polish patients with Alzheimer's disease.,6
Apolipoprotein E and the CNS response to injury.,6
Increased density of olfactory receptor neurons immunoreactive for apolipoprotein E in patients with Alzheimer's disease.,1
Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.,6
Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.,6
Human apolipoprotein E accelerates microtubule polymerization in vitro.,6
Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.,6
Association of apolipoprotein E genotype and intronic polymorphism of the presenilin-1 gene with Alzheimer's disease in elderly Taiwan Chinese.,6
Association of apolipoprotein E genotype and intronic polymorphism of the presenilin-1 gene with Alzheimer's disease in elderly Taiwan Chinese.,6
Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.,6
Regionally specific neuronal expression of human APOE gene in transgenic mice.,6
Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury.,6
Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome.,6
Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism.,6
[The genetics of Alzheimer's disease].,9
Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study.,6
Microglial activation in Alzheimer disease: Association with APOE genotype.,6
Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease.,6
Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease.,6
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.,6
Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.,6
The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations.,6
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.,6
"Apolipoprotein E4, cholinergic integrity and the pharmacogenetics of Alzheimer's disease.",6
"Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease.",6
Epidemiologic and genetic studies of dementia of the alzheimer type in japan.,6
Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease.,6
Gene-environment interaction in Alzheimer's disease: a potential role for cholesterol.,6
Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE.,6
Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity.,9
"The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid.",6
Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.,6
"The relationship between apolipoprotein E, dementia, and vascular illness.",6
Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent.,6
High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes.,6
Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation.,6
The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.,6
"Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4.",6
The role of APOE polymorphisms in late-onset dementias.,6
Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.,6
Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins.,6
[Genetics of Alzheimer's disease].,9
[Genetics of Alzheimer's disease].,9
Apolipoprotein E and alpha1-antichymotrypsin genotypes and age of onset of familial Alzheimer's disease.,6
Reduction of platelet phospholipase C-delta1 activity in Alzheimer's disease associated with a specific apolipoprotein E genotype (epsilon3/epsilon3).,6
Genetics and the central nervous system: apolipoprotein E and brain injury.,6
Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology.,6
The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.,6
The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease.,6
The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population.,6
Recent advances in the genetics of Alzheimer's disease.,9
Recent advances in the genetics of Alzheimer's disease.,9
Human apolipoprotein E allele-specific brain expressing transgenic mice.,6
Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease.,6
Molecular genetics of Alzheimer's disease.,9
Molecular genetics of Alzheimer's disease.,9
[Pathomorphology and pathogenesis of changes in Alzheimer's disease].,9
[Pathomorphology and pathogenesis of changes in Alzheimer's disease].,9
Very early changes in olfactory functioning due to Alzheimer's disease and the role of apolipoprotein E in olfaction.,6
Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease.,6
Microglial activation varies in different models of Creutzfeldt-Jakob disease.,8
"TGF-beta(1), regulation of alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization.",9
Induction of the alpha(1)-antichymotrypsin gene in the brain associated with TGF-beta1 deficiency or systemic administration of endotoxin.,1
Bcl-X(L) inhibits apoptosis and necrosis produced by Alzheimer's beta-amyloid1-40 peptide in PC12 cells.,4
Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice.,1
Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis.,1
Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates.,1
Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease.,6
Transforming growth factor-beta1 induces transforming growth factor-beta1 and transforming growth factor-beta receptor messenger RNAs and reduces complement C1qB messenger RNA in rat brain microglia.,1
Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes.,1
Amyloid precursor protein beta-secretase (BACE) mRNA expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines and growth factors.,1
Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology.,1
TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.,1
Functional role of TGF beta in Alzheimer's disease microvascular injury: lessons from transgenic mice.,1
Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease.,9
Transcriptional activation and increase in expression of Alzheimer's beta-amyloid precursor protein gene is mediated by TGF-beta in normal human astrocytes.,9
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.,1
Transforming growth factor-beta1-modulated cerebral gene expression.,1
Molecular and functional dissection of TGF-beta1-induced cerebrovascular abnormalities in transgenic mice.,1
Regulation of promoter activity of the APP gene by cytokines and growth factors: implications in Alzheimer's disease.,3
TGFbeta1 enhances formation of cellular Abeta/apoE deposits in vascular myocytes.,6
Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis.,1
Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice.,1
Role of cytokines in the gene expression of amyloid beta-protein precursor: identification of a 5'-UTR-binding nuclear factor and its implications in Alzheimer's disease.,3
Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1.,1
Factors produced by activated macrophages reduce accumulation of Alzheimer's beta-amyloid protein in vascular smooth muscle cells.,1
Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.,9
"Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation.",1
Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia.,1
Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease.,1
"Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures.",1
Recent work on Alzheimer's disease transgenics.,9
"Glutathione-S-transferase (GSTM1) genetic polymorphisms do not affect human breast cancer risk, regardless of dietary antioxidants.",2
Glutathione S-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines.,3
A systematic review of genetic polymorphisms and breast cancer risk.,2
Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility.,2
"Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.",2
Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase.,2
"Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility.",2
"Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk.",2
"Glutathione S-transferases M1, T1, and P1 and breast cancer.",2
Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer.,2
The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue.,2
Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer.,2
Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier.,2
Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions.,2
"Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.",2
"Genetic polymorphisms and transcriptional pattern analysis of CYP1A1, AhR, GSTM1, GSTP1 and GSTT1 genes in breast cancer.",2
Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer.,2
"GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene.",2
Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study.,2
Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk.,2
Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1.,2
Significance of genetic variation at the glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase 1 detoxification genes in breast cancer development.,2
"Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.",2
Molecular epidemiologic studies of polycyclic aromatic hydrocarbon-DNA adducts and breast cancer.,2
Association of DNA-protein crosslinks and breast cancer.,2
"Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs).",2
"Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.",3
GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk.,2
"CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women.",2
A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.,2
"Cigarette smoking, glutathione-s-transferase M1 and t1 genetic polymorphisms, and breast cancer risk (United States).",2
GSTT1 null genotype increases risk of premenopausal breast cancer.,2
[Research on breast cancer susceptibility genes].,2
Genetic polymorphisms and cancer susceptibility of breast cancer in Korean women.,2
Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy.,2
"Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk.",2
Cancer and phase II drug-metabolizing enzymes.,2
"Reproductive factors, glutathione S-transferase M1 and T1 genetic polymorphism and breast cancer risk.",2
Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke.,2
"N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.",2
"Urinary isothiocyanate levels, brassica, and human breast cancer.",2
Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism.,2
"Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer.",2
The interaction between alcohol consumption and GSTM1 genotype on polycyclic aromatic hydrocarbon-DNA adduct levels in breast tissue.,2
Glutathione S-transferases (GSTT1 and GSTM1) gene deletions in Tunisians: susceptibility and prognostic implications in breast carcinoma.,2
Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk.,2
[Clinical studies on serum glutathione S-transferase level in human breast cancer patients].,2
Expression of GST-mu transferase in breast cancer patients and healthy controls.,2
Combined depletion of O6-alkylguanine-DNA alkyltransferase and glutathione to modulate nitrosourea resistance in breast cancer.,1
Variability in loss of constitutional heterozygosity across loci and among individuals: association with candidate genes in ductal breast carcinoma.,2
[Glutathione S-transferase mu 1 (GSTM1): susceptibility gene of breast cancer].,2
"Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics.",2
Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases.,2
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.,2
"Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans.",2
"Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer.",2
Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility.,2
Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mu1 gene in primary breast cancers: an update with an additional 114 cases.,2
Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancer.,2
"Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients.",2
Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility.,2
Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.,7
"Wild-type NM23-H1, but not its S120 mutants, suppresses desensitization of muscarinic potassium current.",1
Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro.,7
The NM23 gene and its expression in oral squamous cell carcinoma.,7
"[The correlation between lung cancer lymph node metastasis and nm23-H1 gene mutation, mRNA expression].",7
The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma.,7
Single strand DNA specificity analysis of human nucleoside diphosphate kinase B.,7
nm23 protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors.,7
Human nucleoside diphosphate kinase B (Nm23-H2) from melanoma cells shows altered phosphoryl transfer activity due to the S122P mutation.,7
Immunohistochemical analysis of nm23-H1 gene product in node-positive lung cancer and lymph nodes.,7
"Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.",7
Immunohistochemical analysis of nm23-H1 protein in bladder cancer.,7
Clinical significance of nm23 expression in renal cell carcinoma.,7
Cleavage of DNA by human NM23-H2/nucleoside diphosphate kinase involves formation of a covalent protein-DNA complex.,3
Expression of nm23 in the primary tumor and the metastatic regional lymph nodes of patients with gastric cardiac cancer.,7
Organization and expression of mouse nm23-M1 gene. Comparison with nm23-M2 expression.,7
Molecular pathogenesis of pituitary adenomas: a review.,4
Correlation between nm23-H1 overexpression and clinicopathological variables in human anal canal carcinoma.,7
Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity.,7
Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.,7
The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis.,7
Evidence for interaction between human PRUNE and nm23-H1 NDPKinase.,3
Interaction of the Ras-related protein associated with diabetes rad and the putative tumor metastasis suppressor NM23 provides a novel mechanism of GTPase regulation.,7
"A novel human nucleoside diphosphate (NDP) kinase, Nm23-H6, localizes in mitochondria and affects cytokinesis.",7
Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.,7
nm23: unraveling its biological function in cell differentiation.,7
Expression of nm23 antimetastatic gene product in head and neck squamous cell carcinoma.,7
The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.,7
"Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues.",7
"Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.",7
Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.,7
[nm23 expression and its correlation with lung metastasis in human salivary adenoid cystic carcinoma].,7
Histidine to aspartate phosphotransferase activity of nm23 proteins: phosphorylation of aldolase C on Asp-319.,3
"Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer.",7
Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer.,7
[Slot blot analysis of metastasis suppression gene nm23 expression in human lung cancer].,7
Nucleoside diphosphate kinase (nm23 protein) expression in retinoblastoma.,7
Semiquantitative immunoblot analysis of nm23-H1 and -H2 isoforms in adenocarcinomas of the lung: prognostic significance.,7
Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis.,7
Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis.,7
The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase.,7
The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells.,4
Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.,7
nm23-H1 protein expression in anal canal carcinoma: does it correlate with prognosis?,7
"[Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].",7
[Northern blot analysis of nm23 gene expression in human lung cancer].,7
[Nucleoside diphosphate kinase/nm23H1 expression in ovarian epithelial carcinoma: retroperitoneal lymphatic metastasis and survival].,7
Overexpression of NM23-1 enhances responsiveness of IMR-32 human neuroblastoma cells to differentiation stimuli.,7
Phosphorylation of geranyl and farnesyl pyrophosphates by Nm23 proteins/nucleoside diphosphate kinases.,7
Oxidative modification of nucleoside diphosphate kinase and its identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.,7
"P-glycoprotein, metallothionein and NM23 protein expressions in breast carcinoma.",7
The role of nm23-H1 in the progression of transitional cell bladder cancer.,7
Inhibition of progesterone-induced Xenopus oocyte maturation by Nm23.,7
nm23 Expression in choroidal melanoma.,7
Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis.,7
Molecular cloning of an Atlantic salmon nucleoside diphosphate kinase cDNA and its pattern of expression during embryogenesis.,7
Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.,7
Mutational analysis of the NM23.H1 gene in human breast cancer.,2
Nm23 and cathepsin D expression in laryngeal carcinomas.,7
Nucleoside diphosphate kinase beta (Nm23-R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma.,7
Expression of nm23 protein in human osteosarcoma in relationship with early metastasis.,7
Catalysis of DNA cleavage and nucleoside triphosphate synthesis by NM23-H2/NDP kinase share an active site that implies a DNA repair function.,7
Increased activity of membrane-associated nucleoside diphosphate kinase and inhibition of cAMP synthesis in failing human myocardium.,7
Identification of the tumor metastasis suppressor Nm23-H1/Nm23-R1 as a constituent of the centrosome.,7
Identification by array screening of altered nm23-M2/PuF mRNA expression in mouse retinal degeneration.,7
Preliminary observation on the correlation between nm23 expression and Ki-67 antigen with early metastasis of human osteosarcoma.,7
Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays.,5
Loss of nm23 expression predicts distal metastases and poorer survival for breast cancer.,7
[Study on expression of nm23-H1 protein/NDPK-A in laryngeal carcinoma].,7
[Significance of nm23 expression in malignant carcinoma of salivary gland].,7
Immunohistochemical analysis of nm23-H1 expression in human cervical lesions.,7
Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.,7
Reappraisal of the role of NM23-H1 in colorectal cancers.,7
Correlation of MTS1/p16 and nm23 mRNA expression with survival in patients with peripheral synovial sarcoma.,7
"[Evaluation of CD44 adhesion molecule, nm23 gene product expression and intensity of angiogenesis in patients with laryngeal cancer].",7
The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.,7
Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1.,7
"Structural and catalytic properties and homology modelling of the human nucleoside diphosphate kinase C, product of the DRnm23 gene.",7
nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.,7
"Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23.",7
Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage.,7
nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression.,7
"Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling.",7
[nm23-H1 protein expression and its clinical significance in human laryngeal carcinoma].,7
Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer.,3
Expression of nm23-H1 gene product in mediastinal lymph nodes from lung cancer patients.,7
Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer.,7
[mRNA expression of metastasis-suppressor gene nm23 in carcinoma of buccal mucosa I. Northern blotting study].,7
[mRNA expression of metastasis-suppressor gene nm23 in carcinoma of buccal mucosa. II. Quantitative reverse transcription PCR amplification].,7
"Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma.",7
nm23 expression in malignant ascitic effusions of serous ovarian adenocarcinoma.,7
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity.,7
[Identification of cDNA fragments related to alpha particles radiation induced neoplastic transformation of rat tracheal epithelial cells].,7
Overexpression of nm23-H4 RNA in colorectal and renal tumours.,7
Identification of structural domains affecting transactivation potential of Nm23.,7
Phosphorylation of pyrimidine deoxynucleoside analog diphosphates: selective phosphorylation of L-nucleoside analog diphosphates by 3-phosphoglycerate kinase.,7
"Decreased nm23 expression, but not Ki-67 labeling index, is significantly correlated with lymph node metastasis of breast invasive ductal carcinoma.",7
The human Nm23/nucleoside diphosphate kinases.,7
NM23/nucleoside diphosphate kinase and signal transduction.,7
Human NM23/nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements.,7
Nm23/nucleoside diphosphate kinase in human cancers.,7
Regulation of cellular functions by nucleoside diphosphate kinases in mammals.,7
[Expression of nm23 in breast cancer: correlation with distant metastasis and prognosis].,7
Expression of nm23 gene in gastric cancer is associated with a poor 5-year survival.,7
"The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration.",3
Differential expression of nm23 genes in adult mouse dorsal root ganglia.,7
[Angiogenesis and the expression of nm23-H(1) tumor metastatic suppressor gene in primary breast carcinoma and their relations to lymph node metastasis].,7
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.,7
"Clinical significance of nm23 expression in resected pathologic-stage I, non-small cell lung cancer.",7
Expression and localization of nm23-H1 in the human placenta.,7
Prognostic significance of CD44v6 and nm23 protein immunoexpression in laryngeal squamous cell carcinoma.,7
"The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.",7
Expression of NM23 and tenascin in invasive ductal carcinomas of the breast.,7
Extracellular nucleoside diphosphate kinase NM23/NDPK modulates normal hematopoietic differentiation.,7
"Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23.",7
Human brain nucleoside diphosphate kinase activity is decreased in Alzheimer's disease and Down syndrome.,7
Nm23 gene product expression in invasive breast cancer--immunohistochemical analysis and clinicopathological correlation.,7
Lack of prognostic significance of nm23 expression in human primary breast cancer.,2
"Characterization of the nm23-M2, nm23-M3 and nm23-M4 mouse genes: comparison with their human orthologs.",7
Nucleoside diphosphate kinase (NDPK/NM23) and the waltz with multiple partners: possible consequences in tumor metastasis.,7
The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1.,7
Clinical significance of nm23 expression and chromosome 17 numerical aberrations in primary gastric cancer.,7
Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.,7
[Expression of nm23-H1 gene in oral squamous cell carcinoma and its relation to tumor metastasis].,7
Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.,7
"Isolation and characterization of a novel human NM23-H1B gene, a different transcript of NM23-H1.",7
Clinical significance of high nm23-H1 expression in intraepithelial neoplasia and early-stage squamous cell carcinoma of the uterine cervix.,7
"Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor.",4
P53 is a regulator of the metastasis suppressor gene Nm23-H1.,7
"Analysis of both NM23-h1 and NM23-H2 expression identifies ""at-risk"" patients with colorectal cancer.",7
In vivo cross-linking of nm23/nucleoside diphosphate kinase to the PDGF-A gene promoter.,7
Differential expression of the nm23 protein in the progression of oesophageal adenocarcinoma.,7
Nm23-H1 immunohistochemical expression in multisteps of cervical carcinogenesis.,7
"Genetic abnormalities of cell proliferation, invasion and metastasis, with special reference to gynaecological cancers.",7
Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells.,7
CD44v6 and Nm23-H1 protein expression related to clinico pathological parameters in colorectal cancer.,7
Specific biochemical inactivation of oncogenic Ras proteins by nucleoside diphosphate kinase.,7
Expression of nm23 protein in adult soft tissue sarcoma is correlated with histological grade.,7
Nucleotide binding to nucleoside diphosphate kinases: X-ray structure of human NDPK-A in complex with ADP and comparison to protein kinases.,7
A human NDP-kinase B specifically binds single-stranded poly-pyrimidine sequences.,7
Characterization of the human nm23-H2 promoter region and localization of the microsatellite D17S396.,3
Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland.,7
Loss of nm23 and Alu DNA in human lung cancer propagated in nude mice.,7
"Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.",0
Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma.,7
Quantitation of NM23 expression in human prostate tissues.,7
NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.,7
High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance.,7
Colon carcinoma cells with inactive nm23 show increased motility and response to motility factors.,7
Expression of the nucleoside diphosphate kinase in human skin cancers: an immunohistochemical study.,7
Genetic alterations associated with metastatic dissemination and chemoresistance in neuroblastoma.,7
The potential roles of nm23 in cancer metastasis and cellular differentiation.,7
[Correlation study of allelic gene deletion of nm23-H1 and human colorectal carcinoma metastasis].,7
Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.,7
Immunohistochemical analysis of nm23 gene product in human gallbladder carcinomas.,7
Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells.,7
Analysis of nm23 gene expressions in human bladder and renal cancers.,7
Preferential reduction of nm23-H1 gene product in metastatic tissues from papillary and follicular carcinomas of the thyroid.,7
"The crystal structure of a human nucleoside diphosphate kinase, NM23-H2.",7
"Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression.",7
The association of the Nm23-M1 protein and beta-tubulin correlates with cell differentiation.,7
Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions.,7
"Two isotypes of murine nm23/nucleoside diphosphate kinase, nm23-M1 and nm23-M2, are involved in metastatic suppression of a murine melanoma line.",7
Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.,7
"A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require it's kinase activity.",7
Effect of retinoic acid on Nm/23 nucleoside diphosphate kinase and components of cyclic adenosine monophosphate-dependent signalling in human neuroblastoma cell lines.,7
Purine-binding factor (nm23) gene expression in pituitary tumors: marker of adenoma invasiveness.,7
Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.,7
Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.,7
Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.,7
"The 1.9 A crystal structure of a nucleoside diphosphate kinase complex with adenosine 3',5'-cyclic monophosphate: evidence for competitive inhibition.",7
PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.,3
Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials.,7
[NDPK/nm23 expression and its correlation with lymph node metastasis in human lung cancer].,7
Nm23 protein expression in thyroid neoplasms.,7
The role of nm23 in transforming growth factor beta 1-mediated adherence and growth arrest.,7
Effects of cytokine-mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells.,7
Squamous cell carcinoma of the lung: does the nm23 gene expression correlate to the tumor stage?,7
"[Cloning and sequencing of nm23-H3b, a new gene identified to nm23].",5
NM23 gene expression correlates with cell growth rate and S-phase.,7
"Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.",7
A low NM23.H1 gene expression identifying high malignancy human melanomas.,7
Immunohistochemical analysis of nm23/NDP kinase expression in human lung adenocarcinoma: association with tumor progression in Clara cell type.,7
High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases.,7
Nucleoside diphosphate kinase associated with rat pancreatic membranes regulates CCK receptor affinity.,1
NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival.,7
Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer.,7
A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest.,7
Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues.,2
NM23 protein in neoplastic and nonneoplastic thyroid tissues.,7
Increased expression of nucleoside diphosphate kinases/nm23 in human diploid fibroblasts transformed by SV40 large T antigen or 60Co irradiation.,7
A plant nucleoside diphosphate kinase homologous to the human Nm23 gene product: purification and characterization.,7
Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines.,7
Differential nm23 gene expression at the fetal-maternal interface.,7
"Isolation and characterization of the promoter region of human nm23-H1, a metastasis suppressor gene.",7
Nucleoside diphosphate kinase enzyme activity of NM23-H2/PuF is not required for its DNA binding and in vitro transcriptional functions.,7
Phosphorylation of nm23/nucleoside diphosphate kinase by casein kinase 2 in vitro.,7
Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma.,7
Nm23 'anti-metastatic' gene product expression in colorectal carcinoma.,7
Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.,7
[Nucleoside diphosphate kinase/Nm23 and metastatic potency].,7
"A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential.",7
Isolation and characterization of the human genomic locus coding for the putative metastasis control gene nm23-H1.,7
Clinicopathological features and prognostic significance of nucleoside diphosphate kinase/nm23 gene product in human pancreatic exocrine neoplasms.,7
Expression of nm23 H-1 RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis.,7
Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity.,7
Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.,7
"Expression of nm23-H1 gene product in thyroid, ovary, and breast cancers.",7
A novel serine/threonine-specific protein phosphotransferase activity of Nm23/nucleoside-diphosphate kinase.,7
Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.,7
Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.,7
Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer.,7
A novel function for nucleoside diphosphate kinase in Drosophila.,7
Analysis of nm23 expression as a prognostic parameter in renal cell carcinoma.,7
"Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy.",7
NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas.,7
Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings.,7
"Decreased expression of nucleoside diphosphate kinase alpha isoform, an nm23-H2 gene homolog, is associated with metastatic potential of rat mammary-adenocarcinoma cells.",7
Cellular phosphorylation of anti-HIV nucleosides. Role of nucleoside diphosphate kinase.,7
"Down regulation of NM23.H1, NM23.H2 and c-myc genes during differentiation induced by 1,25 dihydroxyvitamin D3.",7
nm23-H1 protein immunoreactivity in laryngeal carcinoma.,7
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters.,7
A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction.,7
Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11.,2
Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.,7
The nucleoside diphosphate kinase of human neutrophils.,7
Expression of NM23 in human melanoma progression and metastasis.,7
[Immunohistochemical analysis of nm23 gene product/nucleoside-diphosphate kinase expression in human lung carcinoma].,7
[Gastric cancer with P53 overexpression and nm23 low-expression has high potential for lymph node metastasis].,7
[Anti-metastasis gene nm23 expression in buccal cancer studied by immunohistochemistry stain].,7
[nm23 gene product/NDPK expression and its clinical significance in human colorectal carcinoma].,7
Immunohistochemical analysis of the nm23 gene product (NDP kinase) expression in astrocytic neoplasms.,7
Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate.,7
X-ray structure of human nucleoside diphosphate kinase B complexed with GDP at 2 A resolution.,7
Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.,7
Nuclear localization of nucleoside diphosphate kinase type B (nm23-H2) in cultured cells.,7
The enzymatic activity of Drosophila AWD/NDP kinase is necessary but not sufficient for its biological function.,3
Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells.,7
A nucleoside diphosphate kinase from Paramecium tetraurelia with protein kinase activity.,7
Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.,7
Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.,7
The metastasis suppressor candidate nucleotide diphosphate kinase NM23 specifically interacts with members of the ROR/RZR nuclear orphan receptor subfamily.,7
"Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.",7
The value of Nm23 expression as an independent prognostic indicator in primary thick melanoma.,7
Temporal and spatial distributions of yeast nucleoside diphosphate kinase activities and its association with the Cdc8p.,7
Expression of nm23-H1 in prostatic intraepithelial neoplasia and adenocarcinoma.,7
Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia.,7
nm23 expression in tissue sections and tumor effusion cells of ovarian neoplasms.,7
[Expression of nm23/NDP kinase and cancer metastasis].,7
Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.,7
Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal carcinomas. An immunohistochemical study.,7
Nucleoside-diphosphate kinase-mediated signal transduction via histidyl-aspartyl phosphorelay systems in Escherichia coli.,7
Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.,7
nm23 influences proliferation and differentiation of PC12 cells in response to nerve growth factor.,7
"Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas.",7
Immunohistochemical analysis of nucleoside diphosphate kinases in oral squamous cell carcinomas.,7
Inhibition of nucleoside diphosphate kinase (NDPK/nm23) by cAMP analogues.,7
Early stage human colorectal cancer: prognostic value of nm23-H1 protein overexpression.,7
NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.,7
Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro.,7
Nm23 expression in breast ductal carcinomas: a ten year follow-up study in a uniform group of node-negative breast cancer patients.,2
Nm23/nucleoside diphosphate (NDP) kinase expression in human malignant melanomas: significance and implications in tumor biology.,7
Expression of the candidate tumor suppressor gene nm23 in the bronchial system of patients with squamous cell lung cancer.,7
Expression of the nm23 metastasis-suppressor gene product in skin tumors.,7
"Expression of NM23 protein in acquired melanocytic nevi, malignant melanoma and metastases of malignant melanoma: an immunohistological assessment in human skin.",7
"nm23-H4, a new member of the family of human nm23/nucleoside diphosphate kinase genes localised on chromosome 16p13.",7
Immunohistochemical analysis of the nm23 gene products in testicular seminoma.,7
Changes in biomarker expression in the development of prostatic adenocarcinoma.,7
Prognostic significance of nm23 protein expression in malignant melanoma. An immunohistochemical study.,7
"Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein.",7
NMR studies on the flexibility of nucleoside diphosphate kinase.,7
Expression of nm23 protein in pulmonary adenocarcinomas: inverse 1orrelation to tumor progression.,7
An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.,7
"p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma.",7
The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.,7
Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity.,7
Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma.,7
Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas.,7
Squamous cell lung carcinomas: the role of nm23-H1 gene.,7
Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma.,7
Immunohistochemical study on the nm23 gene produce (NDP kinase) in oral squamous cell carcinoma.,7
Down-regulation of the nm23.h1 gene inhibits cell proliferation.,7
Quaternary structural analysis of nucleoside diphosphate kinases using capillary electrophoresis.,7
"Immunohistochemical expression of nm23 gene product, nucleotide diphosphate kinase, in pancreatic neoplasms.",7
Transcription effect of nm23-M2/NDP kinase on c-myc oncogene.,7
Relationship of serum testosterone level with proliferating cell nuclear antigen and nm23 protein in human prostatic carcinoma tissue.,7
Localization of prostate cancer metastasis-suppressor activity on human chromosome 17.,7
Expression of nm23-H1 in human meningioma cells.,7
Role of the nm23-H1 gene in the metastasis of gastric cancer.,7
Association of nucleoside diphosphate kinase nm23-H2 with human telomeres.,7
Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.,7
Differential expression of nucleoside diphosphate kinases (NDPK/NM23) during Xenopus early development.,7
Nm23 and tumour metastasis: basic and translational advances.,7
nm23 expression in human breast cancer: correlation with cell proliferation (S-phase) as observed with a double-labeling immunocytochemical-autoradiographic technique.,2
NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer.,7
Nm23 gene expression in gastric carcinoma: an immunohistochemical study.,7
"C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation.",7
Overexpression of nm23 protein assessed by color video image analysis in metastatic colorectal cancer: correlation with reduced patient survival.,7
Significance of nm23 mRNA expression in human hepatocellular carcinoma.,7
NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.,7
Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression.,7
"nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.",7
Decrease in nucleoside diphosphate kinase (NDPK/nm23) expression during hematopoietic maturation.,7
Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer.,7
Location of several putative genes possibly involved in human breast cancer progression.,2
Nm23: an invasion suppressor gene in CNS tumours?,7
NM23-H1 and NM23-H2 gene expression in human renal tumors.,7
nm23 Protein expression in larynx cancer and the relationship with metastasis.,7
Relations of nm23 expression to clinicopathologic variables and proliferative activity of gastric cancer lesions.,7
nm23 protein expression in renal cell tumors: the role of the cell type.,7
[Study on expression of nm23-H1 gene in laryngeal cancer tissues].,7
Reduced expression and rare genomic alteration of nm23-H1 in human hepatocellular carcinoma and hepatoma cell lines.,7
"The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer.",7
Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer.,7
Prognostic value of nm23 protein expression in renal cell carcinomas.,7
"Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.",7
[Expression and anti-metastatic potential of nm 23/NDP kinase in human head and neck cancer cells].,7
"Relationship of nm23 to proteolytic factors, proliferation and motility in breast cancer tissues and cell lines.",7
[Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer].,7
"[Expression of nm23/NDPK, integrin, type IV collagenase and uPA in transplanted tumors with various metastatic potential in nude mice and surgical specimens].",7
The role of nm23 in melanoma progression and its prognostic significance.,7
Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer.,7
Nm23-H1 expression in intrahepatic or extrahepatic metastases of hepatocellular carcinoma.,7
"Numerical aberrations of chromosome 17 in interphase cell nuclei of breast carcinoma cells: lack of correlation with abnormal expression of p53, neu and nm23 protein.",7
Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (Colon 26 line) transfected with nm23-R2/rat nucleoside diphosphate kinase alpha isoform.,7
Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.,7
Cloning of a second nm23-M1 cDNA: expression in the central nervous system of adult mouse and comparison with nm23-M2 mRNA distribution.,7
"Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.",7
nm23-H1 protein expression in newly diagnosed and relapsed childhood acute lymphoblastic leukemia.,7
NM23-NDP kinase.,7
Cytoskeletal association of the A and B nucleoside diphosphate kinases of interphasic but not mitotic human carcinoma cell lines: specific nuclear localization of the B subunit.,7
nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma.,7
The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins.,2
Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50.,3
Roles of BRCA1 and its interacting proteins.,4
Repression of the putative tumor suppressor gene Bard1 or expression of Notch4(int-3) oncogene subvert the morphogenetic properties of mammary epithelial cells.,4
Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.,2
Identification of an apoptotic cleavage product of BARD1 as an autoantigen: a potential factor in the antitumoral response mediated by apoptotic bodies.,4
The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression.,3
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.,2
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.,2
BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions.,3
BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions.,3
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.,3
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.,3
"Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development.",3
Phonocardiographic diagnosis of aortic ball variance.,1
Identification of residues required for the interaction of BARD1 with BRCA1.,3
Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis.,4
"The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.",3
"The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.",3
Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.,2
Distinct functions of BRCA1 and BRCA2 in double-strand break repair.,3
BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export.,3
BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export.,3
Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.,3
Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.,3
BRCA1-dependent and independent functions of BARD1.,3
BRCA1-dependent and independent functions of BARD1.,3
The BRCA1 and BARD1 association with the RNA polymerase II holoenzyme.,3
Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway.,3
Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.,3
Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.,3
Identification of genes induced by BRCA1 in breast cancer cells.,2
Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.,3
Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex.,3
"Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.",4
BRCA1-independent ubiquitination of FANCD2.,3
BRCA1-independent ubiquitination of FANCD2.,3
The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.,3
Mutational analysis of BARD1 in familial breast cancer patients in Japan.,2
BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks.,3
Characteristic biological features of human megakaryoblastic leukaemia cell lines.,3
Characteristic biological features of human megakaryoblastic leukaemia cell lines.,3
Identification of a RING protein that can interact in vivo with the BRCA1 gene product.,2
Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.,3
"Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.",2
Staurosporine-sensitive protein phosphorylation is required for postreplication DNA repair in human cells.,3
Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein.,3
"In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells.",2
Inherited breast cancer: an emerging picture.,2
Drosophila APC2 is a cytoskeletally-associated protein that regulates wingless signaling in the embryonic epidermis.,0
Adenomatous polyposis coli (APC) protein moves along microtubules and concentrates at their growing ends in epithelial cells.,0
Molecular linkage underlying microtubule orientation toward cortical sites in yeast.,3
Regulation and function of the interaction between the APC tumour suppressor protein and EB1.,0
Fascin is involved in the antigen presentation activity of mature dendritic cells.,3
Actin cytoskeleton: a signaling sensor in cell volume regulation.,3
Actin dynamics: assembly and disassembly of actin networks.,3
Regulating cellular actin assembly.,3
Critical role for the EB1 and APC interaction in the regulation of microtubule polymerization.,0
The adenomatous polyposis coli protein: in the limelight out at the edge.,0
Where is APC going?,0
Drosophila APC2 and Armadillo participate in tethering mitotic spindles to cortical actin.,3
Actin-dependent membrane association of the APC tumour suppressor in polarized mammalian epithelial cells.,0
Human APC2 localization and allelic imbalance.,2
Modular complexes that regulate actin assembly in budding yeast.,3
Identification of a link between the tumour suppressor APC and the kinesin superfamily.,0
"Dissecting interactions between EB1, microtubules and APC in cortical clusters at the plasma membrane.",0
The adenomatous polyposis coli protein unambiguously localizes to microtubule plus ends and is involved in establishing parallel arrays of microtubule bundles in highly polarized epithelial cells.,0
Evidence that an interaction between EB1 and p150(Glued) is required for the formation and maintenance of a radial microtubule array anchored at the centrosome.,3
Adenomatous polyposis coli truncation alters cytoskeletal structure and microtubule stability in early intestinal tumorigenesis.,0
Dynamic properties of APC-decorated microtubules in living cells.,0
Mutations in the APC gene and their implications for protein structure and function.,0
The yeast actin cytoskeleton.,3
"Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways.",3
Novel germline mutations in the APC gene and their phenotypic spectrum in familial adenomatous polyposis kindreds.,0
Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator.,3
Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator.,3
Identification and characterization of novel isoforms of COP I subunits.,3
Intracellular events in the assembly of chylomicrons in rabbit enterocytes.,3
Subcellular distribution of CFTR in rat intestine supports a physiologic role for CFTR regulation by vesicle traffic.,3
Lst1p and Sec24p cooperate in sorting of the plasma membrane ATPase into COPII vesicles in Saccharomyces cerevisiae.,3
New paradigms of CFTR chloride channel regulation.,3
"The endoplasmic reticulum: integration of protein folding, quality control, signaling and degradation.",3
Traffic COPs of the early secretory pathway.,3
Exiting the endoplasmic reticulum.,3
ER export: public transportation by the COPII coach.,3
CFTR: interacting with everything?,3
Non-conventional trafficking of the cystic fibrosis transmembrane conductance regulator through the early secretory pathway.,3
Cystic fibrosis: a brief look at some highlights of a decade of research focused on elucidating and correcting the molecular basis of the disease.,3
Molecular studies of CFTR interacting proteins.,3
Therapeutic approaches to repair defects in deltaF508 CFTR folding and cellular targeting.,3
Traffic-independent function of the Sar1p/COPII machinery in proteasomal sorting of the cystic fibrosis transmembrane conductance regulator.,3
The role of regulated CFTR trafficking in epithelial secretion.,3
Membrane traffic. Call for the COPs.,3
"The biogenesis, traffic, and function of the cystic fibrosis transmembrane conductance regulator.",3
"Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein.",3
Cystic fibrosis: a disease of altered protein folding.,3
What we know and what we do not know about cystic fibrosis transmembrane conductance regulator.,3
Association of protein kinase CK2 with eukaryotic translation initiation factor eIF-2 and with grp94/endoplasmin.,3
A structural model for elongation factor 1 (EF-1) and phosphorylation by protein kinase CKII.,3
Expression and regulation of protein kinase CK2 during the cell cycle.,7
Phosphorylation by CK2 and MAPK enhances calnexin association with ribosomes.,7
Biochemical characterization of 60S acidic ribosomal P proteins associated with CK-II from bamboo shoots and potent inhibitors of their phosphorylation in vitro.,3
Phosphorylation of yeast ribosomal proteins by CKI and CKII in the presence of heparin.,3
Casein kinase II inhibitors isolated from two Brazilian plants Hymenaea parvifolia and Wulffia baccata.,3
Phosphorylation of ribosomal protein L5 by protein kinase CKII decreases its 5S rRNA binding activity.,3
Phosphorylation of the yeast ribosomal stalk. Functional effects and enzymes involved in the process.,3
Protein kinases phosphorylating acidic ribosomal proteins from yeast cells.,7
"Structure and function of the stalk, a putative regulatory element of the yeast ribosome. Role of stalk protein phosphorylation.",3
Ribosomal stalk protein phosphorylating activities in Saccharomyces cerevisiae.,3
Biochemical characterization of 60S acidic ribosomal P proteins from porcine liver and the inhibition of their immunocomplex formation with sera from systemic lupus erythematosus (SLE) patients by glycyrrhizin in vitro.,1
SDS/PAGE characteristics of protein kinases tightly associated with chick embryo brain ribosomes.,3
Subcellular localization of protein kinase CK2. A key to its function?,7
Oligomerization properties of the acidic ribosomal P-proteins from Saccharomyces cerevisiae: effect of P1A protein phosphorylation on the formation of the P1A-P2B hetero-complex.,3
N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis.,3
A chaperone for ribosome maturation.,3
Nucleolar components involved in ribosome biogenesis cycle between the nucleolus and nucleoplasm in interphase cells.,3
Structure and functions of 5S rRNA.,3
Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells.,7
Mapping of the interaction domain of the protein kinase CKII beta subunit with target proteins.,3
Regulation of ribosome biogenesis within the nucleolus.,3
Characterization of a novel protein inhibitor of protein kinases specific to acidic ribosomal proteins.,3
Phosphorylation of mammalian translation initiation factor 5 (eIF5) in vitro and in vivo.,3
Translation and phosphorylation of wheat germ lysate: phosphorylation of wheat germ initiation factor 2 by casein kinase II and in N-ethylmaleimide-treated lysates.,3
Making ribosomes.,3
Inhibition of yeast ribosomal stalk phosphorylation by Cu-Zn superoxide dismutase.,3
Interaction of casein kinase II with ribosomal protein L22 of Drosophila melanogaster.,3
Role of protein kinase CK2 phosphorylation in the molecular chaperone activity of nucleolar protein b23.,3
Casein kinase II phosphorylates translation initiation factor 5 (eIF5) in Saccharomyces cerevisiae.,3
Assembly of the 30S ribosomal subunit.,3
After the ribosome structures: how are the subunits assembled?,3
The protein kinase 60S is a free catalytic CK2alpha' subunit and forms an inactive complex with superoxide dismutase SOD1.,3
Ribosome assembly in eukaryotes.,3
Phosphorylation of wheat germ initiation factor 2 (eIF-2) by N-ethylmaleimide-treated wheat germ lysates and by purified casein kinase II does not affect the guanine nucleotide exchange on eIF-2.,3
Characterization of the in vivo phosphorylation sites of the mRNA.cap-binding complex proteins eukaryotic initiation factor-4E and p20 in Saccharomyces cerevisiae.,3
The nucleolus: an organelle formed by the act of building a ribosome.,3
The highly acidic C-terminal region of the yeast initiation factor subunit 2 alpha (eIF-2 alpha) contains casein kinase phosphorylation sites and is essential for maintaining normal regulation of GCN4.,3
Analysis of phosphorylation of wheat elongation factor 1 beta and beta' by casein kinase II.,3
Protein synthesis in the developing rat liver: participation of initiation factors eIF-2 and eIF-2B.,3
Chloroplast ribosomes and protein synthesis.,3
Processing of eukaryotic ribosomal RNA.,3
Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation.,7
The nucleolus.,3
"Casein kinase II mediates multiple phosphorylation of Saccharomyces cerevisiae eIF-2 alpha (encoded by SUI2), which is required for optimal eIF-2 function in S. cerevisiae.",3
Differential phosphorylation of ribosomal acidic proteins from yeast cell by two endogenous protein kinases: casein kinase-2 and 60S kinase.,7
Interaction of the beta subunit of casein kinase II with the ribosomal protein L5.,3
"Halogenated benzimidazole inhibitors of phosphorylation, in vitro and in vivo, of the surface acidic proteins of the yeast ribosomal 60S subunit by endogenous protein kinases CK-II and PK60S.",3
Phosphorylation of ribosomal proteins by ribosome-associated protein kinases of Trichosporon cutaneum.,3
The highly basic ribosomal protein L41 interacts with the beta subunit of protein kinase CKII and stimulates phosphorylation of DNA topoisomerase IIalpha by CKII.,3
"The phosphorylation sites of ribosomal P proteins from Saccharomyces cerevisiae cells by endogenous CK-2, PK60S and RAP protein kinases.",3
On the physiological role of casein kinase II in Saccharomyces cerevisiae.,3
"Protein kinase CK2 (""casein kinase-2"") and its implication in cell division and proliferation.",7
p53 and the ribosomal protein L5 participate in high molecular mass complex formation with protein kinase CK2 in murine teratocarcinoma cell line F9 after serum stimulation and cisplatin treatment.,3
Phosphorylation of ribosomal protein P0 is not essential for ribosome function but can affect translation.,3
Nucleolin: a multifunctional major nucleolar phosphoprotein.,3
Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis.,4
Immediate-early genes induced by antigen receptor stimulation.,7
Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis.,4
Cyclosporin A blocks apoptosis by inhibiting the DNA binding activity of the transcription factor Nur77.,4
Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas.,4
Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77.,4
[NGFI-B/nur77 family involved in T-cell apoptosis].,1
The role of programmed cell death as an emerging new concept for the pathogenesis of autoimmune diseases.,4
Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis.,4
Novel mechanism of action for Nur77 and antagonism by glucocorticoids: a convergent mechanism for CRH activation and glucocorticoid repression of POMC gene transcription.,3
[Functional role of nur77 family in T-cell apoptosis and stress response].,1
Mechanisms of p53-induced apoptosis: in search of genes which are regulated during p53-mediated cell death.,4
Hyperthermia-induced apoptosis occurs both in a p53 gene-dependent and -independent manner in three human gastric carcinoma cell lines.,4
Transcriptional regulation and induction of apoptosis: implications for the use of monomeric p53 variants in gene therapy.,4
Apoptosis-associated proteins p53 and APO-1/Fas (CD95) in brains of adult patients with Down syndrome.,4
"COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis.",4
Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress.,4
Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.,4
"Effects of wild-type and mutated p53 and Id proteins on the induction of apoptosis by adenovirus E1A, c-Myc, Bax, and Nip3 in p53 null mouse cerebellum cells.",4
"The relationship between cisplatin-induced apoptosis and p53, bcl-2 and bax expression in human lung cancer cells.",4
Introduction: p53--the first twenty years.,4
Mechanisms of p53-mediated apoptosis.,4
The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53.,4
The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo.,4
The TP53 genotype but not immunohistochemical result is predictive of response to cisplatin-based neoadjuvant therapy in stage III non-small cell lung cancer.,7
p53 and apoptosis.,4
Activation of caspases in p53-induced transactivation-independent apoptosis.,4
Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells.,4
"Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype.",4
Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.,4
Inhibition of polyamine synthesis induces p53 gene expression but not apoptosis.,4
Vaccinia virus-mediated expression of wild-type p53 suppresses glioma cell growth and induces apoptosis.,4
Wild-type function of the p53 tumor suppressor protein is not required for apoptosis of mouse hepatoma cells.,4
p53 mediates apoptosis induced by c-Myc activation in hypoxic or gamma irradiated fibroblasts.,4
Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression.,4
Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment.,4
The emerging p53 gene family.,4
[The role of apoptosis in cell physiology and pathology].,4
"Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.",4
Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.,4
Influence of p53 tumor suppressor protein on bias of DNA repair and apoptotic response in human cells.,4
p53 expression and regulation by NMDA receptors in the developing rat brain.,4
Apoptosis and p53 protein expression increase in the process of burn wound healing in guinea-pig skin.,4
Higher susceptibility to apoptosis following ultraviolet B irradiation of xeroderma pigmentosum fibroblasts is accompanied by upregulation of p53 and downregulation of bcl-2.,4
Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells.,4
Correlation between unirradiated cell TP53 protein levels and radiosensitivity in MOLT-4 cells.,4
Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress.,4
Wild-type p53 protein potentiates phototoxicity of 2-BA-2-DMHA in HT29 cells expressing endogenous mutant p53.,4
Antagonism of p53-dependent apoptosis by mitogen signals.,4
Activation of p53 function in carcinoma cells by the alpha6beta4 integrin.,4
Differential apoptosis by indomethacin in gastric epithelial cells through the constitutive expression of wild-type p53 and/or up-regulation of c-myc.,4
Methyl methanesulfonate and hydrogen peroxide differentially regulate p53 accumulation in hepatoblastoma cells.,4
"Determination of mRNA, and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin.",4
Human papillomavirus 18 oncoproteins E6 and E7 enhance irradiation- and chemotherapeutic agent-induced apoptosis in p53 and Rb mutated cervical cancer cell lines.,4
Regulation of p53 and its targets during involution of the mammary gland.,4
Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis.,4
Modulations of glucocorticoid-induced apoptosis linked to the p53 deletion and to the apoptosis susceptibility gene Rapop1 (Radiation-induced apoptosis 1).,4
Roles of p53 and caspases in the induction of cell cycle arrest and apoptosis by HIV-1 vpr.,4
Isolation of differentially expressed cDNAs from p53-dependent apoptotic cells: activation of the human homologue of the Drosophila peroxidasin gene.,4
Increased apoptosis induction by 121F mutant p53.,4
Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth.,4
"Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A.",4
Anti-apoptotic activity of p53 maps to the COOH-terminal domain and is retained in a highly oncogenic natural mutant.,4
Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons.,4
Mechanisms of p53-induced apoptosis.,4
p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells: p21WAF1/CIP1 repression in UV induced apoptosis.,4
Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma.,4
Increased p53 protein expression in human failing myocardium.,4
The role of p53 in bleomycin-induced DNA damage in the lung. A comparative study with the small intestine.,4
"Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.",4
Comparative gene expression profiling in response to p53 in a human lung cancer cell line.,4
p53-induced apoptosis as a safeguard against cancer.,4
"Roles of p53, c-Myc, Bcl-2, Bax and caspases in serum deprivation-induced neuronal apoptosis: a possible neuroprotective mechanism of basic fibroblast growth factor.",4
p53 tumor suppressor gene therapy for cancer.,4
The cellular response to p53: the decision between life and death.,4
p53 and chemosensitivity.,4
Conformational and molecular basis for induction of apoptosis by a p53 C-terminal peptide in human cancer cells.,4
"ei24, a p53 response gene involved in growth suppression and apoptosis.",4
Identification and characterization of genes whose expressions are altered in rat 6 fibroblasts transformed by mutant p53(val135).,4
Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53.,4
Regulation of p53 in response to DNA damage.,4
Role of p53 family members in apoptosis.,4
"Mutations in exons 5-8 of the p53 gene, independent of their type and location, are associated with increased apoptosis and mitosis in invasive breast carcinoma.",2
Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated.,4
"Structure, function and regulation of p63 and p73.",4
Tumour regression in a ligand inducible manner mediated by a chimeric tumour suppressor derived from p53.,4
Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry.,3
An intragenic deletion of nuclear localization signal-1 of p53 tumor suppressor gene results in loss of apoptosis in murine fibroblasts.,4
Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis.,4
Bcl-2 and p53: role in dopamine-induced apoptosis and differentiation.,4
Polyoma virus middle T and small t antigens cooperate to antagonize p53-induced cell cycle arrest and apoptosis.,4
Spontaneous apoptosis in ovarian carcinomas: a positive association with p53 gene mutation is dependent on growth fraction.,4
p53-dependent apoptosis in melanoma cells after treatment with camptothecin.,4
Expression of the p53 gene and apoptosis in gestational trophoblastic disease.,4
Apoptosis of fetal testicular cells is regulated by both p53-dependent and independent mechanisms.,4
Role of p53 and apoptosis in carcinogenesis.,4
Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells.,4
Suppression of p53: a new approach to overcome side effects of antitumor therapy.,4
"Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.",7
A role for E2F1 in the induction of apoptosis during thymic negative selection.,4
In situ apoptosis in the thyroid.,4
Resistance of senescent keratinocytes to UV-induced apoptosis.,4
CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types.,4
"Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?",4
Activation of p53 by oncogenes.,4
"PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family.",4
The amyloid beta peptide abeta (25-35) induces apoptosis independent of p53.,4
"Changes in p21WAF1, pRb, Mdm-2, Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus.",4
Mild hyperthermia-induced apoptosis is dependent on p53 in human lymphoid cells.,4
Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells.,4
p53 and thymic 'death by neglect': thymic epithelial cell-induced apoptosis of CD4+8+ thymocytes is p53-independent.,4
Regulation of p53 stability and activity in response to genotoxic stress.,4
Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.,4
DNA repair is activated in early stages of p53-induced apoptosis.,4
Drosophila p53 is a structural and functional homolog of the tumor suppressor p53.,4
"Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas.",4
Role of NF-kappaB in p53-mediated programmed cell death.,4
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour.,4
"Nuclear accumulation of p53 protein and apoptosis induced by various anticancer agents, u.v.-irradiation and heat shock in primary normal human skin fibroblasts.",4
Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling.,4
c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells.,4
Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage.,4
Calpain inhibitor 1 activates p53-dependent apoptosis in tumor cell lines.,4
Induction of cell proliferation arrest and apoptosis in hepatoma cells through adenoviral-mediated transfer of p53 gene.,4
Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2;5) in a nude mouse model.,4
"[Radiation-induced apoptosis and p53, bcl-2 gene expression products in QGY-7703 cell line in vitro].",4
Comparative analysis of brain proteins from p53-deficient mice by two-dimensional electrophoresis.,1
P53 and IGFBP-3: apoptosis and cancer protection.,4
p53 accumulation due to down-regulation of ubiquitin: relevance for neuronal apoptosis.,4
The p53 tumor suppressor gene: from molecular biology to clinical investigation.,4
Radiation-induced apoptosis in the adult central nervous system is p53-dependent.,4
p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53.,4
Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis.,4
Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.,4
Role for p53 in the recovery of transcription and protection against apoptosis induced by ultraviolet light.,4
p53 pathway in apoptosis induced by all-trans-retinoic acid in acute myeloblastic leukaemia cells.,4
"Barrett's esophagus, apoptosis and cell cycle regulation: correlation of p53 with Bax, Bcl-2 and p21 protein expression.",4
Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma.,7
The p53-inducible gene EI24/PIG8 localizes to human chromosome 11q23 and the proximal region of mouse chromosome 9.,4
"Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis.",4
Profile of p53 expression in bladder and oral tumours. Effects of in vitro manipulations of p53 on the behaviour of established human tumour cell lines.,4
Mechanism of the combination effect of wild-type TP53 gene transfection and cisplatin treatment for ovarian cancer xenografts.,4
Essential role for caspase-8 in transcription-independent apoptosis triggered by p53.,4
New insights into p53 regulation and gene therapy for cancer.,4
Pituitary tumor transforming gene causes aneuploidy and p53-dependent and p53-independent apoptosis.,4
"The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression.",4
Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.,4
P53 null mice: damaging the hypothesis?,4
Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.,4
Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.,4
Role for the p53 homologue p73 in E2F-1-induced apoptosis.,4
Development of a p53 responsive GFP reporter; identification of live cells with p53 activity.,4
Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.,4
Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53.,4
Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines.,4
Immunocytochemical accumulation of p53 in corticotroph adenomas: relationship with heat shock proteins and apoptosis.,3
Characterization of the molecular mechanisms for p53-mediated differentiation.,4
MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells.,4
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.,4
Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells.,4
Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line.,4
Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.,4
Inhibiting effect of murine double minute-2 oncogene on apoptosis induced by retroviral-mediated wild-type p53.,4
Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis.,4
Introduction of mutant p53 into a wild-type p53-expressing glioma cell line confers sensitivity to Ad-p53-induced apoptosis.,4
Early stages of p53-induced apoptosis are reversible.,4
Reciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis.,4
"p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells.",4
A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.,4
Telomerase activity and p53-dependent apoptosis in ovarian cancer cells.,4
Functional interaction of p53 and BLM DNA helicase in apoptosis.,4
p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.,4
DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1.,4
"Tumor hypoxia, p53, and prognosis in cervical cancers.",7
p53-dependent apoptosis pathways.,4
p53 activates the mitochondrial death pathway and apoptosis of ventricular myocytes independent of de novo gene transcription.,4
The effect of methyl methanesulfonate (MMS)-induced excision repair on p53-dependent apoptosis in human lymphoid cells.,4
Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence.,3
Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosis in myeloma cell lines.,4
[Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].,4
Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.,4
Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.,4
p53 is dispensable for apoptosis but controls neurogenesis of mouse dentate gyrus cells following gamma-irradiation.,4
Induction of apoptosis in p53-deficient human hepatoma cell line by wild-type p53 gene transduction: inhibition by antioxidant.,4
APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death.,4
The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth.,4
Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis.,4
Restoration of endogenous wild-type p53 activity in a glioblastoma cell line with intrinsic temperature-sensitive p53 induces growth arrest but not apoptosis.,4
Regulation of rheumatoid synoviocyte proliferation by endogenous p53 induction.,4
hADA3 is required for p53 activity.,4
Mechanisms of p53-dependent apoptosis.,4
[Problems of radiobiology and p53 protein].,4
A potential role of p53 and WOX1 in mitochondrial apoptosis (review).,4
Activation and activities of the p53 tumour suppressor protein.,4
The heparin-binding domain and V region of fibronectin regulate apoptosis by suppression of p53 and c-myc in human primary cells.,4
p53 gene status and chemosensitivity in ovarian cancer.,4
Bax and BH3-domain-only proteins in p53-mediated apoptosis.,4
P53 and Fas are sequential mechanisms of testicular germ cell apoptosis.,4
The role of p53 and pRB in apoptosis and cancer.,4
Multiple roles of the tumor suppressor p53.,4
Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein.,3
p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.,4
Distinct apoptotic phenotypes induced by radiation and ceramide in both p53-wild-type and p53-mutated lymphoblastoid cells.,4
Tumor suppressor p53 mediates apoptotic cell death triggered by cyclosporin A.,4
Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice.,1
A link between the p53 germ line polymorphisms and white blood cells apoptosis in lung cancer patients.,4
Regulation of the mitochondrial checkpoint in p53-mediated apoptosis confers resistance to cell death.,4
Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.,4
Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas.,4
Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis.,4
Involvement of TP53 in apoptosis induced in human lymphoblastoid cells by fast neutrons.,4
"Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma.",4
P53 is necessary for the apoptotic response mediated by a transient increase of Ras activity.,4
"Expression of apoptosis-regulating proteins p53, Bcl-2, and Bax in primary resected esophageal squamous cell carcinoma.",7
Fas is involved in the p53-dependent apoptotic response to ionizing radiation in mouse testis.,4
Effect of C-terminal deletion of P53 on heat induced CD95 expression and apoptosis in a rat histiocytoma.,4
Epithelial cell cycling predicts p53 responsiveness to gamma-irradiation during post-natal mammary gland development.,4
A mutant P53 can activate apoptosis through a mechanism distinct from those induced by wild type P53.,4
The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA.,4
Regulation of apoptosis during mammary involution by the p53 tumor suppressor gene.,4
p53 leans on its siblings.,4
"Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane.",4
Induction of apoptosis by high linear energy transfer radiation: role of p531.,4
The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1).,4
The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro.,3
The ferredoxin reductase gene is regulated by the p53 family and sensitizes cells to oxidative stress-induced apoptosis.,4
The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.,4
Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.,3
Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications.,4
p53 as a therapeutic target: unresolved issues on the road to cancer therapy targeting mutant p53.,4
Switching from life to death: the Miz-ing link between Myc and p53.,4
"Gene p53 mutations, protein p53, and anti-p53 antibodies as biomarkers of cancer process.",3
p53RDL1 regulates p53-dependent apoptosis.,4
"Different contribution of apoptosis to the antiproliferative effects of diosgenin and other plant steroids, hecogenin and tigogenin, on human 1547 osteosarcoma cells.",4
p53 and apoptosis: it's not just in the nucleus anymore.,4
p53 has a direct apoptogenic role at the mitochondria.,4
Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family.,4
Oligodendrocyte injury in multiple sclerosis: a role for p53.,4
p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation.,4
Prognostic value of p53 protein expression and vascular endothelial growth factor expression in resected squamous cell carcinoma of the esophagus.,7
The phosphatase MKP1 is a transcriptional target of p53 involved in cell cycle regulation.,4
p73 can suppress the proliferation of cells that express mutant p53.,4
P53 and radiation responses.,4
Integral role of Noxa in p53-mediated apoptotic response.,4
Tumor suppressor p53 inhibits transcriptional activation of invasion gene thromboxane synthase mediated by the proto-oncogenic factor ets-1.,4
Influence of induced reactive oxygen species in p53-mediated cell fate decisions.,4
Induction of apoptosis by tumor suppressor genes and oncogenes.,4
Correlation of p53 protein expression with apoptotic incidence in colorectal neoplasia.,4
bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells.,4
"Apoptosis, cancer and the p53 tumour suppressor gene.",4
The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest.,4
Stopped for repairs.,4
Delay of dimethylbenz[a]anthracene-induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein.,4
Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus.,3
"P53, cell cycle control and apoptosis: implications for cancer.",4
Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways.,4
Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest.,4
Viability of wild type p53-containing and p53-deficient tumor cells following anticancer treatment: the use of human papillomavirus E6 to target p53.,4
The human papilloma virus 16E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage.,4
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.,4
"Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo.",4
The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival.,4
Androgen suppressed apoptosis is modified in p53 deficient mice.,4
p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis.,4
Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.,4
Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal.,4
p53 and E2F-1 cooperate to mediate apoptosis.,4
p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation.,4
Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.,4
The p53 gene and protein in human brain tumors.,4
Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.,4
Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor.,4
Cooperation between p53-dependent and p53-independent apoptotic pathways in myeloid cells.,4
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.,4
[Role of the p53 gene in apoptosis].,4
p53 involves cytosine arabinoside-induced apoptosis in cultured cerebellar granule neurons.,4
p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells.,4
"Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis.",4
Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels.,4
The role of p53 in cell cycle regulation.,4
Anti-apoptotic activity of low levels of wild-type p53.,4
The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis.,4
The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells.,4
p53 expression in CMV-infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2.,4
Radiation-induced apoptosis is not enhanced by expression of either p53 or BAX in SW626 ovarian cancer cells.,4
p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta.,4
Expression of p53 in differentiation and apoptosis and its deregulation in tumor cell.,4
Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis.,4
A role for the tumour suppressor gene p53 in regulating neuronal apoptosis.,4
p53 tumor-suppressor gene: clues to molecular carcinogenesis.,4
The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo.,4
"Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines.",4
p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.,4
Role of p53 in UVB-induced apoptosis in human HaCaT keratinocytes.,4
A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers.,4
[An overview of research on p53 tumor suppressor gene].,4
Apoptosis in the murine rd1 retinal degeneration is predominantly p53-independent.,1
p53--an acrobat in tumorigenesis.,4
The apoptotic and transcriptional transactivation activities of p53 can be dissociated.,4
Heterogeneous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection.,4
[p53 mutation and chemoresistance in oral-maxillofacial squamous cell carcinoma. Role of p53 in the cell cycle control and in the modulating action of chemotherapeutic agents].,4
p53 inhibits hypoxia-inducible factor-stimulated transcription.,3
Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells.,4
Role of a mutant p53 protein in apoptosis: characterization of a function independent of transcriptional trans-activation.,4
[Induction of apoptosis by expression of retroviral mediated wild type p53 gene in laryngocarcinoma cell line].,4
p53-dependent ceramide response to genotoxic stress.,4
The role of p53 and cell death by apoptosis and necrosis in 4-hydroperoxycyclophosphamide-induced limb malformations.,4
"DNA double-strand breaks, p53, and apoptosis during lymphomagenesis in scid/scid mice.",4
Mutant p53 protein expression interferes with p53-independent apoptotic pathways.,4
Essential role of p53 in phenethyl isothiocyanate-induced apoptosis.,4
Mechanisms of p53-mediated apoptosis.,4
Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.,4
Structures and functions of the tumor suppressor p53.,4
Post-translational modification of p53 and the integration of stress signals.,4
A question of life or death: the p53 tumor suppressor gene.,4
Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells.,4
The p53 tumour suppressor gene.,4
The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis.,4
Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.,1
Action of ethanol on responses to nicotine from cerebellar Purkinje neurons: relationship to methyllycaconitine (MLA) inhibition of nicotine responses.,1
alpha7 nicotinic receptor-mediated protection against ethanol-induced oxidative stress and cytotoxicity in PC12 cells.,1
Ethanol inhibition of nicotinic acetylcholine type alpha 7 receptors involves the amino-terminal domain of the receptor.,1
Mu opioids enhance mossy fiber synaptic transmission indirectly by reducing GABAB receptor activation.,1
The effects of general anesthetics on excitatory and inhibitory synaptic transmission in area CA1 of the rat hippocampus in vitro.,1
Astrocyte-mediated potentiation of inhibitory synaptic transmission.,1
Neurosteroid regulation of inhibitory synaptic transmission in the rat hippocampus in vitro.,1
Comparison of antagonist potencies at pre- and post-synaptic GABA(B) receptors at inhibitory synapses in the CA1 region of the rat hippocampus.,1
New perspectives in the functional role of GABA(A) channel heterogeneity.,1
Parental imprinting and Angelman syndrome.,1
Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice.,1
Interactions between GABA and glycine at inhibitory amino acid receptors on rat olfactory bulb neurons.,1
A fragment of recombinant GABA(A) receptor alpha1 subunit forming rosette-like homo-oligomers.,1
GABAA receptor mediated elevation of Ca2+ and modulation of gonadotrophin-releasing hormone action in alphaT3-1 gonadotropes.,1
GABAB receptors mediate frequency-dependent depression of excitatory potentials in rat perirhinal cortex in vitro.,1
GABA spillover activates postsynaptic GABA(B) receptors to control rhythmic hippocampal activity.,1
Somatostatin inhibits GABAergic transmission in the sensory thalamus via presynaptic receptors.,1
Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons.,1
Slow synaptic inhibition mediated by metabotropic glutamate receptor activation of GIRK channels.,1
GABA spillover from single inhibitory axons suppresses low-frequency excitatory transmission at the cerebellar glomerulus.,1
Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action.,1
Regulation of spontaneous inhibitory synaptic transmission by endogenous glutamate via non-NMDA receptors in cultured rat hippocampal neurons.,1
Isoflurane blocks synaptic plasticity in the mouse hippocampus.,1
Dominant gating governing transient GABA(A) receptor activity: a first latency and Po/o analysis.,1
Distinct signal transduction pathways for GABA-induced GABA(A) receptor down-regulation and uncoupling in neuronal culture: a role for voltage-gated calcium channels.,1
Analysis of the function of GABA(B) receptors on inhibitory afferent neurons of Purkinje cells in the cerebellar cortex of the rat.,1
Expression and distribution of metabotropic GABA receptor subtypes GABABR1 and GABABR2 during rat neocortical development.,1
GABABR1 receptor protein expression in human mesial temporal cortex: changes in temporal lobe epilepsy.,1
Differences in GABAergic transmission between two inputs into the perirhinal cortex.,1
Calcium/calmodulin-dependent kinase II phosphorylation of the GABAA receptor alpha1 subunit modulates benzodiazepine binding.,1
Furosemide reveals heterogeneous GABA(A) receptor expression at adult rat Golgi cell to granule cell synapses.,1
Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy.,1
Opposite effects of alpha 1- and beta-adrenoceptor stimulation on both glutamate- and gamma-aminobutyric acid-mediated spontaneous transmission in cultured rat hippocampal neurons.,1
"Enhanced G protein-dependent modulation of excitatory synaptic transmission in the cerebellum of the Ca2+ channel-mutant mouse, tottering.",1
Roles of inhibitory interneurons in the cerebellar cortex.,1
Molecular biology and ontogeny of gamma-aminobutyric acid (GABA) receptors in the mammalian central nervous system.,1
Long-term depression of synaptic inhibition is expressed postsynaptically in the developing auditory system.,1
"Control of synaptic strength, a novel function of Akt.",1
Pre- and postsynaptic contribution of GABAC receptors to GABAergic synaptic transmission in rat collicular slices and cultures.,1
Calcium channel involvement in GABAB receptor-mediated inhibition of GABA release in area CA1 of the rat hippocampus.,1
GABAB receptors.,1
Properties of isolated GABAB-mediated inhibitory postsynaptic currents in hippocampal pyramidal cells.,1
[Recent advances in studies of GABA receptors: neurochemical aspects].,1
Desensitized states prolong GABAA channel responses to brief agonist pulses.,1
GABAB receptor-mediated presynaptic inhibition in guinea-pig hippocampus is caused by reduction of presynaptic Ca2+ influx.,1
G protein activation kinetics and spillover of gamma-aminobutyric acid may account for differences between inhibitory responses in the hippocampus and thalamus.,1
"[The activation of GABA-B receptors, the decrease in intracellular Ca++ concentration and the inhibition of protein kinases--the possible mechanisms of prolonged posttetanic modification in the efficiency of inhibitory transmission in the neocortex].",1
In vitro development of vertebrate central synapses.,1
Postnatal maturation of gamma-aminobutyric acidA and B-mediated inhibition in the CA3 hippocampal region of the rat.,1
Selective suppression of intrinsic but not afferent fiber synaptic transmission by baclofen in the piriform (olfactory) cortex.,1
Metabotropic glutamate receptor-induced disinhibition is mediated by reduced transmission at excitatory synapses onto interneurons and inhibitory synapses onto pyramidal cells.,1
Hippocampal inhibitory interneurons are functionally disconnected from excitatory inputs by anoxia.,1
Omega-conotoxin sensitivity and presynaptic inhibition of glutamatergic sensory neurotransmission in vitro.,1
GABAB receptors modulate an omega-conotoxin-sensitive calcium current that is required for synaptic transmission in the Xenopus embryo spinal cord.,1
Temporally distinct mechanisms of use-dependent depression at inhibitory synapses in the rat hippocampus in vitro.,1
Neurotrophin 3 potentiates neuronal activity and inhibits gamma-aminobutyratergic synaptic transmission in cortical neurons.,1
Weak excitation and simultaneous inhibition induce long-term depression in hippocampal CA1 neurons.,1
Heterogeneity in presynaptic regulation of GABA release from hippocampal inhibitory neurons.,1
A physiological role for GABAB receptors and the effects of baclofen in the mammalian central nervous system.,1
High-threshold Ca2+ currents in rat hippocampal interneurones and their selective inhibition by activation of GABA(B) receptors.,1
"Activation by GABAb, reduction of the intracellular concentration of Ca++, and inhibition of protein kinases are possible mechanisms of the long-term posttetanic modification of the efficiency of inhibitory transmission in the new cortex.",1
Role of GABA receptor subtypes in inhibition of primate spinothalamic tract neurons: difference between spinal and periaqueductal gray inhibition.,1
In vitro study of afferent synaptic transmission in the rostral gustatory zone of the rat nucleus of the solitary tract.,1
GABAB receptors presynaptically modulate excitatory synaptic transmission in the rat supraoptic nucleus in vitro.,1
GABAA and GABAB receptors differentially regulate synaptic transmission in the auditory thalamo-amygdala pathway: an in vivo microiontophoretic study and a model.,1
Gamma-aminobutyric acid type B receptor-dependent burst-firing in thalamic neurons: a dynamic clamp study.,1
Brain-derived peptides inhibit synaptic transmission via presynaptic GABAB receptors in CA1 area of rat hippocampal slices.,1
Cerebral GABA receptors.,1
"Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior.",1
GABAB receptor-mediated inhibition of spontaneous inhibitory synaptic currents in rat midbrain culture.,1
"GABAergic modulation of hippocampal population activity: sequence learning, place field development, and the phase precession effect.",1
G-Protein-coupled modulation of presynaptic calcium currents and transmitter release by a GABAB receptor.,1
GABAB receptor-mediated modulation of presynaptic currents and excitatory transmission at a fast central synapse.,1
"[Gamma aminobutyric acid--its function, disorders and their sequelae].",1
Human gamma-aminobutyric acid type B receptors are differentially expressed and regulate inwardly rectifying K+ channels.,1
Neuronal discriminator formed by metabotropic gamma-aminobutyric acid receptors.,1
Glutamate and gamma-aminobutyric acid mediate a heterosynaptic depression at mossy fiber synapses in the hippocampus.,1
Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter.,3
Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome.,3
"A mechanism for selective induction of 2'-5' oligoadenylate synthetase, anti-viral state, but not MHC class I genes by interferon-beta in neurons.",1
HTLV-I-infected T cells evade the antiproliferative action of IFN-beta.,3
Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures.,3
Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response.,3
Early clearance of circulating hepatitis C virus enhanced by induction therapy with twice-a-day intravenous injection of IFN-beta.,1
Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.,3
Reovirus triggers cell type-specific proinflammatory responses dependent on the autocrine action of IFN-beta.,3
Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy.,1
Interferon activation and innate immunity.,3
High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load. IFN-beta Research Group.,1
Rapid decrease of plasma HCV RNA in early phase of twice daily administration of 3 MU doses interferon-beta in patients with genotype 1b hepatitis C infection: a multicenter randomized study.,1
Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen.,1
Gene induction pathways mediated by distinct IRFs during viral infection.,3
Interferon-beta in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10?,1
"PACT, a double-stranded RNA binding protein acts as a positive regulator for type I interferon gene induced by Newcastle disease virus.",3
Antiviral actions of interferons.,3
Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models.,1
"Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente.",3
Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells.,3
Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta.,3
"Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis.",3
Viral mediated gene transfer to sprouting blood vessels during angiogenesis.,3
Interleukin-1-mediated inhibition of cytomegalovirus replication is due to increased IFN-beta production.,3
Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection.,3
Absence of PKR attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-beta.,3
Current concepts in multiple sclerosis: Part II.,1
Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.,3
HLA-A2-restricted cytotoxic T lymphocyte activity during interferon beta therapy in patients with chronic hepatitis C.,1
"New aspects of IFN-alpha/beta signalling in immunity, oncogenesis and bone metabolism.",3
Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.,3
Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway.,3
Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta.,3
Stable antiviral expression (SAVE) as an approach to somatic cell gene therapy directed against HIV infection.,3
"Regulation of IFN-alpha/beta, MxA, 2',5'-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells.",3
Neutralization of endogenous interferon-beta increases the efficiency of adenoviral vector-mediated gene transduction.,1
Coronavirus MHV-A59 causes upregulation of interferon-beta RNA in primary glial cell cultures.,1
RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.,3
Insights into the functions of BRCA1 and BRCA2.,2
Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.,3
Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity.,2
"Expression of BRCA1, NBR1 and NBR2 genes in human breast cancer cells.",2
Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.,3
Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells.,7
Fanconi anemia and DNA repair.,3
Cooperation of HECT-domain ubiquitin ligase hHYD and DNA topoisomerase II-binding protein for DNA damage response.,3
"The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.",3
Molecular pathogenesis of fanconi anemia.,3
Highlight: BRCA1 and BRCA2 proteins in breast cancer.,2
Breast cancer and Fanconi anemia: what are the connections?,3
Control of biochemical reactions through supramolecular RING domain self-assembly.,3
Human syndromes with genomic instability and multiprotein machines that repair DNA double-strand breaks.,3
"RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer.",3
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors.,3
Degradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damage.,3
BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.,2
Nucleotides 1506-1625 of bovine papillomavirus type 1 genome can enhance DNA packaging by L1/L2 capsids.,3
Human papillomavirus vaccines.,3
"Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2.",3
Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.,3
Improvement of gene transfer to cervical cancer cell lines using non-viral agents.,3
Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.,3
Regulation of human papillomavirus late gene expression.,3
L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.,3
Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression.,3
Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.,3
Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins.,3
Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera.,3
DNA binding of L1 is required for human papillomavirus morphogenesis in vivo.,3
Assembly and translocation of papillomavirus capsid proteins.,3
Interaction of human papillomavirus type 16 L2 with cellular proteins: identification of novel nuclear body-associated proteins.,3
Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products.,3
Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor.,3
Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection.,3
Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.,3
Cell surface-binding motifs of L2 that facilitate papillomavirus infection.,3
Interactions between papillomavirus L1 and L2 capsid proteins.,3
Construction and production of fluorescent papillomavirus-like particles.,3
Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.,3
Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles.,3
Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells.,3
Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae.,3
Papillomavirus capsid binding and uptake by cells from different tissues and species.,3
Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe.,3
Sequence variation in the capsid protein genes of human papillomavirus type 16.,3
Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells.,3
Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence.,3
Early phase in the infection of cultured cells with papillomavirus virions.,3
Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles.,3
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.,3
"Synthesis, properties and applications of papillomavirus-like particles.",3
Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions.,3
"The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains.",3
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.,3
DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1.,3
A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.,1
Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2.,3
Infectious human papillomavirus type 18 pseudovirions.,3
Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells.,3
Overexpression of protein kinase C betaII induces colonic hyperproliferation and increased sensitivity to colon carcinogenesis.,3
The Yin-Yang of TCF/beta-catenin signaling.,3
Biochemical interactions in the wnt pathway.,3
The impact of developmental biology on cancer research: an overview.,3
The control of beta-catenin and TCF during embryonic development and cancer.,3
Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.,0
Wnt/beta-catenin signaling.,3
New steps in the Wnt/beta-catenin signal transduction pathway.,3
PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2.,3
A possible role for the WNT-1 pathway in oral carcinogenesis.,7
Wingless-type frizzled protein receptor signaling and its putative role in human colon cancer.,3
Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability.,0
[Role of Wnt signaling and APC protein in the etiology of colorectal cancer].,0
Drosophila Apc1 and Apc2 regulate Wingless transduction throughout development.,0
Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.,3
The ins and outs of APC and beta-catenin nuclear transport.,0
A Wnt-Wnt situation.,3
Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes.,0
Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function.,3
Signal transduction by the Wnt family of ligands.,3
Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.,3
"Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.",0
p125 is a novel mammalian Sec23p-interacting protein with structural similarity to phospholipid-modifying proteins.,3
"Determination of functional regions of p125, a novel mammalian Sec23p-interacting protein.",3
Activation of phospholipase D by the small GTPase Sar1p is required to support COPII assembly and ER export.,3
Phosphatidic acid formation by phospholipase D is required for transport from the endoplasmic reticulum to the Golgi complex.,3
Evidence that phospholipase A2 activity is required for Golgi complex and trans Golgi network membrane tubulation.,3
Retrograde protein translocation: ERADication of secretory proteins in health and disease.,3
Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis.,3
An unstable transmembrane segment in the cystic fibrosis transmembrane conductance regulator.,3
Localization of sequences within the C-terminal domain of the cystic fibrosis transmembrane conductance regulator which impact maturation and stability.,3
Expression and degradation of the cystic fibrosis transmembrane conductance regulator in Saccharomyces cerevisiae.,3
"Membrane insertion, processing, and topology of cystic fibrosis transmembrane conductance regulator (CFTR) in microsomal membranes.",3
Co- and posttranslational translocation mechanisms direct cystic fibrosis transmembrane conductance regulator N terminus transmembrane assembly.,3
"The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary.",3
Neuronal nicotinic acetylcholine receptors: a new target site of ethanol.,1
Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers.,6
Insulin and glucocorticoid-dependent suppression of the IGF-I system in diabetic wounds.,1
Differential roles of insulin receptor and insulin-like growth factor-1 receptor in differentiation of murine skin keratinocytes.,7
Role of insulin receptors and IGF receptors in growth and development.,1
Structural and functional characterization of insulin receptor substrate proteins and the molecular mechanisms of their interaction with insulin superfamily tyrosine kinase receptors and effector proteins.,7
Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.,7
Characterization of glucose transport system in keratinocytes: insulin and IGF-1 differentially affect specific transporters.,1
The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes.,1
Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors.,7
PKCdelta activation: a divergence point in the signaling of insulin and IGF-1-induced proliferation of skin keratinocytes.,7
Glucose effects on skin keratinocytes: implications for diabetes skin complications.,1
Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.,7
Insulin and IGF-1 induce different patterns of gene expression in mouse fibroblast NIH-3T3 cells: identification by cDNA microarray analysis.,7
Characterization of the receptor for insulin-like growth factor on Leishmania promastigotes.,1
Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.,7
Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.,7
"Insulin-like growth factor-related genes, receptors, and binding proteins in cultured human retinal pigment epithelial cells.",7
Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phosphorylation.,7
Evidence for a differential interaction of SHC and the insulin receptor substrate-1 (IRS-1) with the insulin-like growth factor-I (IGF-I) receptor in the yeast two-hybrid system.,3
A functional assessment of insulin/insulin-like growth factor-I hybrid receptors.,1
Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor.,7
Physiological concentrations of insulin induce cellular desensitization to the mitogenic effects of insulin-like growth factor I.,1
Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts.,1
Defective receptors for platelet-derived growth factor AA in human fibroblasts with mutant insulin receptors.,7
Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction.,7
Interaction of a GRB-IR splice variant (a human GRB10 homolog) with the insulin and insulin-like growth factor I receptors. Evidence for a role in mitogenic signaling.,3
Homozygous nonsense mutation in the insulin receptor gene of a patient with severe congenital insulin resistance: leprechaunism and the role of the insulin-like growth factor receptor.,1
The dominant negative effect of a kinase-defective insulin receptor on insulin-like growth factor-I-stimulated signaling in Rat-1 fibroblasts.,7
Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor.,7
Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.,7
The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts.,1
Insulin-like growth factor II stimulates cell proliferation through the insulin receptor.,7
A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism.,7
Insulin and interleukin-4 induce desensitization to the mitogenic effects of insulin-like growth factor-I. Pivotal role for insulin receptor substrate-2.,7
Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation.,7
The carboxyl-terminal domain of insulin-like growth factor-I receptor interacts with the insulin receptor and activates its protein tyrosine kinase.,3
"Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway.",1
Insulin receptor-deficient cells as a new tool for dissecting complex interplay in insulin and insulin-like growth factors.,1
Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.,7
Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.,3
Sensitivity of virally-driven luciferase reporter plasmids to members of the steroid/thyroid/retinoid family of nuclear receptors.,3
Synergistic activation of the Atlantic salmon hepatocyte nuclear factor (HNF) 1 promoter by the orphan nuclear receptors HNF4 and chicken ovalbumin upstream promoter transcription factor I (COUP-TFI).,3
Transcriptional control of the human aldehyde dehydrogenase 2 promoter by hepatocyte nuclear factor 4: inhibition by cyclic AMP and COUP transcription factors.,3
Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1.,3
Identification of a liver preference enhancer element of the rat hemopexin gene and its interaction with nuclear factors.,3
Regions flanking exon 1 regulate constitutive expression of the human antithrombin gene.,3
Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter.,3
Chicken ovalbumin upstream promoter transcription factors act as auxiliary cofactors for hepatocyte nuclear factor 4 and enhance hepatic gene expression.,3
Differential regulation of the pre-C and pregenomic promoters of human hepatitis B virus by members of the nuclear receptor superfamily.,3
"Functional interactions between nuclear receptors recognizing a common sequence element, the direct repeat motif spaced by one nucleotide (DR-1).",3
Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter.,3
Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development.,3
Expression of c-ret promotes morphogenesis and cell survival in mIMCD-3 cells.,3
Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF).,1
"Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse.",3
GDNF and its receptors in the regulation of the ureteric branching.,3
Abnormal RNA expression of 11p15 imprinted genes and kidney developmental genes in Wilms' tumor.,3
Cross-talk in kidney development.,3
Kidney development: regulatory molecules crucial to both mice and men.,3
GDNF and GFRalpha-1 are components of the axolotl pronephric duct guidance system.,3
Vitamin A controls epithelial/mesenchymal interactions through Ret expression.,3
Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase.,3
Genes and proteins in renal development.,3
RET receptor tyrosine kinase isoforms in kidney function and disease.,3
"Developmental expression of glial cell-line derived neurotrophic factor, neurturin, and their receptor mRNA in the rat urinary bladder.",1
Biology of congenital obstructive nephropathy.,3
GDNF promotes tubulogenesis of GFRalpha1-expressing MDCK cells by Src-mediated phosphorylation of Met receptor tyrosine kinase.,3
Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development.,3
Expression of the c-ret proto-oncogene during mouse embryogenesis.,3
Differential expression of neurotrophin receptors during renal development.,1
GDNF signalling through the Ret receptor tyrosine kinase.,3
Gene targeting in kidney development.,3
Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis.,3
The molecular basis of embryonic kidney development.,3
Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs.,1
"Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNFR-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs.",3
GDNF induces branching and increased cell proliferation in the ureter of the mouse.,3
The tip-top branching ureter.,3
Molecular development of the kidney: a review of the results of gene disruption studies.,3
Mutational analysis of the GDNF/RET-GDNFR alpha signaling complex in a kindred with vesicoureteral reflux.,3
Glial cell line-derived neurotrophic factor stimulates ureteric bud outgrowth and enhances survival of ureteric bud cells in vitro.,3
GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney.,1
GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys.,1
The RET-glial cell-derived neurotrophic factor (GDNF) pathway stimulates migration and chemoattraction of epithelial cells.,3
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.,2
[Mutations in the BRCA1 gene in young Spanish women with breast cancer].,2
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.,2
Germline BRCA1 alterations in a population-based series of ovarian cancer cases.,2
Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.,3
Systematic sequencing of the BRCA-1 coding region for germ-line mutation detection in 70 French high-risk families.,2
"Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.",7
Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.,2
Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families.,2
Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation.,2
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.,2
Three primary malignancies related to BRCA mutation successively occurring in a BRCA1 185delAG mutation carrier.,2
Effect of BRCA mutations on the length of survival in epithelial ovarian tumors.,2
Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population.,2
A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.,2
Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds.,2
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.,2
BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.,2
"Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites.",2
High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian Cancer.,2
Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis.,2
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.,2
Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families.,2
Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.,2
Is hereditary site-specific ovarian cancer a distinct genetic condition?,2
Clinical and genetic evaluation of thirty ovarian cancer families.,2
The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.,2
"BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins.",4
Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors.,2
Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.,1
Impaired synaptic plasticity in mice carrying the Huntington's disease mutation.,1
Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin.,1
Recent advances on the pathogenesis of Huntington's disease.,1
[Huntington's disease: clinical and molecular genetics].,1
Recent advances in understanding the pathogenesis of Huntington's disease.,1
Sla2p is associated with the yeast cortical actin cytoskeleton via redundant localization signals.,3
"Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.",1
Are there multiple pathways in the pathogenesis of Huntington's disease?,1
Evidence for a recruitment and sequestration mechanism in Huntington's disease.,1
Evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease in cell culture and in transgenic mice expressing mutant huntingtin.,1
Pathological mechanisms in Huntington's disease and other polyglutamine expansion diseases.,1
Tissue transglutaminase is increased in Huntington's disease brain.,1
Huntington aggregates may not predict neuronal death in Huntington's disease.,1
Huntingtin is required for normal hematopoiesis.,1
Alpha-synuclein overexpression promotes aggregation of mutant huntingtin.,1
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.,1
Recent insights into the molecular pathogenesis of Huntington disease.,1
Mice transgenic for the human Huntington's disease mutation have reduced sensitivity to kainic acid toxicity.,1
Wild-type huntingtin protects from apoptosis upstream of caspase-3.,1
Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.,1
Transcriptional dysregulation in Huntington's disease.,1
Huntingtin's WW domain partners in Huntington's disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington's disease pathogenesis.,1
[Huntington disease. A review].,1
The early cellular pathology of Huntington's disease.,1
Recent advances in Huntington's disease.,1
"Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy.",1
Identification and characterization of the miniature pig Huntington's disease gene homolog: evidence for conservation and polymorphism in the CAG triplet repeat.,1
Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?,1
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis.,1
Protein kinase C beta II mRNA levels decrease in the striatum and cortex of transgenic Huntington's disease mice.,1
Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.,1
Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration.,1
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.,1
Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.,1
HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2.,3
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.,1
Juvenile onset Huntington's disease--clinical and research perspectives.,1
"Modeling Huntington's disease in cells, flies, and mice.",1
"Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.",1
Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.,1
Expression of full-length polyglutamine-expanded Huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells.,1
Does tissue transglutaminase play a role in Huntington's disease?,1
"Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription.",1
[Huntington disease--yet another mad protein?].,1
Interaction of Huntington disease protein with transcriptional activator Sp1.,1
Lessons from animal models of Huntington's disease.,1
Mutant huntingtin aggregates do not sensitize cells to apoptotic stressors.,1
The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.,1
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.,1
Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.,1
Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions.,1
Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons.,1
Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice.,1
Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.,1
Transglutaminase cross-links in intranuclear inclusions in Huntington disease.,1
Insoluble TATA-binding protein accumulation in Huntington's disease cortex.,1
"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.",1
Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy.,1
Transcriptional abnormalities in Huntington disease.,1
Huntingtin aggregation and toxicity in Huntington's disease.,1
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.,1
Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease.,1
Neural expression of the Huntington's disease gene as a chordate evolutionary novelty.,1
Depletion of wild-type huntingtin in mouse models of neurologic diseases.,1
Histone deacetylase activity is retained in primary neurons expressing mutant huntingtin protein.,1
How does the Huntington's disease mutation damage cells?,1
Pro-apoptotic protein kinase C delta is associated with intranuclear inclusions in a transgenic model of Huntington's disease.,1
Targeted nucleotide exchange in the CAG repeat region of the human HD gene.,1
Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity.,1
Huntington disease: new insights into the relationship between CAG expansion and disease.,1
Huntington's disease: translating a CAG repeat into a pathogenic mechanism.,1
"Huntingtin-associated protein 1 (HAP1) binds to a Trio-like polypeptide, with a rac1 guanine nucleotide exchange factor domain.",1
HAP1-huntingtin interactions do not contribute to the molecular pathology in Huntington's disease transgenic mice.,1
Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways.,1
Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.,1
Isolation and characterization of the rat huntingtin promoter.,1
In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease.,1
Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition.,1
Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin.,1
Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease.,1
Identification of sonic hedgehog as a candidate gene responsible for the polydactylous mouse mutant Sasquatch.,3
Developmental pathways: Sonic hedgehog-Patched-GLI.,3
Progress toward understanding craniofacial malformations.,3
Acromelic frontonasal dysostosis.,3
Gli genes and limb development.,3
From head to toe: conservation of molecular signals regulating limb and craniofacial morphogenesis.,3
Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling.,3
Expression of ptc and gli genes in talpid3 suggests bifurcation in Shh pathway.,3
Sonic hedgehog signaling is required during the appearance of spinal cord oligodendrocyte precursors.,3
Roles for PDGF-A and sonic hedgehog in development of mesenchymal components of the hair follicle.,3
Current concepts on lung development.,3
"Sonic hedgehog (SHH) specifies muscle pattern at tissue and cellular chick level, in the chick limb bud.",3
A role for Sonic hedgehog in axon-to-astrocyte signalling in the rodent optic nerve.,3
Notochord-dependent expression of MFH1 and PAX1 cooperates to maintain the proliferation of sclerotome cells during the vertebral column development.,3
Dorsal-ventral patterning defects in the eye of BF-1-deficient mice associated with a restricted loss of shh expression.,3
Overexpression of ptc1 inhibits induction of Shh target genes and prevents normal patterning in the neural tube.,3
Differences in left-right axis pathways in mouse and chick: functions of FGF8 and SHH.,3
Constitutive activation of sonic hedgehog signaling in the chicken mutant talpid(2): Shh-independent outgrowth and polarizing activity.,3
Expression of the Sonic hedgehog (SHH ) gene during early human development and phenotypic expression of new mutations causing holoprosencephaly.,3
Vertebrate limb development and malformations.,3
The patched signaling pathway in tumorigenesis and development: lessons from animal models.,3
Functional association of retinoic acid and hedgehog signaling in Xenopus primary neurogenesis.,3
Mouse patched1 controls body size determination and limb patterning.,3
Multiple left-right asymmetry defects in Shh(-/-) mutant mice unveil a convergence of the shh and retinoic acid pathways in the control of Lefty-1.,3
"Expression of sonic hedgehog signal transducers, patched and smoothened, in human basal cell carcinoma.",3
The Shh signalling pathway in early tooth development.,3
The role of sonic hedgehog in normal and abnormal craniofacial morphogenesis.,3
Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds.,3
Molecular mechanisms of holoprosencephaly.,3
Ocular malformations and developmental genes.,3
Sonic hedgehog signaling during digit pattern duplication after application of recombinant protein and expressing cells.,3
The mutational spectrum of the sonic hedgehog gene in holoprosencephaly: SHH mutations cause a significant proportion of autosomal dominant holoprosencephaly.,3
Absence of ventral cell populations in the developing brain in a rat model of the Smith-Lemli-Opitz syndrome.,3
Inhibition of sonic hedgehog signaling in vivo results in craniofacial neural crest cell death.,3
Hedgehog signal transduction: from flies to vertebrates.,3
Skewed sex ratios in familial holoprosencephaly and in people with isolated single maxillary central incisor.,3
Actions of hedgehog proteins on skeletal cells.,3
Variable expression of Gorlin syndrome may reflect complexity of the signalling pathway.,3
New mouse models of congenital anorectal malformations.,3
Two distinct cell populations in the floor plate of the zebrafish are induced by different pathways.,3
A new function of BMP4: dual role for BMP4 in regulation of Sonic hedgehog expression in the mouse tooth germ.,3
Zebrafish wnt4b expression in the floor plate is altered in sonic hedgehog and gli-2 mutants.,3
Holoprosencephaly: molecular study of a California population.,3
Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation.,3
Alteration of the retinotectal projection map by the graft of mesencephalic floor plate or sonic hedgehog.,3
The concentric structure of the developing gut is regulated by Sonic hedgehog derived from endodermal epithelium.,3
Function for Hedgehog genes in zebrafish retinal development.,3
Sonic hedgehog signal peptide mutation in a patient with holoprosencephaly.,3
The zebrafish slow-muscle-omitted gene product is required for Hedgehog signal transduction and the development of slow muscle identity.,3
Regular articles: conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration.,3
The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched.,3
Role of cholesterol in embryonic development.,3
The bHLH transcription factor dHAND controls Sonic hedgehog expression and establishment of the zone of polarizing activity during limb development.,3
Hedgehog signals regulate multiple aspects of gastrointestinal development.,3
The Pitx2 protein in mouse development.,3
Smoothened activates Galphai-mediated signaling in frog melanophores.,3
UV-specific mutations of the human patched gene in basal cell carcinomas from normal individuals and xeroderma pigmentosum patients.,3
"Life, death and Sonic hedgehog.",3
Role of transcription factors in fetal lung development and surfactant protein gene expression.,3
Online Mendelian Inheritance in Man (OMIM) as a knowledgebase for human developmental disorders.,3
Involvement of PTCH gene in various noninflammatory cysts.,3
Genetic approaches to understanding brain development: holoprosencephaly as a model.,3
Targeted disruption of the Nkx3.1 gene in mice results in morphogenetic defects of minor salivary glands: parallels to glandular duct morphogenesis in prostate.,3
Mutations in holoprosencephaly.,3
Direct action of the nodal-related signal cyclops in induction of sonic hedgehog in the ventral midline of the CNS.,3
Effective targeted gene 'knockdown' in zebrafish.,3
Expression of Sonic hedgehog and retinal opsin genes in experimentally-induced myopic chick eyes.,3
Regulation of pancreas development by hedgehog signaling.,3
The role of cholesterol in Shh signaling and teratogen-induced holoprosencephaly.,3
Major events in the development of the forebrain.,3
Expression of Sonic Hedgehog downstream genes is modified in rat embryos exposed in utero to a distal inhibitor of cholesterol biosynthesis.,3
Sonic hedgehog is a survival factor for hypaxial muscles during mouse development.,3
Murine models of VACTERL syndrome: Role of sonic hedgehog signaling pathway.,3
The hedgehog pathway and basal cell carcinomas.,3
Induced repatterning of type XVIII collagen expression in ureter bud from kidney to lung type: association with sonic hedgehog and ectopic surfactant protein C.,3
Temporal and spatial effects of Sonic hedgehog signaling in chick eye morphogenesis.,3
The VACTERL association: lessons from the Sonic hedgehog pathway.,3
Gli2 mediation of hedgehog signals in slow muscle induction in zebrafish.,3
Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R asymmetry by the mouse node.,3
Genetic evaluation and counseling in head and neck syndromes.,3
"Brain, eye, and face defects as a result of ectopic localization of Sonic hedgehog protein in the developing rostral neural tube.",3
"Evidence for the ""midline"" hypothesis in associated defects of laterality formation and multiple midline anomalies.",3
SHH mutation is associated with solitary median maxillary central incisor: a study of 13 patients and review of the literature.,3
Manifestation of the limb prepattern: limb development in the absence of sonic hedgehog function.,3
Identification of novel mutations in SHH and ZIC2 in a South American (ECLAMC) population with holoprosencephaly.,3
Anorectal malformations caused by defects in sonic hedgehog signaling.,3
N-terminal fatty-acylation of sonic hedgehog enhances the induction of rodent ventral forebrain neurons.,3
"Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations.",3
Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L/R symmetry by the mouse node.,3
"Expression of the Sonic Hedgehog receptor ""PATCHED"" in basal cell carcinomas and odontogenic keratocysts.",3
Monstrous attempts at adnexogenesis: regulating hair follicle progenitors through Sonic hedgehog signaling.,3
Prx1 and Prx2 are upstream regulators of sonic hedgehog and control cell proliferation during mandibular arch morphogenesis.,3
Clinical aspects of disrupted Hedgehog signaling (Review).,3
Zebrafish smoothened functions in ventral neural tube specification and axon tract formation.,3
Mutations in the human homologue of the Drosophila segment polarity gene patched in oral squamous cell carcinoma cell lines.,3
Midline and laterality defects: left and right meet in the middle.,3
Unique functions of Sonic hedgehog signaling during external genitalia development.,3
Holoprosencephaly: the Maastricht experience.,3
A mouse model for medulloblastoma and basal cell nevus syndrome.,3
"vhnf1, the MODY5 and familial GCKD-associated gene, regulates regional specification of the zebrafish gut, pronephros, and hindbrain.",3
"Suppression of hair follicle development inhibits induction of sonic hedgehog, patched, and patched-2 in hair germs in mice.",3
Thyroid hormone-induced expression of sonic hedgehog correlates with adult epithelial development during remodeling of the Xenopus stomach and intestine.,3
Mutational analysis of the Sonic Hedgehog gene in 220 newborns with oral clefts in a South American (ECLAMC) population.,3
Extreme variability of expression of a Sonic Hedgehog mutation: attention difficulties and holoprosencephaly.,3
"Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly.",3
Introduction of wild-type patched gene suppresses the oncogenic potential of human squamous cell carcinoma cell lines including A431.,3
Disorders of post-squalene cholesterol biosynthesis leading to human dysmorphogenesis.,3
Hedgehog in the human: a possible explanation for the VATER association.,3
Mutations in SUFU predispose to medulloblastoma.,3
Several PATCHED1 missense mutations display activity in patched1-deficient fibroblasts.,3
GLI3 is not mutated commonly in sporadic medulloblastomas.,3
Hedgehog signaling and human disease.,3
Sonic hedgehog regulates otic capsule chondrogenesis and inner ear development in the mouse embryo.,3
Conserved expression control and shared activity between cognate T-box genes Tbx2 and Tbx3 in connection with Sonic hedgehog signaling during Xenopus eye development.,3
Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity.,3
Hedgehog signal transduction: recent findings.,3
Progression of vertebrate limb development through SHH-mediated counteraction of GLI3.,3
Comparative gene expression profile analysis of GLI and c-MYC in an epithelial model of malignant transformation.,3
Embryonic retinal gene expression in sonic-you mutant zebrafish.,3
"Mouse GLI3 regulates Fgf8 expression and apoptosis in the developing neural tube, face, and limb bud.",3
Ski is involved in transcriptional regulation by the repressor and full-length forms of Gli3.,3
"Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1.",3
Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells.,3
Unusual pattern of Sonic hedgehog expression in the polydactylous mouse mutant Hemimelic extra-toes.,3
"The mouse polydactylous mutation, luxate (lx), causes anterior shift of the anteroposterior border in the developing hindlimb bud.",3
The chick oligozeugodactyly (ozd) mutant lacks sonic hedgehog function in the limb.,3
Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients.,3
Novel mutation in sonic hedgehog in non-syndromic colobomatous microphthalmia.,3
Tbx1 is regulated by tissue-specific forkhead proteins through a common Sonic hedgehog-responsive enhancer.,3
Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development.,3
Down-regulation of sonic hedgehog expression in pulmonary hypoplasia is associated with congenital diaphragmatic hernia.,3
Previously undescribed nonsense mutation in SHH caused autosomal dominant holoprosencephaly with wide intrafamilial variability.,3
"Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung.",3
Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models.,3
Megalin and the neurodevelopmental biology of sonic hedgehog and retinol.,3
Sonic hedgehog: restricted expression and limb dysmorphologies.,3
Hedgehog signalling is required for correct anteroposterior patterning of the zebrafish otic vesicle.,3
Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy.,3
Multiple roles for Hedgehog signaling in zebrafish pituitary development.,3
Unique and conserved aspects of gut development in zebrafish.,3
Ventral axial organs regulate expression of myotomal Fgf-8 that influences rib development.,3
A novel function for Hedgehog signalling in retinal pigment epithelium differentiation.,3
Notochord anomalies in the adriamycin rat model: A morphologic and molecular basis for the VACTERL association.,3
Expression of the developmental Sonic hedgehog (Shh) signalling pathway is up-regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes.,3
Mouse models of holoprosencephaly.,3
"Doubleridge, a mouse mutant with defective compaction of the apical ectodermal ridge and normal dorsal-ventral patterning of the limb.",3
Notch activates sonic hedgehog and both are involved in the specification of dorsal midline cell-fates in Xenopus.,3
The interplay of genetic and environmental factors in craniofacial morphogenesis: holoprosencephaly and the role of cholesterol.,3
SONIC HEDGEHOG mutations causing human holoprosencephaly impair neural patterning activity.,3
SHH and FGF8 play distinct roles during development of noradrenergic neurons in the locus coeruleus of the zebrafish.,3
The amino-terminal region of Gli3 antagonizes the Shh response and acts in dorsoventral fate specification in the developing spinal cord.,3
Craniofacial anomalies: Clinical and molecular perspectives.,3
Expression of the GLI2 oncogene and its isoforms in human basal cell carcinoma.,3
Analysis of gene expression in the normal and malignant cerebellum.,3
Specific congenital heart defects in RSH/Smith-Lemli-Opitz syndrome: postulated involvement of the sonic hedgehog pathway in syndromes with postaxial polydactyly or heterotaxia.,3
Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning.,3
Gli2 is required for normal Shh signaling and oligodendrocyte development in the spinal cord.,3
"Genetic analysis of the roles of Hh, FGF8, and nodal signaling during catecholaminergic system development in the zebrafish brain.",3
"Methoprene photolytic compounds disrupt zebrafish development, producing phenocopies of mutants in the sonic hedgehog signaling pathway.",3
Spectrum of PTCH1 mutations in French patients with Gorlin syndrome.,3
Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-alpha-stimulated STAT2-independent production of IFN-gamma in the brain.,3
Defective sonic hedgehog signaling in esophageal atresia with tracheoesophageal fistula.,3
Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches.,3
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis.,3
UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis.,3
Expression of hedgehog proteins in the human thymus.,3
Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice.,3
Hedgehog signalling in the mouse requires intraflagellar transport proteins.,3
The hedgehog gene family in Drosophila and vertebrate development.,3
Vertebrate limb development.,3
Patterning activities of vertebrate hedgehog proteins in the developing eye and brain.,3
Induction of dopaminergic neuron phenotype in the midbrain by Sonic hedgehog protein.,3
Sonic hedgehog is an endodermal signal inducing Bmp-4 and Hox genes during induction and regionalization of the chick hindgut.,3
Midline signalling is required for Pax gene regulation and patterning of the eyes.,3
Expression of zebrafish nk2.2 is influenced by sonic hedgehog/vertebrate hedgehog-1 and demarcates a zone of neuronal differentiation in the embryonic forebrain.,3
Anterior duplication of the Sonic hedgehog expression pattern in the pectoral fin buds of zebrafish treated with retinoic acid.,3
A duplicated zone of polarizing activity in polydactylous mouse mutants.,3
Xenopus sonic hedgehog as a potential morphogen during embryogenesis and thyroid hormone-dependent metamorphosis.,3
Polydactylous limbs in Strong's Luxoid mice result from ectopic polarizing activity.,3
Expression of genes encoding bone morphogenetic proteins and sonic hedgehog in talpid (ta3) limb buds: their relationships in the signalling cascade involved in limb patterning.,3
Sonic hedgehog: a key mediator of anterior-posterior patterning of the limb and dorso-ventral patterning of axial embryonic structures.,3
Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes of mouse limb.,3
Mechanisms of limb patterning.,3
Sonic hedgehog and Fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud.,3
Ectopic expression of Sonic hedgehog alters dorsal-ventral patterning of somites.,3
"Roles for FGF8 in the induction, initiation, and maintenance of chick limb development.",3
The limb deformity mutation disrupts the SHH/FGF-4 feedback loop and regulation of 5' HoxD genes during limb pattern formation.,3
"Sonic hedgehog is expressed in epithelial cells during development of whisker, hair, and tooth.",3
"cAMP, an activator of protein kinase A, suppresses the expression of sonic hedgehog.",3
Conservation in hedgehog signaling: induction of a chicken patched homolog by Sonic hedgehog in the developing limb.,3
Analysis of Hox gene expression in the chick limb bud.,3
A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities.,3
Complex expression of the zp-50 pou gene in the embryonic zebrafish brain is altered by overexpression of sonic hedgehog.,3
Activation of Fgf-4 and HoxD gene expression by BMP-2 expressing cells in the developing chick limb.,3
Induction of a specific muscle cell type by a hedgehog-like protein in zebrafish.,3
Spatial regulation of a zebrafish patched homologue reflects the roles of sonic hedgehog and protein kinase A in neural tube and somite patterning.,3
Regulation of patched by sonic hedgehog in the developing neural tube.,3
"Shh, HoxD, Bmp-2, and Fgf-4 gene expression during development of the polydactylous talpid2, diplopodia1, and diplopodia4 mutant chick limb buds.",3
Inhibition of protein kinase A phenocopies ectopic expression of hedgehog in the CNS of wild-type and cyclops mutant embryos.,3
Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function.,3
Retinoic acid alters the expression of pattern-related genes in the developing rat lung.,3
Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly.,3
Mutations in the human Sonic Hedgehog gene cause holoprosencephaly.,3
Gene expression in the limbless mutant: polarized gene expression in the absence of Shh and an AER.,3
Sonic Hedgehog in feather morphogenesis: induction of mesenchymal condensation and association with cell death.,3
Expression of axial and sonic hedgehog in wildtype and midline defective zebrafish embryos.,3
Sonic hedgehog differentially regulates expression of GLI and GLI3 during limb development.,3
Sonic hedgehog regulates patterning in early embryos.,3
Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog?,3
Transcription factors in early development of the central nervous system.,3
Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development.,3
Limb deformity proteins: role in mesodermal induction of the apical ectodermal ridge.,3
Mutations affecting development of the midline and general body shape during zebrafish embryogenesis.,3
"Genetic analysis of fin formation in the zebrafish, Danio rerio.",3
The chick limbless mutation causes abnormalities in limb bud dorsal-ventral patterning: implications for the mechanism of apical ridge formation.,3
"A chick wingless mutation causes abnormality in maintenance of Fgf8 expression in the wing apical ridge, resulting in loss of the dorsoventral boundary.",3
Basal cell carcinomas in mice overexpressing sonic hedgehog.,3
Fibroblasts expressing Sonic hedgehog induce osteoblast differentiation and ectopic bone formation.,3
Evidence for genetic control of Sonic hedgehog by Gli3 in mouse limb development.,3
The role of sonic hedgehog in vertebrate development.,3
Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog.,3
Sonic hedgehog participates in craniofacial morphogenesis and is down-regulated by teratogenic doses of retinoic acid.,3
Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours.,3
Axial (HNF3beta) and retinoic acid receptors are regulators of the zebrafish sonic hedgehog promoter.,3
Sonic hedgehog promotes rod photoreceptor differentiation in mammalian retinal cells in vitro.,3
Cytogenetic rearrangements involving the loss of the Sonic Hedgehog gene at 7q36 cause holoprosencephaly.,3
Expression of Sonic hedgehog gene in regenerating newt limb blastemas recapitulates that in developing limb buds.,3
Altered neural cell fates and medulloblastoma in mouse patched mutants.,3
Evidence for the involvement of the Gli gene family in embryonic mouse lung development.,3
Mutations in the C-terminal domain of Sonic Hedgehog cause holoprosencephaly.,3
Notochord induction of zebrafish slow muscle mediated by Sonic hedgehog.,3
Left-right pattern of cardiac BMP4 may drive asymmetry of the heart in zebrafish.,3
"Relationship between dose, distance and time in Sonic Hedgehog-mediated regulation of anteroposterior polarity in the chick limb.",3
Vitronectin is expressed in the ventral region of the neural tube and promotes the differentiation of motor neurons.,3
Polydactyly and ectopic ZPA formation in Alx-4 mutant mice.,3
"Limb, genital, CNS, and facial malformations result from gene/environment-induced cholesterol deficiency: further evidence for a link to sonic hedgehog.",3
Hoxd-12 differentially affects preaxial and postaxial chondrogenic branches in the limb and regulates Sonic hedgehog in a positive feedback loop.,3
Activating Smoothened mutations in sporadic basal-cell carcinoma.,3
Expression profile of Gli family members and Shh in normal and mutant mouse limb development.,3
De novo 7q36 deletion: breakpoint analysis and types of holoprosencephaly.,3
Molecular cytogenetic analysis of patients with holoprosencephaly and structural rearrangements of 7q.,3
"Abnormalities of floor plate, notochord and somite differentiation in the loop-tail (Lp) mouse: a model of severe neural tube defects.",3
Strong variable clinical presentation in 3 patients with 7q terminal deletion.,3
Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.,3
Holoprosencephaly: from Homer to Hedgehog.,3
Diminished Sonic hedgehog signaling and lack of floor plate differentiation in Gli2 mutant mice.,3
Mutations in mouse Aristaless-like4 cause Strong's luxoid polydactyly.,3
Cloning and expression pattern of chicken Pitx2: a new component in the SHH signaling pathway controlling embryonic heart looping.,3
The Shh signalling pathway in tooth development: defects in Gli2 and Gli3 mutants.,3
Regulation of netrin-1a expression by hedgehog proteins.,3
one-eyed pinhead is required for development of the ventral midline of the zebrafish (Danio rerio) neural tube.,3
Holoprosencephaly: a paradigm for the complex genetics of brain development.,3
"Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus.",3
Sonic hedgehog is essential to foregut development.,3
Stage-specific effects of sonic hedgehog expression in the epidermis.,3
"Involvement of the sonic hedgehog, patched 1 and bmp2 genes in patterning of the zebrafish dermal fin rays.",3
Human developmental disorders and the Sonic hedgehog pathway.,3
Role of sonic hedgehog in branchiomotor neuron induction in zebrafish.,3
Sonic hedgehog signaling is essential for hair development.,3
Regionalization within the mammalian telencephalon is mediated by changes in responsiveness to Sonic Hedgehog.,3
Expression of sonic hedgehog gene in regenerating newt limbs.,3
Regionalization of Sonic hedgehog transcription along the anteroposterior axis of the mouse central nervous system is regulated by Hnf3-dependent and -independent mechanisms.,3
Essential role for Sonic hedgehog during hair follicle morphogenesis.,3
Cadherin-mediated cell adhesion and cell motility in Drosophila trachea regulated by the transcription factor Escargot.,3
Complexity of developmental control: analysis of embryonic cell lineage specification in Caenorhabditis elegans using pes-1 as an early marker.,3
Head-specific gene expression in Hydra: complexity of DNA- protein interactions at the promoter of ks1 is inversely correlated to the head activation potential.,3
The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.,1
"Solution structure of a new hypothalamic neuropeptide, human hypocretin-2/orexin-B.",1
Hypocretin (orexin) deficiency in human narcolepsy.,1
The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders.,1
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.,1
"The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding.",1
Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines.,1
The role of the hypothalamic neuropeptides hypocretin/orexin in the sleep-wake cycle.,1
[Involvement of orexins/hypocretins in multiple physiological functions].,1
Hypocretin levels in sporadic and familial cases of canine narcolepsy.,1
[Genetics of human narcolepsy].,1
"Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors.",1
The role of hypocretins (orexins) in sleep regulation and narcolepsy.,1
Hypocretin stimulates [(35)S]GTP gamma S binding in Hcrtr 2-transfected cell lines and in brain homogenate.,1
Hypocretins/orexins as integrators of physiological information: lessons from mutant animals.,1
Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602.,1
"Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background.",1
Orexins and their receptors: structural aspects and role in peripheral tissues.,1
Involvement of hypocretins/orexins in sleep disorders and narcolepsy.,1
Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.,1
The genetics of sleep disorders.,1
"Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.",1
Narcolepsy.,1
Impaired proteolytic processing of presenilin-1 in chromosome 14-linked familial Alzheimer's disease patient lymphocytes.,9
A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures.,9
Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: central roles of superoxide production and caspase activation.,1
Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice.,1
"Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes.",1
No association between the intronic presenilin 1 polymorphism and Alzheimer's disease in the Chinese population.,6
Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspases.,3
The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing.,9
Effects of presenilin N-terminal fragments on production of amyloid beta peptide and accumulation of endogenous presenilins.,9
Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes.,1
Pathogenic presenilin 1 mutations (P436S & I143F) in early-onset Alzheimer's disease in the UK. Mutations in brief no. 223. Online.,9
Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation.,1
Characterization of detergent-insoluble complexes containing the familial Alzheimer's disease-associated presenilins.,9
Missense mutation in exon 11 (Codon 378) of the presenilin-1 gene in a French family with early-onset Alzheimer's disease and transmission study by mismatch enhanced allele specific amplification. Mutations in brief no. 141. Online. besancon@rockefeller1.univ.lyon1.fr.,9
Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity.,9
A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.,9
Early-onset Alzheimer's disease caused by a novel mutation at codon 219 of the presenilin-1 gene.,9
The amyloid precursor protein of Alzheimer's disease and the Abeta peptide.,9
Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation.,9
Genes and susceptible loci of Alzheimer's disease.,9
Enhancement of amyloid beta 42 secretion by 28 different presenilin 1 mutations of familial Alzheimer's disease.,9
A Polish pedigree with Alzheimer's disease determined by a novel mutation in exon 12 of the presenilin 1 gene: clinical and molecular characterization.,9
Analysis of presenilin 1 and presenilin 2 expression and processing by newly developed monoclonal antibodies.,9
Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway.,3
Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations.,9
Implications of presenilin 1 mutations in Alzheimer's disease.,9
Biology of presenilins as causative molecules for Alzheimer disease.,9
The Alzheimer-related gene presenilin 1 facilitates notch 1 in primary mammalian neurons.,1
Future directions in the analysis of gene expression in Alzheimer disease.,5
"Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport.",3
Presenilins in their infancy.,9
Accumulation of murine amyloidbeta42 in a gene-dosage-dependent manner in PS1 'knock-in' mice.,9
Processing of wild-type and mutant familial Alzheimer's disease-associated presenilin-1 in cultured neurons.,1
Inhibition of neurite outgrowth by familial Alzheimer's disease-linked presenilin-1 mutations.,9
Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion.,9
C-terminal maturation fragments of presenilin 1 and 2 control secretion of APP alpha and A beta by human cells and are degraded by proteasome.,9
Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease.,9
No influence of presenilin1 I143T and G384A mutations on endogenous tau phosphorylation in human and mouse neuroblastoma cells.,1
A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer's disease.,9
"Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.",9
Intracellular APP processing and A beta production in Alzheimer disease.,9
A novel missense mutation (G209R) in exon 8 of the presenilin 1 gene in a Japanese family with presenile familial Alzheimer's disease. Mutation in brief no. 254. Online.,9
Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.,9
[Mutation of presenilin ++ genes and their role in pathogenesis of Alzheimer's disease].,9
Inhibition of AMPA responses by mutated presenilin 1.,1
"The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.",9
Differential effects of transforming growth factor-beta(s) and glial cell line-derived neurotrophic factor on gene expression of presenilin-1 in human post-mitotic neurons and astrocytes.,7
Aberrant presenilin-1 expression downregulates LDL receptor-related protein (LRP): is LRP central to Alzheimer's disease pathogenesis?,1
Presenilins: molecular switches between proteolysis and signal transduction.,9
Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.,6
Presenilins: structural aspects and posttranslational events.,9
No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a German population.,6
Expression of presenilin 1 mRNA in rat peripheral organs and brain.,9
Twenty-nine missense mutations linked with familial Alzheimer's disease alter the processing of presenilin 1.,9
Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons.,9
Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation.,1
"Alzheimer's disease associated presenilin 1 interacts with HC5 and ZETA, subunits of the catalytic 20S proteasome.",3
[Neuropathological findings in early-onset Alzheimer's disease (E280a-PS1 mutation)].,9
[Image characterization of Alzheimer's disease associated with the E280A-PS1 mutation. Case-control study: MRI findings].,9
DGGE method for the mutational analysis of the coding and proximal promoter regions of the Alzheimer's disease presenilin-1 gene: two novel mutations.,9
Familial Alzheimer's disease: genetic influences on the disease process (Review).,9
The presenilins in Alzheimer's disease--proteolysis holds the key.,9
Amyloidogenic function of the Alzheimer's disease-associated presenilin 1 in the absence of endoproteolysis.,9
Proteolytic processing of presenilin-1 in human lymphoblasts is not affected by the presence of the I143T and G384A mutations.,9
The L392V mutation of presenilin 1 associated with autosomal dominant early-onset Alzheimer's disease alters the secondary structure of the hydrophilic loop.,9
Mice lacking both presenilin genes exhibit early embryonic patterning defects.,9
No detected mutations in the genes for the amyloid precursor protein and presenilins 1 and 2 in a swiss early-onset Alzheimer's disease family with a dominant mode of inheritance.,9
Genetic association of the presenilin-1 regulatory region with early-onset Alzheimer's disease in a population-based sample.,9
The role of beta-catenin stability in mutant PS1-associated apoptosis.,4
[A study on mutation of exon 5 of presenilin-1 in Alzheimer's disease].,9
Polymorphisms in the presenilin 1 and presenilin 2 genes and risk for sporadic Alzheimer's disease.,6
Staurosporine-induced activation of caspase-3 is potentiated by presenilin 1 familial Alzheimer's disease mutations in human neuroglioma cells.,4
Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response.,9
Alzheimer's presenilin 1 is a putative membrane receptor for rab GDP dissociation inhibitor.,9
Altered binding of mutated presenilin with cytoskeleton-interacting proteins.,3
Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer's disease?,9
Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy.,9
The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation.,9
[Detection of antibodies to beta-amyloid in carriers of E280A mutation in the presenilin-1 gene].,9
Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.,9
The function of presenilin-1 in amyloid beta-peptide generation and brain development.,9
The physiological role of presenilins in cellular differentiation: lessons from model organisms.,9
The biological and pathological function of presenilin proteins--simple cell systems and a worm in Alzheimer's disease research.,9
Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression.,9
Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis.,4
Posttranslational modification and plasma membrane localization of the Drosophila melanogaster presenilin.,9
Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis.,1
Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms.,9
Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine.,1
[Molecular cell biology of presenilins].,9
Presenilin I expression in yeast lowers secretion of the amyloid precursor protein.,9
"Molecular interactions between presenilin and calpain: inhibition of m-calpain protease activity by presenilin-1, 2 and cleavage of presenilin-1 by m-, mu-calpain.",3
Alzheimer disease: mouse models pave the way for therapeutic opportunities.,9
Microglia and neuritic plaques in familial Alzheimer's disease induced by a new mutation of presenilin-1 gene. An ultrastructural study.,9
Molecular genetics of Alzheimer disease.,9
The nonconserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced abeta 42 production mediated by familial early onset Alzheimer's disease-linked PS variants.,9
The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta.,9
Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons.,1
A novel presenilin 1 mutation (Leu166Arg) associated with early-onset Alzheimer disease.,9
Presenilin-1 differentially facilitates endoproteolysis of the beta-amyloid precursor protein and Notch.,9
Functional phenotype in transgenic mice expressing mutant human presenilin-1.,1
Presenilins: multifunctional proteins involved in Alzheimer's disease pathology.,9
Mutant presenilin 1 increases the levels of Alzheimer amyloid beta-peptide Abeta42 in late compartments of the constitutive secretory pathway.,9
Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice.,1
Separation of presenilin function in amyloid beta-peptide generation and endoproteolysis of Notch.,9
Presenilin 1 regulates pharmacologically distinct gamma -secretase activities. Implications for the role of presenilin in gamma -secretase cleavage.,9
Presenilin-1 regulates neuronal differentiation during neurogenesis.,1
Phospholipid composition and levels are not altered in fibroblasts bearing presenilin-1 mutations.,1
Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of tau-positive neurofibrillary tangles.,9
Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?,9
Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.,9
Familial Alzheimer's disease-associated mutations block translocation of full-length presenilin 1 to the nuclear envelope.,3
[Alzheimer's disease: basic aspects].,9
"Presenilin structure, function and role in Alzheimer disease.",9
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors.,9
Cognitive decline in patients with familial Alzheimer's disease associated with E280a presenilin-1 mutation: a longitudinal study.,9
LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis.,9
Association between presenilin-1 polymorphism and maternal meiosis II errors in Down syndrome.,6
Role of presenilin in gamma-secretase cleavage of amyloid precursor protein.,9
Familial Alzheimer's disease: site of mutation influences clinical phenotype.,9
Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction.,9
Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations.,1
Notch-1 activation by familial Alzheimer's disease (FAD)-linked mutant forms of presenilin-1.,9
The presenilin 1 C92S mutation increases abeta 42 production.,9
Novel presenilin 1 mutations associated with early onset of dementia in a family with both early-onset and late-onset Alzheimer disease.,9
Presenilin affects arm/beta-catenin localization and function in Drosophila.,9
A pathogenic presenilin-1 deletion causes abberrant Abeta 42 production in the absence of congophilic amyloid plaques.,9
Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation.,9
Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation.,9
"Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.",9
[Analysis of the interaction of the polymorphisms of presenilin-1 gene and ApoE gene in Alzheimerns disease].,6
FAD mutations in presenilin-1 or amyloid precursor protein decrease the efficacy of a gamma-secretase inhibitor: evidence for direct involvement of PS1 in the gamma-secretase cleavage complex.,9
Alzheimer's disease: a dysfunction of the amyloid precursor protein(1).,9
Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest.,4
"Brain expression of presenilins in sporadic and early-onset, familial Alzheimer's disease.",9
Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression.,3
"Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation.",1
The role of Alzheimer's disease-related presenilin 1 in intercellular adhesion.,3
Detection of the presenilin 1 gene mutation (M139T) in early-onset familial Alzheimer disease in Spain.,9
Platelet APP isoform ratios in asymptomatic young adults expressing an AD-related presenilin-1 mutation.,9
Presenilin function in APP processing.,9
"Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex.",3
Intramembrane proteolysis by presenilins.,9
The role of presenilin 1 during somite segmentation.,3
Neuropsychological profiles of familial Alzheimer's disease associated with mutations in the presenilin 1 and amyloid precursor protein genes.,9
"Alzheimer's disease: genes, proteins, and therapy.",9
Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice.,1
Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments.,9
Inhibitory effect of a presenilin 1 mutation on the Wnt signalling pathway by enhancement of beta-catenin phosphorylation.,3
Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.,9
Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype.,9
The -48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased Abeta load in brain.,9
Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease.,9
Alzheimer's disease. Molecular consequences of presenilin-1 mutation.,9
Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin 1 mutation.,9
Presenilin mutations line up along transmembrane alpha-helices.,9
"Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease.",9
Presenilin function: connections to Alzheimer's disease and signal transduction.,9
[beta-amyloid cascade: current status and future directions].,9
Human wild presenilin-1 mimics the effect of the mutant presenilin-1 on the processing of Alzheimer's amyloid precursor protein in PC12D cells.,9
Endoproteolysis of the ER stress transducer ATF6 in the presence of functionally inactive presenilins.,9
Presenilin mutations and calcium signaling defects in the nervous and immune systems.,9
Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations.,9
Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations.,3
[From gene to disease; amyloid-beta precursor protein gene instrumental in hereditary cerebral amyloid angiopathies].,9
Homodimerization of presenilin N-terminal fragments is affected by mutations linked to Alzheimer's disease.,9
Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia.,9
Endoplasmic reticulum stress-induced cysteine protease activation in cortical neurons: effect of an Alzheimer's disease-linked presenilin-1 knock-in mutation.,1
Aberrant induction of Par-4 is involved in apoptosis of hippocampal neurons in presenilin-1 M146V mutant knock-in mice.,4
[Familial Alzheimer's disease connected with mutation in presenilin gene 1 (P117L)].,9
A novel presenilin mutation (M233V) causing very early onset Alzheimer's disease with Lewy bodies.,9
[From gene to disease; presenilins and Alzheimer disease].,9
Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation.,9
Cotton wool plaques in non-familial late-onset Alzheimer disease.,9
A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.,9
Akt activity in presenilin 1 wild-type and mutation transfected human SH-SY5Y neuroblastoma cells after serum deprivation and high glucose stress.,4
Association between the presenilin-1 mutation Glu318Gly and complaints of memory impairment.,9
Variable expression of presenilin 1 is not a major determinant of risk for late-onset Alzheimer's disease.,6
"Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures.",9
[Presenilins in the genesis of Alzheimer s disease].,9
Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1.,1
A novel mutation (V89L) in the presenilin 1 gene in a family with early onset Alzheimer's disease and marked behavioural disturbances.,9
Genotype and phenotype in Alzheimer's disease.,9
[Etiology and genetics of Alzheimer disease].,9
A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing.,9
Presenilin-1 protects against neuronal apoptosis caused by its interacting protein PAG.,1
New developments in animal models of Alzheimer's disease.,9
"Beta-amyloid, neuronal death and Alzheimer's disease.",9
Generation of amyloid beta protein from a presenilin-1 and betaAPP complex.,9
Molecular evidence of presenilin 1 mutation in familial early onset dementia.,9
Transgenic mice expressing the human presenilin 1 gene demonstrate enhanced hippocampal reorganization following entorhinal cortex lesions.,1
FAD-linked mutations in presenilin 1 alter the length of Abeta peptides derived from betaAPP transmembrane domain mutants.,9
[Genetic aspects of Alzheimer disease].,9
Intraneuronal advanced glycation endproducts in presenilin-1 Alzheimer's disease.,9
Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition.,9
Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.,9
F175S change and a novel polymorphism in presenilin-1 gene in late-onset familial Alzheimer's disease.,6
[Clinical characteristics of a family with early-onset Alzheimer's disease associated with a presenilin 1 mutation (M139T)].,9
Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production.,9
Presenilin 1 overexpressions in Chinese hamster ovary (CHO) cells decreases the phosphorylation of retinoblastoma protein: relevance for neurodegeneration.,7
Familial frontotemporal dementia associated with a novel presenilin-1 mutation.,9
Object recognition memory and cholinergic parameters in mice expressing human presenilin 1 transgenes.,1
Oxidative stress in synaptosomal proteins from mutant presenilin-1 knock-in mice: implications for familial Alzheimer's disease.,1
Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice.,1
A novel mutation (G217D) in the Presenilin 1 gene ( PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum.,9
No association of the -48CT polymorphism of the presenilin 1 gene with Alzheimer disease in a late-onset sporadic population.,6
Very early-onset familial Alzheimer's disease: a novel presenilin 1 mutation.,9
Presenilins are not required for A beta 42 production in the early secretory pathway.,9
Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane.,3
Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population.,9
Ca(2+) stores and capacitative Ca(2+) entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer's disease presenilin-1 mutation.,1
"Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.",9
The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease.,9
Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.,1
[Beta-amyloid protein: recent progress in basic research and therapeutic approaches].,9
Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis.,3
Alleles at the Nicastrin locus modify presenilin 1- deficiency phenotype.,9
Involvement of Gadd153 in the pathogenic action of presenilin-1 mutations.,4
Alzheimer's disease with spastic paresis and cotton wool type plaques.,9
"NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.",9
Failure of the interaction between presenilin 1 and the substrate of gamma-secretase to produce Abeta in insect cells.,9
"Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.",9
Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.,9
The presenilins.,9
Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter.,3
Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain.,9
Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein.,9
[Gene diagnosis of Alzheimer's disease and Parkinson's disease].,9
Beta-secretase (BACE) as a drug target for Alzheimer's disease.,9
Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12.,4
A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease.,9
[The mechanism of A beta production and its inhibition as a therapeutic strategy for the prevention of Alzheimer's disease].,9
Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy.,9
Differential display analysis of presenilin 1-deficient mouse brains.,9
Early onset familial Alzheimer's disease: Mutation frequency in 31 families.,9
Mice expressing human mutant presenilin-1 exhibit decreased activation of NF-kappaB p50 in hippocampal neurons after injury.,1
[Mutation site of presenilin-1 gene in familial Alzheimer's disease].,9
Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions.,9
"Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice.",1
A novel mutation (L250V) in the presenilin 1 gene in a Japanese familial Alzheimer's disease with myoclonus and generalized convulsion.,9
Homocysteine and folate deficiency sensitize oligodendrocytes to the cell death-promoting effects of a presenilin-1 mutation and amyloid beta-peptide.,1
Contribution of presenilin/gamma-secretase to calsenilin-mediated apoptosis.,4
Enhanced long-term potentiation in the hippocampus of rats expressing mutant presenillin-1 is age related.,1
"Early-onset Alzheimer's disease with presenilin-1 M139V mutation: clinical, neuropsychological and neuropathological study.",9
Presenilin 1 mutation in an african american family presenting with atypical Alzheimer dementia.,9
Neuropsychological study of familial Alzheimer's disease caused by mutation E280A in the presenilin 1 gene.,9
Molecular genetics of Alzheimer's disease: presenilin 1 gene analysis in a cohort of patients from the Poznań region.,9
[Autosomal dominant Alzheimer's disease. Study of a Moroccan family].,9
Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer's disease.,9
Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.,9
"Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view.",9
Behavioral and neurochemical characterization of transgenic mice carrying the human presenilin-1 gene with or without the leucine-to-proline mutation at codon 235.,9
Identification of new presenilin gene mutations in early-onset familial Alzheimer disease.,9
[Neuropathology of Alzheimer's disease: recent experimental aspects].,1
The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families.,9
Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.,9
"Molecular analysis of the presenilin 1 (S182) gene in ""sporadic"" cases of Alzheimer's disease: identification and characterisation of unusual splice variants.",9
Mutations of the presenilin I gene in families with early-onset Alzheimer's disease.,9
Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain.,1
Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.,9
Three different mutations of presenilin 1 gene in early-onset Alzheimer's disease families.,9
Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease.,9
A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene.,9
Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing.,9
Molecular biology of brain aging and neurodegenerative disorders.,9
Molecular basis of Alzheimer's disease.,9
Neurogenetic diseases: molecular diagnosis and therapeutic approaches.,9
The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology.,9
Presenile because of presenilin: the presenilin genes and early onset Alzheimer's disease.,9
The presenilin genes: a new gene family involved in Alzheimer disease pathology.,9
Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.,9
[Genetics of Alzheimer's disease].,9
Presenilin 1 mRNA expression in hippocampi of sporadic Alzheimer's disease patients.,9
A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years.,9
A presenilin 1 mutation in an early onset Alzheimer's family: no association with presenilin 2.,9
A further presenilin 1 mutation in the exon 8 cluster in familial Alzheimer's disease.,9
A novel mutation of presenilin 1 in familial Alzheimer's disease in Israel detected by denaturing gradient gel electrophoresis.,9
Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.,9
Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patients.,9
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.,9
The clinical phenotype of two missense mutations in the presenilin I gene in Japanese patients.,9
Familial Alzheimer's disease co-segregates with a Met146I1e substitution in presenilin-1.,9
Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation.,9
"Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer disease.",3
"[Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes].",9
"Amyloid, the presenilins and Alzheimer's disease.",9
A presenilin-1 mutation in a Japanese family with Alzheimer's disease and distinctive abnormalities on cranial MRI.,9
Presenilin-1 gene intronic polymorphism in sporadic and familial Alzheimer's disease.,9
Presenilin-1 is processed into two major cleavage products in neuronal cell lines.,9
Genes contributing to Alzheimer's disease.,9
An intronic polymorphism in the presenilin-1 gene does not influence the amount or molecular form of the amyloid beta protein deposited in Alzheimer's disease.,9
Presenilin-1 intron 8 polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease.,6
No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples.,9
Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C.,3
Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals.,4
Unraveling the molecular pathway of Alzheimer's disease: research about presenilins gathers momentum.,9
Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype.,9
Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue.,9
"T/G polymorphism at intron 9 of presenilin 1 gene is associated with, but not responsible for sporadic late-onset Alzheimer's disease in Japanese population.",6
No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease.,6
The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease.,6
Presenilin-1 protein expression in familial and sporadic Alzheimer's disease.,9
A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes.,9
Processing of presenilin 1 in brains of patients with Alzheimer's disease and controls.,9
Alzheimer's disease-associated presenilins 1 and 2: accelerated amyloid fibril formation of mutant 410 Cys-->Tyr and 141 Asn-->Ile peptides.,9
Increased A beta 42(43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene.,9
A polymorphism in the presenilin 1 gene does not modify risk for Alzheimer's disease in a cohort with sporadic early onset.,9
Presenilins and early-onset familial Alzheimer's disease.,9
Differential regulation of adenylyl cyclase in fibroblasts from sporadic and familial Alzheimer's disease cases with PS1 and APP mutations.,9
Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease.,9
Different effects of Alzheimer-associated mutations of presenilin 1 on its processing.,9
"Presenilin-1 polymorphism and hereditary cerebral hemorrhage with amyloidosis, Dutch type.",9
Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation.,9
Presenilin-1 is associated with Alzheimer's disease amyloid.,9
Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia.,6
Nerve growth factor-independent reduction in choline acetyltransferase activity in PC12 cells expressing mutant presenilin-1.,3
A novel missense mutation in the presenilin-1 gene in a familial Alzheimer's disease pedigree with abundant amyloid angiopathy.,9
The presenilins and Alzheimer's disease.,9
Presenilin 1 binds to amyloid precursor protein directly.,9
A novel pathogenic mutation (Leu262Phe) found in the presenilin 1 gene in early-onset Alzheimer's disease.,9
No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease.,6
Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.,9
Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly.,6
Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease.,9
Presenilins and Alzheimer's disease.,9
Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.,9
Proteolytic processing of presenilin-1 (PS-1) is not associated with Alzheimer's disease with or without PS-1 mutations.,9
No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies.,6
Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.,9
Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene.,9
Biology of A beta amyloid in Alzheimer's disease.,9
A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease.,9
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein.,9
Increased Abeta42(43) from cell lines expressing presenilin 1 mutations.,9
Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer's disease.,9
A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years.,9
Presenilin mutations in Alzheimer's disease.,9
Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene.,9
The presenilin 1 mutation (M146V) linked to familial Alzheimer's disease attenuates the neuronal differentiation of NTera 2 cells.,1
An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos.,9
Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Abeta1-42/43 expression.,9
Amyloid precursor protein heat shock response in lymphoblastoid cell lines bearing presenilin-1 mutations.,9
A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1.,9
"Abeta42, presenilins, and Alzheimer's disease.",9
Metabolism of presenilin 1: influence of presenilin 1 on amyloid precursor protein processing.,9
Regulation of apoptosis by presenilin 1.,4
Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease.,6
Screening for presenilin-1 gene mutations by PCR-SSCP analysis in patients with early-onset Alzheimer's disease.,9
Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene.,9
Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production.,4
Lack of association between an intronic polymorphism in the presenilin-1 gene and sporadic late-onset Alzheimer disease in Polish patients.,6
"Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells.",3
Presenilin-1 mutations associated with familial Alzheimer's disease do not disrupt protein transport from the endoplasmic reticulum to the Golgi apparatus.,9
[Mutation analysis of S182 (presenilin-I) in patients with familial Alzheimer's disease and its biological function].,9
[Biochemistry of presenilin 1].,9
"Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing.",9
Localization and possible functions of presenilins in brain.,9
Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.,9
Proteolytic processing of Alzheimer's disease associated proteins.,9
Presenilin 1 Met146Leu variant due to an A --> T transversion in an early-onset familial Alzheimer's disease pedigree from Argentina.,9
"De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group.",9
The pathogenesis of Alzheimer's disease.,9
Early-onset Alzheimer's disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139.,9
Cell-type-specific enhancement of amyloid-beta deposition in a novel presenilin-1 mutation (P117L).,9
Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein.,9
[Presenilins as a marker of Alzheimer's disease].,9
Genetic association of two chromosome 14 genes (presenilin 1 and alpha 1-antichymotrypsin) with Alzheimer's disease.,6
[Diagnosis of Alzheimer's disease].,9
Germline mutational analysis of presenilin 1 and APP genes in Jewish-Israeli individuals with familial or early-onset Alzheimer disease using denaturing gradient gel electrophoresis (DGGE).,9
Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis.,9
Monogenic determinants of familial Alzheimer's disease: presenilin-1 mutations.,9
No association of presenilin-1 intronic polymorphism and Alzheimer's disease in Australia.,6
Familial Alzheimer's disease genes in Japanese.,9
"Familial Alzheimer's disease: oxidative stress, beta-amyloid, presenilins, and cell death.",9
[Progress of the molecular genetic analysis for Alzheimer's disease].,9
Overexpression in neurons of human presenilin-1 or a presenilin-1 familial Alzheimer disease mutant does not enhance apoptosis.,4
Two novel presenilin-1 mutations (Ser169Leu and Pro436Gln) associated with very early onset Alzheimer's disease.,9
A novel Leu171Pro mutation in presenilin-1 gene in a Mexican family with early onset Alzheimer disease.,9
The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease.,9
"An overview of the etiology, diagnosis, and treatment of Alzheimer disease.",1
Lack of association of presenilin-1 intron-8 polymorphism with neuropathological features of Alzheimer's disease.,6
A pedigree with a novel presenilin 1 mutation at a residue that is not conserved in presenilin 2.,9
"Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex.",9
Heteromeric complexes of alpha 5 and/or alpha 7 subunits. Effects of calcium and potential role in nicotine-induced presynaptic facilitation.,1
Recent animal models of alcoholism.,1
Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications.,1
Neuroscience research: how has it contributed to our understanding of alcohol abuse and alcoholism? A review.,1
Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics.,1
Genetics of alcohol misuse.,1
The molecular biology of neuronal nicotinic acetylcholine receptors.,1
Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.,1
Functional characterization of a mutated chicken alpha7 nicotinic acetylcholine receptor subunit with a leucine residue inserted in transmembrane domain 2.,1
"Identification of a new amino acid residue capable of modulating agonist efficacy at the homomeric nicotinic acetylcholine receptor, alpha7.",1
Calcium channelopathies in the central nervous system.,1
Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation.,1
Abnormal intracellular ca(2+)homeostasis and disease.,1
Detection of a novel missense mutation and second recurrent mutation in the CACNA1A gene in individuals with EA-2 and FHM.,9
Disorders of membrane channels or channelopathies.,1
Inherited ion channel disorders.,1
Ion channels-related diseases.,1
Familial hemiplegic migraine: a ion channel disorder.,1
An increased expression of Ca(2+) channel alpha(1A) subunit immunoreactivity in deep cerebellar neurons of rolling mouse Nagoya.,1
The neuronal channelopathies.,1
[The molecular aspects of the functional heterogeneity of the GABA receptors].,1
An update on GABAA receptors.,1
Recent advances in GABA research.,1
Anxiety: at the intersection of genes and experience.,1
"The actions of ether, alcohol and alkane general anaesthetics on GABAA and glycine receptors and the effects of TM2 and TM3 mutations.",1
A single glycine residue at the entrance to the first membrane-spanning domain of the gamma-aminobutyric acid type A receptor beta(2) subunit affects allosteric sensitivity to GABA and anesthetics.,1
Somato-synaptic variation of GABA(A) receptors in cultured murine cerebellar granule cells: investigation of the role of the alpha6 subunit.,1
Alcohol actions on GABA(A) receptors: from protein structure to mouse behavior.,1
alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential.,1
Two different mechanisms of disinhibition produced by GABAA receptor mutations linked to epilepsy in humans.,1
Behavior and physiology of mice lacking the GABAA-receptor delta subunit.,1
Deletion of GABAA receptor alpha 1 subunit-containing receptors alters responses to ethanol and other anesthetics.,1
Biological function of GABAA/benzodiazepine receptor heterogeneity.,1
Schizophrenia and GABAA receptor subunit genes.,1
Analysis of GABAA receptor subunit genes in multiplex pedigrees with manic depression.,1
From ion currents to genomic analysis: recent advances in GABAA receptor research.,1
Structural and pharmacological aspects of the GABAA receptor: involvement in behavioral pathogenesis.,1
Candidate gene study of eight GABAA receptor subunits in panic disorder.,1
